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1 Introduction 
1.1 Oocyte development 
Mammalian oocytes originate from primordial germ cells (PGCs) that are formed during 
female embryonic development and migrate from the gut to the genital ridge (Molyneaux et 
al. 2001). In mice, the PGCs enter the genital ridge around embryonic day 11.5 where their 
numbers vastly increase through mitotic divisions (Figure 1; Tam and Snow 1981). These 
divisions continue once the cells reach the gonad, resulting in millions of gamete precursors 
that commence meiosis. At birth mammalian oocytes are arrested at prophase I at the 
diplotene stage. This stage of the first meiotic cycle is also known as germinal vesicle (GV) 
stage, based on the large nucleus that is visible in these oocytes (Lüllmann-Rauch 2003). 
 
 
Figure 1: Messenger RNA levels during oocyte growth, maturation and early embryonic development. 
During embryonic development PGCs migrate to the genital ridge, where they increase in number through 
mitotic divisions. At day 13.5 of embryonic development meisosis is initiated, which coincides with oocyte 
growth and enrichment of maternal mRNAs. At the pachytene stage of meiosis, transcription is arrested and 
maternal transcripts are stored. These stored mRNAs are recruited for protein translation during oocyte 
maturation, which is followed by their degradation. Since embryonic genome activation does not occur before 
the 2-cell stage, maternal transcripts present in the zygote regulate early preimplantation development. Figure 
adapted from Kang and Han (2011).  
 
Oocytes resume their development in a process called oocyte maturation consisting of three 
major steps: 1) resumption of meiosis, which is characterized by germinal vesicle breakdown, 
chromosome condensation and spindle formation; 2) passage from meiosis I to meiosis II; and 
3) subsequent arrest in metaphase II of the second meiotic cycle. Meiosis I resumes as a 
response to the surge of luteinizing hormone (LH) prior to ovulation, which leads to the 
separation of the homologues chromosomes and the expulsion of the first polar body. 
 Introduction 
9 
 
Completion of meiosis II is triggered by fertilization and leads to division of the sister 
chromatids and extrusion of the second polar body (Lüllmann-Rauch 2003).  
Fertilization is followed by the first cleavage stages of embryonic development (Figure 1). 
During this time, the embryo migrates from the oviduct to the uterus, which it reaches at the 
blastocyst stage ready for implantation. The first embryonic cell divisions still depend largely 
on maternal factors that are stored and recruited by the oocyte during growth and maturation 
(Figure 1; Li et al. 2013). Therefore, the developmental competence of the oocyte is of crucial 
importance for embryonic development and reproductive outcome and, amongst others, 
defined by these maternal factors that regulate the preimplantation phase.  
1.2 Preovulatory aging 
Since oocyte growth, maturation, fertilization and preimplantation development are tightly 
coordinated processes that depend on many highly regulated factors, disturbances of these 
processes may severely impact the developmental competence of the oocyte. Deregulation of 
the timely development of the oocytes is an example of such a disturbance. For instance, 
delay in ovulation or fertilization cause oocyte overripeness, also known as pre- and 
postovulatory aging. These deregulations have been postulated long ago as causative for a 
significant amount of birth defects in humans (Butcher 1976). The present study focused 
mainly on the effects of preovulatory aging on oocyte developmental competence since much 
less is known about this form of oocyte overripeness.  
Delayed ovulation can happen naturally in animals and humans due to an irregular menstrual 
cycle. In women this can occur during the whole reproductive life span, but is more frequent 
in certain phases, such as the first postmenarchal years, the last premenopausal years and the 
first months following pregnancy (Smits et al. 1995). Prolonged menstrual cycles correlate 
with an increased incidence in congenital malformations in women (Spira et al. 1985). 
Preovulatory aging can also arise in the course of assisted reproduction techniques (ART), 
which is getting increasingly important since more and more children are born this way 
(Kupka et al. 2014). Over 5 million babies worldwide have been born after ART treatment 
since the birth of the first in vitro fertilization (IVF) baby, Louise Brown, in 1978. Prolonged 
hormonal treatment prior to superovulation is avoided during ART, since it coincides with a 
lower number of oocytes. Due to ethical reasons the sparse knowledge about the effects of 
preovulatory aging in humans has been gathered through indirect evidence (Smits et al. 1995). 
Therefore, animal models are essential for understanding the consequences of preovulatory 
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oocyte overripeness on the developmental capacity of the oocyte and the embryo that derives 
from it.  
Preovulatory aging in vivo has been studied in several different animal species and was 
shown to decrease the developmental competence of the oocyte and impair embryonic and 
fetal development in e.g. fish, frogs, urodeles and guinea pigs. In rats an induced delay of 
ovulation for 24-48 hours (h) decreased the fertilization rate of the aged oocytes and led to 
chromosome aberrations, abnormal development of the preimplantation embryo, implantation 
failure, fetal malformations and high mortality rates (Smits et al. 1995). Hardly anything is 
known about the molecular processes in the oocyte during preovulatory aging that cause the 
decreased oocyte quality. In rats induced preovulatory aging is known to alter the cell 
organization and RNA transcription of the oocyte as well as the hormonal levels of the 
animals. Natural preovulatory aging, defined by spontaneously delayed cycles, has been 
described to cause cytoplasmic degeneration in the oocyte and to lead to increased 
implantation failure and embryonic malformations in rats (Smits et al. 1995). Recently an in 
vivo mouse model has been established to investigate the consequences of preovulatory aging 
in more detail (Bittner et al. 2011).  
1.2.1 In vivo mouse model for preovulatory aging 
The in vivo mouse model that was used in this study was established by Bittner and 
colleagues (2011). It is based on the gonadotropin releasing hormone (GnRH) antagonist 
cetrorelix that also finds broad application in human ART (Al-Inany 2007; Al-Inany et al. 
2011). GnRH is secreted by the hypothalamus and stimulates the pituitary to produce follicle 
stimulating hormone (FSH) and LH (Lüllmann-Rauch 2003). FSH in turn, induces the 
secretion of aromatase by the granulosa cells which mediates the modulation of androgens 
into estrogens in the ovary. It stimulates follicle growth and ripening. LH is responsible for 
inducing ovulation (Lüllmann-Rauch 2003). By blocking GnRH, cetrorelix suppresses the 
whole intrinsic sex-hormonal axis and allows regulating follicle ripening and ovulation by 
external application of hormones. This way ovulation can be postponed inducing preovulatory 
aging of oocytes (see Figure 4 for detailed hormone application scheme).  
It was shown with this mouse model that preovulatory aging leads to an increase in embryo 
resorption after implantation and a decreased embryonic weight (Bittner et al. 2011). This 
indicates that preovulatory aging in this mouse model impairs oocyte quality and interferes 
with embryo development. The preovulatory-aged oocytes that derive from these cetrorelix-
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treated mice have not been analyzed on a molecular level so far; neither have the processes of 
fertilization and preimplantation development. That is why the present study focused on the 
investigation of molecular mechanisms in preovulatory in vivo-aged oocytes and embryos 
that derived from these oocytes. 
1.2.2 Preovulatory aging in a follicle culture model 
Another possible setting to investigate the molecular consequences of preovulatory aging is in 
vitro in a follicle culture model. The importance of growth and maturation in follicle culture is 
increasing, for instance in the context of cryopreservation or as experimental model 
(Cortvrindt and Smitz 2002; Sun et al. 2004; Chian et al. 2013). Cryopreservation of oocytes, 
also known as vitrification, is the most commonly used method for fertility preservation in 
women. In the case of cancer patients it is not always possible to collect mature oocytes after 
hormonal treatment for vitrification. In these cases, unstimulated ovarian tissue or immature 
oocytes from this tissue can be preserved and maturated in vitro (Chian et al. 2013). In vitro 
culture allows a strict control of the environment in which the follicles develop and can 
therefore serve as a suitable experimental model to investigate the impact of adverse 
exposures, altered follicle environment or prolonged follicle culture time (Cortvrindt and 
Smitz 2002; Sun et al. 2004). The fertilization rate as well as the developmental competence 
of preovulatory-aged oocytes to the blastocyst stage is known to be reduced when prolonging 
the culture period (Segers et al. 2010). Not much is known though about the molecular 
mechanisms, such as RNA dynamics, in preovulatory-aged in vitro-grown oocytes.  
1.3 Postovulatory aging 
Another form of oocyte overripeness can result from postovulatory aging caused by a delay in 
fertilization. Early research on pre- and postovulatory aging of mammalian oocytes found 
similarities between the two mechanisms of timely interference of oocyte development 
leading to the hypothesis that similar pathogeneses might apply (Smits et al. 1995). In contrast 
to preovulatory aging, delayed fertilization has been studied much more intensely and it is 
known to have detrimental effects on molecular processes in the oocyte, impairing 
fertilization and embryonic development (Lord and Aitken 2013). For example, one important 
cause for the reduced oocyte quality after postovulatory aging is oxidative stress caused by 
accumulation of electrophilic aldehydes. This sets off many cascades that influence oocyte 
developmental competence, like mitochondrial dysfunction, DNA damage, DNA methylation 
defects and perturbed Ca2+ homeostasis, eventually leading to apoptosis (Chi et al. 1988; 
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Liang et al. 2008; Miao et al. 2009; Zhang et al. 2011; Lord et al. 2015). It has been shown for 
Xenopus tropicalis that also disturbances in posttranscriptional regulation of transcripts such 
as degradation of maternal mRNA or loss of poly(A) tail length might decrease the 
developmental potential of the oocyte and lead to a decline in fertilization rates and aberrant 
embryonic development (Kosubek et al. 2010). To investigate if effects on posttranscriptional 
regulation can also be found in mammals, the current study analyzed poly(A) tail dynamics in 
the postovulatory-aged mouse oocyte on a transcriptome-wide level.  
1.4 Epigenetic histone modifications in the growing oocyte 
Around midgrowth in prophase I, transcription declines progressively until it is nearly halted, 
such that full-grown oocytes are essentially transcriptionally quiescent (Moore and Lintern-
Moore 1978). Transcriptional silencing of the oocyte genome is mediated by epigenetic 
histone modifications and DNA methylation. Genomic DNA in eukaryotes is folded around 
histones and other proteins to form chromatin. Histones are small proteins that consist of a 
globular domain and a flexible and charged NH2-terminus, the histone tail that obtrudes from 
the nucleosome. Epigenetic modifications such as methylation, acetylation and 
phosphorylation of amino acids in this histone tail determine the functional characteristics of 
the chromatin (Jenuwein and Allis 2001). The structural organization of chromatin can be 
divided into two major categories: euchromatin and heterochromatin. Euchromatin is less 
condensed and it is therefore generally thought to be easier accessible and transcribed. 
Heterochromatin is highly condensed, inaccessible and is well known to function in gene 
silencing and repression of recombination, although there is evidence for a multifaceted role 
of heterochromatin in both transcriptional repression as well as activation of target loci (Li 
2002; Grewal and Jia 2007). Euchromatin is typically characterized by a histone-modification 
profile that includes histone acetylation and methylation of histone H3 at lysine 4 (H3K4me), 
whereas heterochromatin is marked by hypoacetylation and trimethylation of histone H3 at 
lysine 9 and 27 (H3K9me3 and H3K27me3; Grewal and Jia 2007). 
Histone modifications can influence transcription of DNA directly. For example, H3K9me3 
prohibits binding of transcription factors to the DNA, by making DNA binding domains 
inaccessible to them (Soufi et al. 2012). On a longer term, histone modifications can also 
organize DNA methylation levels, by recruiting or inhibiting binding of DNA 
methyltransferases (Cedar and Bergman 2009). For instance, H3K4 interacts with the DNA 
methyltransferase Dnmt3a and its regulatory factor Dnmt3l, inducing DNA methylation (Jia 
et al. 2007). Methylation of H3K4 at CpG islands inhibits the binding of Dnmt3l, therefore 
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repressing DNA methylation at these sites (Ooi et al. 2007). During oogenesis histone 
modifications and DNA methylation change, establishing the epigenetic landscape of the 
oocyte. For example, H3K4 di- and trimethylation increases, which is followed by inhibition 
of DNA methylation in these regions (Stewart et al. 2015). In contrast, H3K36 trimethylation 
is a marker for sites in the genome that will be methylated on DNA in the course of oocyte 
growth (Stewart et al. 2015). 
H3K9me3 has long been thought to be involved in silencing repetitive sequences, such as 
tandem-repeat satellites near centromeres and telomeres, retrotransposons and endogenous 
retroviruses (Becker et al. 2016). When active, these regions pose a risk for the genome 
integrity, which is why it is important to keep them physically inaccessible by packing them 
in condensed heterochromatin. These regions are classified as constitutive heterochromatin 
and they are silenced universally in all tissues (Saksouk et al. 2015). In contrast, facultative 
heterochromatin is dynamically regulated during development and tissue specific. It affects 
cell-type specific genes and enhancers (Trojer and Reinberg 2007). More recent genome-wide 
mapping studies suggested a role of H3K9me3 in cell type specific regulation of facultative 
heterochromatin during development and differentiation (Vogel et al. 2006; O'Geen et al. 
2007; Hawkins et al. 2010; Zhu et al. 2013). For example, during human embryonic 
development H3K9me3 mediates the differentiation from pluripotent stem cells to 
differentiated cells by blocking access to pluripotent transcription factors such as Oct4 and 
Sox2 (Soufi et al. 2012). H3K9 trimethylation is nearly absent at the time of oogenesis that 
takes place during early postnatal development from day 5 until day 15. Then it increases 
prominently in the GV stage of oocyte maturation and is thought to function in the silencing 
of the oocyte genome at this stage (Kageyama et al. 2007).  
At the pericentric regions of heterochromatin H3K9 is methylated through the selective 
histone methyltransferase Suv39h1 and Suv39h2, creating a binding site for the chromatin 
modulator HP1 (Bannister et al. 2001; Lachner et al. 2001). HP1 is a member of the highly 
conserved chromodomain protein family and involved in gene silencing and genome 
organization (Jones et al. 2000). The Suv39h histone methyltransferases are required in mice 
for normal pre- and postnatal development (Peters et al. 2001). Loss of Suv39h leads to 
growth retardation and infertility. H3K9 methylation is dependent on Suv39h and protects 
genomic stability at the pericentric regions of constitutive heterochromatin. Suv39h is also 
required for H3K9 methylation during male meiosis, since impairments lead to aberrant 
centromere clustering and nonhomologous interactions (Peters et al. 2001). It is likely that 
Suv39h mediated H3K9 methylation is also important for female meiosis. Other H3K9 
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methyltransferases are Eset, EuHmt1 and G9a (Li 2002). Whereas Suv39h is required for 
H3K9me in pericentric heterochromatin, G9a methylates histone H3K9 in euchromatin 
regions. G9a and Suv39h have distinct, non-overlapping regions of the chromosomes to 
which they localize, which indicates different functions in chromatin organization for the two 
proteins, but also for H3K9 methylation depending on whether it is associated with 
euchromatin or heterochromatin (Tachibana et al. 2002). Like Suv39h, G9a is indispensible 
for postimplantation embryonic development (Tachibana et al. 2002). If G9a also functions in 
oocytes and preimplantation embryos is unknown. 
1.5 Posttranscriptional regulation of protein synthesis in the oocyte 
Oocyte volume increases 200- to 300-fold during oocyte growth. In this time, the oocyte 
accumulates a vast amount of RNA in the cytoplasm (Figure 1) resulting in a fully grown 
oocyte containing approximately 80 pg of mRNA and 350-500 pg of total RNA (Bachvarova 
et al. 1985). After accumulation of RNA, transcription is arrested until the time point of 
embryonic genome activation. Following transcriptional silencing meiosis is accompanied 
with a slow but steady decrease of maternal mRNA levels, which accelerates after fertilization 
during the oocyte-to-embryo transition (Figure 1). In between, the stored transcripts are 
needed to regulate the processes of oocyte maturation, fertilization or oocyte-to-embryo 
transition. They are essential for oocyte survival and recruited for translation in a time-
dependent manner (Kang and Han 2011).  
Due to the absence of transcription, synthesis of proteins during oocyte growth and 
maturation has to be regulated almost exclusively on a posttranscriptional level. RNA storage 
and protein synthesis are closely regulated. One important and well-studied mechanism of 
RNA storage and translation in the oocyte is modification of the poly(A) tail length (Weill et 
al. 2012). It is known that postovulatory aging reduces the transcript levels and poly(A) tail 
length in Xenopus oocytes, which might be a cause for the reduced developmental 
competence that is observed in oocytes with delayed fertilization (Kosubek et al. 2010). But 
also subcellular localization and factors like Musashi1, Dazl and Y-box proteins (e.g. Ybx2) 
regulate storage and translation of transcripts (Molyneaux et al. 2001; Flemr et al. 2010; 
Yurttas et al. 2010; Chen et al. 2011). If preovulatory aging also affects transcript storage has 
not been studied so far.  
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1.5.1 Ybx2-mediated mRNA storage and recruitment 
Ybx2 (Y-box protein 2; formerly known as Msy2) is a germ cell specific RNA binding 
protein that belongs to the family of the Y-box proteins (Gu et al. 1998). Y-box proteins form 
a large family that is conserved from bacteria to humans (Yu et al. 2002). Ybx2 for example, 
is the mouse ortholog of the X. laevis FRGY2 and human CONTRTIN proteins (Matsumoto 
and Wolffe 1998; Tekur et al. 1999). It is one of the most abundant proteins in growing 
oocytes, constituting approximately 2% of total protein in the cell (Yu et al. 2002). It has a 
major role in regulating mRNA stability and repressing protein translation during oocyte 
growth (Yu et al. 2002). Considering the importance, it is not surprising that loss of Ybx2 was 
found to lead to infertility in mice (Yang et al. 2005). The growth rate of oocytes lacking 
Ybx2 is reduced, leading to improper maturation. Furthermore, oocytes fail to become 
transcriptional quiescent, show transcript and poly(A) tail instability, spindle malformations, 
deficiencies in chromosome arrangement and a dramatic perturbation of the transcriptome in 
absence of Ybx2 expression (Medvedev et al. 2011).  
1.5.2 Poly(A) tail dynamics 
In eukaryotic cells, DNA is transcribed into pre-mRNA which has to be modified in the 
nucleus after transcription. First introns are spliced out, then an m7Gppp group is attached to 
the 5’ end (the cap structure) of the mRNA and finally a poly(A) tail of approximately 
250-300 adenosine residues is added to the 3’ end (Piccioni et al. 2005). After transportation 
of the mRNA into the cytoplasm, the 5’ cap and the 3’ poly(A) tail facilitate the initiation of 
translation, the rate-limiting step of protein translation (Figure 2A; Sachs 2000; Preiss and 
Hentze 2003). The 5’ cap binds the eukaryotic translation initiation factor eIF4E, which in 
turn binds the scaffolding protein eIF4G (Sonenberg et al. 1978; 1979; Lamphear et al. 1995; 
Mader et al. 1995). The poly(A) binding protein (PABP) binds to the 3’end and associates to 
eIF4G (Tarun and Sachs 1995; 1996). Together, these interactions form a platform for the 
recruitment of several other eIFs including the RNA helicase eIF4A, which in the end leads to 
the formation of the eIF4F complex and a closed-loop formation of the mRNA (Figure 2A; 
Wells et al. 1998; Preiss and Hentze 2003). This pseudo-circularization of the mRNA 
stabilizes the eIF4F complex. At last, the eIF4F complex recruits the ribosome subunits and 
the initiation of translation is completed (Preiss and Hentze 2003).  
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Figure 2: The role of the poly(A) tail during initiation of translation (A) and the process of cytoplasmic 
polyadenylation through CPEB1 phosphorylation (B). A) The poly(A) tail is bound by PABPs, which interact 
with eIF4G, the scaffolding protein of the eIF4F complex that induces the initiation of translation. This leads to a 
closed-loop formation of the mRNA, enhancing translation efficiency. Motifs in the 3’UTR, such as CPE and 
PA, promote cytoplasmic polyadenylation and therefore translation. B) CPEB1 binds to CPEs and interacts with 
the scaffolding protein Symplekin that is also associated with CPSF-bound PAs. When CPEB1 is 
phosphorylated it recruits the poly(A) polymerase GLD-2, which elongates the poly(A) tail. However, without 
its phosphorylation mark, CPEB1 attracts the poly(A) deadenylase PARN that blocks GLD-2 and shortens the 
poly(A) tail, giving this protein a dual function in the regulation of poly(A) tail length. Figure adapted from 
Weill et al. 2012.  
 
Translation efficiency is known to depend on the poly(A) tail length although a recent study 
found that this correlation can only be found in certain tissues or cells such as oocytes and 
early embryos (Beilharz and Preiss 2007; Subtelny et al. 2014). The oocyte seems to be a very 
special in regard to poly(A) tail dynamics. In most tissues mRNA turnover in the cytoplasm 
starts with the degradation of the poly(A) tail inducing a pathway that leads to translation 
followed by degradation of the transcript (Parker and Song 2004). In contrast, oocytes have 
the possibility to protect certain transcripts after deadenylation. This allows them to store 
mRNAs in a dormant state until they are needed. They are recruited for translation by 
elongating their poly(A) tail again through a process known as cytoplasmic polyadenylation. 
The best studied mechanism of cytoplasmic de- and polyadenylation in the oocyte is mediated 
by the cytoplasmic polyadenylation element binding protein 1 (CPEB1; Figure 2B; Richter 
2007; Weill et al. 2012). This process depends on two elements in the 3’ untranslated region 
(UTR) of the mRNA: 1) a polyadenylation site (PA), which is also required for nuclear 
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polyadenylation and found in all mRNAs and 2) a cytoplasmic polyadenylation element 
(CPE; McGrew et al. 1989; Paris and Richter 1990; Gebauer et al. 1994). CPEs can only be 
found in certain transcripts (15-20% of the vertebrate genome) and are recognized by CPEB1 
(Paris et al. 1991; Hake and Richter 1994; Pique et al. 2008).  
CPEB1 has a dual function in mediating poly(A) tail length of maternal transcripts during 
oogenesis depending on its phosphorylation status (Kim and Richter 2006). Non-
phosphorylated CPEB1 bound to a CPE recruits a ribonucleoprotein complex containing the 
poly(A) deadenylase PARN, which deadenylates the transcripts and leads to the repression of 
maternal mRNAs. Phosphorylation of CPEB1 causes expulsion of PARN from this complex 
(Kim and Richter 2006). Through the scaffolding protein Symplekin phosphorylated CPEB1 
can interact with the cleavage and polyadenylation specific factor (CPFS) that binds to the PA 
(Dickson et al. 1999; Barnard et al. 2004). Together CPEB1 and CPSF recruit the cytoplasmic 
poly(A) polymerase GLD-2 to elongate the poly(A) tail and promote translation of the 
transcript (Figure 2B; Barnard et al. 2004).  
It is known that transcript levels are reduced after postovulatory aging. It was shown in 
Xenopus that this coincides with deadenylation of certain maternal transcripts which contain a 
CPE and PA in their 3’UTR (Kosubek et al. 2010). If this also applies to mammalian oocytes 
and whether the poly(A) tail length is also affected by preovulatory aging has not been studied 
so far.  
1.6 Oocyte-to-embryo transition 
The process of oocyte-to-embryo transition describes the conversion of a fully grown, highly 
specialized and almost transcriptionally quiescent oocyte into a developmentally active and 
mitotically dividing embryo (Robertson and Lin 2013). This process starts with oocyte 
maturation and includes fertilization, embryonic genome activation and the transition from 
maternal-to-zygotic control.  
1.6.1 Maternal effect genes 
The oocyte-to-embryo transition is mainly regulated by maternal effect (ME) genes. These are 
genes are expressed by the oocyte but function in the early embryo. Some ME genes are 
exclusive to the oocyte and function during the oocyte-to-embryo transition, while others are 
needed later during embryo development and are expressed by both the oocyte and the 
embryo. This makes it difficult to distinguish between maternal and embryonic defects. ME 
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genes have three major roles: 1) processing of the paternal genome, 2) removal of maternal 
factors and 3) the activation of the embryonic genome (Li et al. 2010). Defects in ME genes 
usually lead to developmental impairments and embryonic arrest during early preimplantation 
stages (Acevedo and Smith 2005). The present study investigated a selection of the over 30 
described ME genes (Li et al. 2010), focusing mainly on genes involved in early embryonic 
genetic processes, e.g. RNA dynamics (Zar1), embryonic genome activation (Smarca4) and 
epigenetic reprogramming (Tet3, Trim28, Zfp57, Dnmt1). Furthermore, the transcription 
factor Pou5f1 as well as members of the Nlrp gene family were analyzed.  
Zar1 (Zygotic arrest 1) is an example of an ME gene that is involved in the very early 
processes after fertilization, probably in syngamy of the pronuclei. It is essential for 
development past the 1-cell stage (Wu et al. 2003). Studies in Xenopus indicate that Zar1 
encodes an RNA-binding protein involved in posttranscriptional regulation in the oocyte. It 
binds to the translational control region in the 3’UTR of maternal mRNAs, leading to their 
translational repression (Yamamoto et al. 2013).  
One very crucial ME gene seems to be Pou5f1 (encoding the Oct4 protein), which is better 
known as a marker for pluripotent stem cells during early embryonic development (Pesce et 
al. 1998; Foygel et al. 2008). During oocyte growth Pou5f1 is first down regulated during 
early oogenesis, to be up regulated de novo in the final stages of meiotic prophase I (Pesce et 
al. 1998). Pou5f1 plays a critical role by controlling the expression of many transcription 
regulators involved in embryonic genome activation, maternal RNA degradation and 
reprogramming processes (Foygel et al. 2008). This Pou5f1-regulated transcriptional network 
in the oocyte consists of 182 genes (Zuccotti et al. 2011). Within this network there is a core 
group of 80 ME genes, which escape post-fertilization degradation and which are involved in 
oocyte-to-embryo transition (Zuccotti et al. 2011). It has been proposed that Pou5f1 can 
directly or indirectly affect many essential processes such as chromatin remodeling, 
epigenetic regulation, apoptosis, cell cycle regulation and signaling during early 
developmental reprogramming (Foygel et al. 2008; Zuccotti et al. 2011).  
Several members of the Nlrp gene family have been found to be ME genes. Nlrp (also known 
as Nalp) stands for nucleotide-binding oligomerization domain, leucine rich repeat and pyrin 
domain containing gene and the Nlrp genes are members of the Nlr (Nod-like receptor) gene 
family. Nlrps were previously found to be involved in the innate immune system of mammals 
but recently they have been discovered to play a role in reproduction (Zhang et al. 2008; Tian 
et al. 2009). In mice Nlrp2, 4, 5, 9 and 14, all situated on chromosome 11, are known to be 
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involved in reproduction. Their exact functions as well as the mechanisms in which they act 
are mainly unknown. Nlrp2 and Nlrp14 are both oocyte specific ME genes required for proper 
embryonic preimplantation development (Horikawa et al. 2005; Peng et al. 2012). Nlrp5 (also 
known as Mater) is an oocyte specific gene and was one of the first described ME genes 
(Tong et al. 2000). Nlrp5 protein is part of the subcortical maternal complex (SCMC), where 
it interacts with other proteins such as Filia, Floped and Tle6 (Li et al. 2008a). The SCMC is 
known to be essential for preimplantation development and required for symmetric division of 
the zygote (Li et al. 2008a; Yu et al. 2014). Nlrp5 is known to function in mitochondria 
localization and activity and distribution of the endoplasmatic reticulum and calcium 
homeostasis. Nlrp4 and 9 are also oocyte specific genes and are expansive in rodents, having 
7 and 3 copies respectively (Tian et al. 2009). Their function in early embryonic development 
remains unknown. Therefore, and because Nlrp4 and 9 are difficult to assess due to the many 
isoforms that exist, the focus in this study lay on the remaining Nlrp genes known to be 
involved in mouse reproduction (Nlrp2, 5 and 14).  
To release the genome from its repressive state and initiating transcription maternal factors 
are required. Smarca4 (SWI/SNF related, matrix associated, actin dependent regulator of 
chromatin, subfamily a, member 4, also known as Brg1) is an ME gene involved in chromatin 
remodeling and required for development past the 2-cell stage (Bultman et al. 2006). Smarca4 
protein is the catalytic subunit of SWI/SNF-related complexes and has a DNA-dependent 
ATPase activity. The energy derived from ATP hydrolysis alters the conformation and 
position of nucleosomes, causing DNA-histone contacts to break and histone octamers to 
slide several hundred base pairs upstream or downstream (Bazett-Jones et al. 1999; Kingston 
and Narlikar 1999; Whitehouse et al. 1999). This chromatin remodeling then in turn makes 
promoters accessible for transcription initiation by inducing H3K9 demethylation. Smarca4 is 
known to regulate the expression of 30% of the genes expressed at the 2-cell stage, of which 
most are involved in transcription, RNA processing and cell cycle regulation (Bultman et al. 
2006).   
Other ME genes investigated in this study are Tet3, Trim28, Zfp57 and Dnmt1. They will be 
described later, in the context of epigenetic reprogramming and DNA methylation 
maintenance of genomic imprints.  
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1.6.2 Embryonic genome activation 
Embryonic genome activation is the first major step to occur after fertilization, in which 
control of the developmental program switches from regulation by maternally inherited 
mRNAs and proteins to regulation by embryonic genes. The parental genomes that were 
repressed during germ cell growth and maturation have to be reactivated, which involves 
epigenetic reprogramming. In the course of embryonic genome activation maternal factors 
have to be degraded and replaced by embryonic factors. Also extensive reprogramming has to 
take place since the transition from a highly specialized oocyte and sperm to totipotent 
blastomers requires a large-scale change of the gene expression pattern (Schultz 2002).  
In mice transcription is activated in several waves. The first major step occurs around the 2-
cell stage (Schultz 1993; Hamatani et al. 2004; Wang et al. 2004). In comparison, in other 
vertebrate species the embryonic genome activation is later, e.g. at the 4- to 8-cell stage in 
other mammals like ovine, bovine, porcine and human embryos or after 12 rounds of DNA 
replication at the mid-blastula stage in Xenopus (Newport and Kirschner 1982; Telford et al. 
1990). The first minor wave of transcription occurs in the S-phase of the 1-cell embryo and 
mRNAs during this first wave of transcription are mainly transcribed from the male 
pronucleus (Nothias et al. 1996; Aoki et al. 1997). This is possibly due to a higher 
concentration of transcription factors in the male pronucleus (Worrad et al. 1994). Because 
the first minor wave of transcription correlates with the start of DNA replication, it was 
hypothesized that DNA replication might be a trigger for the transcriptional onset in the 
zygote. This is supported by the observation that inhibiting DNA replication leads to a 
decrease in transcription in the early embryo although it does not inhibit transcription 
completely (Aoki et al. 1997). It is thought that maternal proteins translated from maternal 
transcripts during the 1-cell stage trigger the first minor wave of embryonic genome activation 
(Hamatani et al. 2004).  
A second, bigger wave of transcription starts during the S- and G2-phase in the 2-cell embryo 
and continues until the 4-cell stage (Aoki et al. 1997; Hamatani et al. 2004; Wang et al. 2004). 
Several other waves of genome activation follow around the 8-cell, morula and blastocyst 
stage (Hamatani et al. 2004). Each wave activates a specific group of genes of which the 
majority is downregulated again soon after. The maternal proteins and the proteins from the 
first wave are in subsequent steps required for initiation of the next waves of transcription 
(Hamatani et al. 2004). Chromatin remodeling such as histone acetylation that is needed for 
DNA replication might allow access for maternally inherited transcription machineries to 
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promotors which were silenced during oocyte maturation (Wiekowski et al. 1993; Patterton 
and Wolffe 1996). Indeed, hyperacetylation was shown to increase transcription in the 2-cell 
embryo (Aoki et al. 1997). Due to the focus on how maternal transcripts in preovulatory-aged 
oocytes affect the developmental competence, the present study concentrated on the first 
major wave of embryonic genome activation at the 2-cell stage.  
1.7 DNA methylation 
DNA methylation of cytosines (5-methyl-cytosine, 5mC) within CpG dinucleotides is the 
most widely studied epigenetic modification in mammals and has for example a central role in 
imprinting (Li et al. 1993; Peters 2014). DNA methylation of CpGs is generally related with 
transcriptional silencing and chromosome stability. Even though CpGs are underrepresented 
in the genome, there are certain regions in which the sequence differs significantly from the 
rest in being CpG-rich. These DNA sequences are known as CpG islands and are mainly 
nonmethylated (Deaton and Bird 2011).  
One of the most important regulators of DNA methylation is the family of DNA 
methyltransferases (Dnmt; Bestor 2000; Goll and Bestor 2005). This family consists of three 
members with methyltransferase activity, Dnmt1, Dnmt3a and Dnmt3b, who are conserved in 
the plant and animal kingdom (Bestor 2000). A fourth member, Dnmt2, shows sequence 
similarities but does not show DNA methylation catalyzing activity (Okano et al. 1998). 
Instead it was found to specifically methylate cytosine 38 of the aspartic acid tRNA (Goll et 
al. 2006). All DNA methyltransferases use S-adenosyl-methionine as a methyl-donor (Goll 
and Bestor 2005). The first eukaryotic DNA methyltransferase to be found in mammals was 
Dnmt1 (Bestor et al. 1988). It is known as the maintenance methyltransferase and restores 
DNA methylation during the S-phase of each cell replication cycle (Leonhardt et al. 1992; 
Lyko et al. 1999; Goll and Bestor 2005). It binds preferentially to hemimethylated DNA and 
catalyzes methylation of the unmethylated newly synthesized DNA strand (Yoder et al. 1997). 
Dnmt1 is crucial to maintain DNA methylation patterns of certain regions, such as imprinting 
control centers and repetitive sequences during pre- and postimplantation embryonic 
development (Li et al. 1992; Howell et al. 2001; Gaudet et al. 2004; Kurihara et al. 2008). In 
contrast, Dnmt3a and Dnmt3b are de novo methyltransferases that are required for the 
establishment of DNA methylation and, like Dnmt1, are also mandatory for successful 
embryonic development (Okano et al. 1999). Function of Dnmt3 depends on Dnmt3l, which 
itself has no enzymatic activity but interacts with Dnmt3a and Dnmt3b during imprint 
establishment (Bourc'his et al. 2001; Hata et al. 2002).  
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DNA methylation is an important and widely employed mechanism of epigenetic control. It 
has a central role in e.g. X-chromosome inactivation, retrotransposon repression, chromosome 
structure and gene silencing (Dean et al. 2005; Brockdorff 2011; Probst and Almouzni 2011). 
One of the best studied mechanisms of DNA methylation function is genomic imprinting, 
which is of special interest due to its heritability to the next generation (Reik and Walter 
2001).   
1.7.1 Genomic imprinting 
For successful embryonic development a maternal and paternal copy of the genome is 
required. Manipulation of murine zygotes to generate embryos with either two maternal or 
two paternal pronuclei showed that uniparental diploid embryos are non-viable due to severe 
developmental failures (Barton et al. 1984; McGrath and Solter 1984; Surani et al. 1984). The 
requirement for both the maternal and the paternal genome is a result of asymmetric DNA 
methylation, causing parent-of-origin specific gene expression pattern at certain gene loci 
known as genomic imprinting (Li et al. 1993). Approximately 150 of these imprinted genes 
have been identified in mice and roughly half of them also in humans (www.mousebook.org/ 
mousebook-catalogs/imprinting-resource and http://igc.otago.ac.nz/home.html). Most 
imprinted genes (>80%) are organized in clusters, which enclose a cis-acting imprinting 
control region (ICR) that contains a differentially methylated CpG island (Barlow 2011; 
Peters 2014). Methylation of an ICR is maintained throughout development and preserved in 
adult tissues.  
There are several strategies how DNA methylation is involved in gene regulation of imprinted 
genes. Most ICRs are methylated on the maternal allele, e.g. the Snrpn and Igf2r clusters 
(Stoger et al. 1993; Shemer et al. 1997). Maternally methylated ICRs often enclose promoters 
of long non-coding RNAs (lncRNA), which silence protein-coding gene(s) in the cluster in cis 
by running antisense to it/them (Barlow 2011; Peters 2014). In the case of the Snrpn cluster 
the maternally methylated ICR inhibits the expression of Snrpn on the maternal allele 
(Shemer et al. 1997). On the paternal allele Snrpn is expressed, as well as the lncRNA 
Ube3a-as that in the brain extends into the Ube3a gene and inhibits Ube3a expression from 
the paternal allele (Rougeulle et al. 1998; Chamberlain and Brannan 2001; Horsthemke and 
Wagstaff 2008). Ube3a is expressed only from the maternal allele in the brain but biallelic in 
other tissues (Rougeulle et al. 1997; Vu and Hoffman 1997). In the case of the Igf2r locus, 
maternal methylation of an intronic DMR in the Igf2r gene inhibits the expression of the 
lncRNA Airn in mice (Wutz et al. 1997; Sleutels et al. 2002). This leads to maternal 
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expression of Igf2r in murine post-implantation embryos (Lerchner and Barlow 1997). Airn is 
expressed from the unmethylated paternal allele where its transcription overlaps and therefore 
interferes with Igf2r expression causing Igf2r silencing (Sleutels et al. 2002; Latos et al. 
2012). In contrast to mice, the human Igf2r locus appears to be mainly biallelically expressed 
(Kalscheuer et al. 1993; Ogawa et al. 1993; Xu et al. 1993). 
Paternal methylated ICRs are typically located in intergenic regions, e.g. the Igf2/H19 cluster 
(Bartolomei et al. 1993; Peters 2014). The Igf2/H19 cluster is an example of the insulator 
model for regulation of imprinted gene expression (Bell and Felsenfeld 2000; Hark et al. 
2000; Nordin et al. 2014). The ICR is located between the two genes. It is methylated on the 
paternal allele resulting in maternal expression of H19. The ICR contains a binding site for 
the zinc-finger protein CCCTC-binding factor (CTCF). CTCF binds to the non-methylated 
maternal ICR, thereby blocking access of downstream enhancers to Igf2 promotors and 
inhibiting transcription of Igf2 from the maternal allele (Bell and Felsenfeld 2000; Hark et al. 
2000). Genetic or epigenetic defects such as deletions or impaired methylation levels can 
cause disruption of imprinted gene expressions. This is related with diseases and imprinting 
disorders in humans, for instance Angelman and Prader-Willi syndromes (SNRPN cluster) or 
Beckwith-Wiedemann and Silver-Russel syndromes (IGF2/H19 cluster; Horsthemke and 
Wagstaff 2008; Eggermann 2009).  
1.7.2 Epigenetic reprogramming of the embryo 
Throughout mammalian development two major waves of epigenetic reprogramming occur 
(Dean et al. 2003). The first takes place in primordial germ cells, where DNA methylation of 
imprints is erased upon entry to the genital ridge and then reset during germ cell development 
(Hajkova et al. 2002; Lee et al. 2002). The reacquisition of imprints is mediated by Dnmt3a in 
dependence of Dnmt3l in growing germ cells (Figure 3; Bourc'his et al. 2001; Hata et al. 
2002; Kaneda et al. 2004). In males imprints are set in the genital ridge during late fetal 
development (Davis et al. 2000; Ueda et al. 2000). In females imprints are established 
postnatally in a time-specific manner for each gene in the growing oocyte (Obata and Kono 
2002; Lucifero et al. 2004). Especially in the oocyte the imprint setting seems to be highly 
dependent on Dnmt3l (Kobayashi et al. 2012).  
The second wave of epigenetic reprogramming is during preimplantation development and 
involves large scale demethylation during embryonic genome activation from which 
imprinted genes need to be protected (Figure 3; Messerschmidt 2012). The oocyte and sperm 
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genome are very distinct, which requires different approaches to process the DNA after 
fertilization in order to activate the zygotic genome. The oocyte only completes meiosis after 
fertilization, whereas the sperm has a haploid genome packed around protamines. So, upon 
fertilization the sperm genome has to undergo nuclear envelope breakdown, replacement of 
protamines by histones and chromatin decondensation to form the male pronucleus (Wright 
1999). Protamine replacement is directly followed by chromatin decondensation and 
completed within the first hour after fertilization (Santos et al. 2002).  
 
 
Figure 3: DNA methylation levels throughout mammalian development and protection of DNA 
methylation of imprinted genes. DNA methylation levels rise in growing germ cells until they reach a peak in 
mature germ cells. In this phase Dnmt3a and Dnmt3l set genomic imprints by de novo methylation of ICRs. 
After fertilization major epigenetic reprogramming takes place, in which first the paternal genome is actively 
demethylated and then the maternal genome is passively demethylated. In the blastocyst, both parental genomes 
of the cells in the inner cell mass undergo de novo methylation. ICRs have to be protected and maintained during 
these demethylation and remethylation events. This is mediated by Stella (Dppa3), Trim28, Zfp57 and Dnmt1. 
Figure from Messerschmidt 2012.  
 
While the paternal genome is highly methylated prior to fertilization (89%), the maternal 
genome is undermethylated (40%; Monk et al. 1987; Kobayashi et al. 2012). Further 
processing of the parental genomes in the zygote then involves global demethylation. Maybe 
due to the different levels of methylation, demethylation seems to be differentially regulated 
for the maternal and paternal genome (Mayer et al. 2000; Oswald et al. 2000; Santos et al. 
2002). The exact mechanisms are not completely clear but it is thought that first the paternal 
genome undergoes progressive demethylation. This is completed within 4-8 hours after 
fertilization before the first DNA replication (Mayer et al. 2000; Oswald et al. 2000; Santos et 
al. 2002). It is therefore commonly known as active demethylation. Tet3 (Ten-eleven 
translocation protein 3) is an ME gene that has been associated with this active demethylation 
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in zygotes (Gu et al. 2011). The Tet3 protein is enriched in the male pronucleus where it 
oxidates 5mC to 5-hydroxymethylcytosine (5hmC), which is thought to be the first step in 
active demethylation (Gu et al. 2011; Wossidlo et al. 2011; Santos et al. 2013).  
The maternal genome was thought to be protected from active demethylation and mainly 
passively demethylated through exclusion of Dnmt1 from the nucleus during cell replication 
(Carlson et al. 1992; Rougier et al. 1998; Santos et al. 2002). Processing of the maternal 
genome takes until the morula stage. This is longer than active demethylation causing a delay 
in demethylation of the maternal genome in comparison to the paternal genome (Santos et al. 
2002; Dean et al. 2003). However, a recent study showed that also the maternal genome is 
subject to Tet3 oxidation suggesting multiple demethylation pathways in the embryo that 
might function redundantly (Peat et al. 2014). After completion of global demethylation, 
massive de novo methylation occurs in the inner cell mass but not in the trophectoderm of the 
blastocyst (Santos et al. 2002).  
1.7.3 Imprint maintenance in preimplantation embryos 
As described above, imprinted genes must be protected from demethylation during epigenetic 
reprogramming (Figure 3). There are several proteins that are encoded by ME genes, which 
are known to be involved in this imprint maintenance during preimplantation development 
(Messerschmidt 2012). Dppa3 (Developmental pluripotency-associated 3 protein, also known 
as Pgc7 or Stella) was the first identified ME gene encoding a protein with an imprint 
protection function (Payer et al. 2003; Nakamura et al. 2007). It prevents demethylation at 
certain imprinted regions, e.g. Snrpn and Peg3 (Nakamura et al. 2007). Trim28 (tripartite 
motif-containing 28; previously named Kap1 or Tif1β) is a central scaffolding component of 
an epigenetic modifying corepressor complex. It binds for instance the H3K9me3-catalizing 
histone methyltransferase Setdb1, which in turn recruits the heterochromatin protein Hp1 that 
is involved in epigenetic silencing (Schultz 2002). This heterochromatin-inducing complex 
binds DNA specifically through interaction of Trim28 with Krüppel-associated box-
containing zinc-finger proteins (KRAB-ZFPs) such as Zfp57 (Li et al. 2008b). Trim28 and 
Zfp57 are both ME genes that are essential for imprint maintenance during preimplantation 
development (Li et al. 2008b; Messerschmidt et al. 2012). They encode proteins that bind 
selectively to all H3K9 and DNA methylation bearing ICRs in embryonic stem cells and 
conserve the imprints through recruitment of Setb1 and Hp1 to methylated DNA (Quenneville 
et al. 2011). Zfp57 recognizes ICRs and several other locis that carry Zfp57-dependent 
methylation in ESCs through a hexanucleotide motif that is found in all murine ICRs 
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(Quenneville et al. 2011). This hexanucleotide motif (TGCCGC) contains a CpG and Zfp57 
binds more efficiently to the sequence when it is methylated, explaining the parent-of-origin 
specific sequence recognition by Zfp57. Trim28/Zfp57 was also found to be associated with 
DNA methyltransferases Dnmt1, Dnmt3a and Dnmt3b (Quenneville et al. 2011). Dnmt1 is 
another ME gene, which is not only important for processing of the maternal genome after 
methylation but also required for imprint maintenance (Howell et al. 2001; Borowczyk et al. 
2009). In oocytes both a truncated, oocyte specific variant (Dnmt1o) and, although to a far 
lesser extent, the somatic variant (Dnmt1s) are expressed (Mertineit et al. 1998; Kurihara et al. 
2008). Dnmt1o and Dnmt1s proteins are present at all times during oocyte growth, maturation 
and preimplantation development and protect methylation and ICRs (Cirio et al. 2008; 
Hirasawa et al. 2008; Kurihara et al. 2008). Since at the same time exclusion of Dnmt1 is 
supposed to cause passive demethylation of the maternal genome, a scenario is assumed that 
in the early embryo Dnmt1 binds specifically to imprinted gene loci enabling the majority of 
the genome to be demethylated. Indeed a region conserved in mammals in the N-terminus of 
the Dnmt1 protein has been found that seems to be associated with binding to specific regions 
like ICRs and some repetitive sequences (Borowczyk et al. 2009). 
Correct imprint establishment in the oocyte and imprint maintenance during epigenetic 
reprogramming are of vital importance for oocyte quality and developmental potential. It is 
not known if preovulatory aging might affect imprint setting and protection in oocytes.  
1.8 Aim 
Hardly anything is known on the molecular mechanisms that occur in the preovulatory-aged 
oocyte. Therefore, the aim of the present study was to investigate the effects of preovulatory 
aging on several aspects of RNA dynamics and the developmental competence of 
preimplantation embryos. For this, a previously described in vivo mouse model was employed 
in which ovulation is delayed using the GnRH antagonist cetrorelix (Bittner et al. 2011).   
First, RNA dynamics in preovulatory aged oocytes were assessed on different levels using 
several methods: 1) as indicator of transcriptional silencing and stability of the oocyte genome 
(Kageyama et al. 2007) the repressive histone modification mark H3K9me3 was assessed by 
immunofluorescent analysis. 2) The germ cell-specific RNA-binding protein Ybx2 is one of 
the most abundant proteins in the growing oocyte and required for RNA storage and 
recruitment of transcripts for protein translation (Yu et al. 2002; Medvedev et al. 2011). 
Because it is essential for oocyte developmental potential, it was analyzed on transcript and 
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protein level by qRT-PCR and immunofluorescent analysis. 3) ME-genes are of crucial 
importance for oocyte quality since they are needed for regulation of early embryonic 
development (Li et al. 2010). Transcript levels of selected ME-genes were determined by 
qRT-PCR. Considering that poly(A) tail length is an important regulator of translation 
efficiency in the oocyte (Kang and Han 2011) changes in poly(A) tail length after 
preovulatory aging of the investigated ME genes were analyzed by priming cDNA conversion 
with random or oligo(dT) primers. RNA dynamics of ME genes in oocytes aged in vivo were 
compared to preovulatory-aged oocytes grown and maturated in vitro in a follicle culture 
system. 
In postovulatory-aged Xenopus oocytes, it is known that poly(A) tail length is affected 
(Kosubek et al. 2010). To determine if this is also true for mammals, it was aimed to establish 
a poly(A) RNA sequencing method to investigate poly(A) tail length after postovulatory 
aging on a transcriptome-wide level in mouse oocytes. 
Possible effects on RNA dynamics in preovulatory-aged oocytes are likely to affect the 
developmental potential of oocytes. It has been previously shown that preovulatory aging in 
the cetrorelix mouse model impairs postimplantation development (Bittner et al. 2011). The 
current study investigated the developmental potential of preovulatory-aged oocytes in 
preimplantation embryos at several stages: 1) Fertilization success after preovulatory aging 
was determined by assessing the 2-cell rate after natural mating. 2) For embryonic 
development, the onset of transcription in the course of embryonic genome activation is 
essential (Schultz 2002). The first major wave of embryonic genome activation at the 2-cell 
stage was analyzed by determining BrUTP incorporation into nascent RNA. 3) Early 
embryonic development is dominated by the oocyte-to-embryo transition which involves 
extensive epigenetic reprogramming. During this phase, DNA methylation levels of imprinted 
genes need to be maintained (Messerschmidt 2012). The present study investigated DNA 
methylation levels of 3 imprinted genes (H19, Snrpn, Igf2r) and one unmethylated control 
gene (Pou5f1) at the 8-cell stage of preimplantation development by deep amplicon bisulfite 
sequencing of single embryos after preovulatory aging.  
This study was the first, to address molecular processes in the preovulatory-aged oocyte in 
such detail and to find mechanisms that might give possible explanations for the low 
fertilization rates and impaired embryonic development previously described in the present 
mouse model or other animal models (Smits et al. 1995; Bittner et al. 2011).   
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2 Materials and Methods 
2.1 Ethics statement 
This study was conducted according to the recommendations stated in the Guide for the Care 
and Use of Laboratory Animals of the German government. The investigations were 
authorized by the Committee on the Ethics of Animal Experiments of the responsible 
authorities (Landesamt für Natur, Umwelt und Verbraucherschutz, LANUV AZ 84-
02.04.2011. A374). 
 
2.2 Materials 
2.2.1 Chemicals and Substances 
4′,6-Diamidin-2-phenylindol (DAPI; Sigma Aldrich) 
5-Bromouridine-5'-triphosphate (BrUTP; Sigma Aldrich) 
DABCO (Sigma Aldrich) 
Fluoresceinisothyiocyanate (FITC; Sigma Aldrich) 
Forene (Isoflurane; Abbvie) 
Oligo(dT)25 Dynabeads (Life Technologies) 
Poly-L-Lysin Hydrobromide (Sigma Aldrich) 
Triton X-100 (AppliChem) 
6xMassRuler DNA Loading Dye (Thermo Scientific) 
Vectashield Mounting Medium with DAPI (Vector Laboratories) 
All other chemicals not mentioned here were obtained from Applichem, Life Technologies, 
Merck, Peqlab Biotechnologie and Sigma Aldrich in pro analysis quality.   
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2.2.2 Buffers and solutions 
Purchased buffers and solutions: 
1x Dulbecco's Phosphate-Buffered Saline (DPBS; Life Technologies) 
10x Tris-acetate-EDTA (TAE; Applichem) 
Prepared buffers: 
All buffers were mixed using double distilled water, unless stated otherwise. 
Blocking buffer for immunofluorescent analysis of H3K9me3 and BrUTP: 
Bovine serum albumin (BSA)  1.0 % (w/v) 
Milk powder     0.2 % (w/v) 
Norm goat serum    2.0 % (v/v) 
Glycine     0.1 M  
Triton X-100     10.0 % (v/v) 
Chemicals were filled up with DPBS and sterilized by filtration. 
Blocking buffer for immunofluorescent analysis of Ybx2: 
Tween 20      0.01 % (v/v) 
BSA      0.10 % (v/v) 
Chemicals were filled up with DPBS and sterilized by filtration. 
FITC solution: 
FITC      10 mg 
C3H7NO     1 ml 
Guanidine thiocyanate (GTC) buffer: 
C2H6N4S     4 M 
Na3C6H5O7     25 mM 
C2H6OS     2 % (v/v) 
pH7.1 
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Sodium carbonate buffer: 
Na2CO3     160 mM 
NaHCO3     333 mM 
pH9.5 
Paraformaldehyde (PFA) 4%: 
PFA      8 g 
DPBS      200 ml 
PFA was dissolved in approximately 170 ml hot DPBS (80 °C). The pH was set with NaOH 
to 7.3 and the solution filled up with DPBS to 200 ml. Aliquots of 50 µL were stored 
at -20 °C. 
Physiological buffer: 
CH3CO2K     100.0 mM 
KCl      30.0 mM 
MgCl2      1.0 mM 
Na2HPO4 (7H2O)    10.0 mM 
ATP      1.0 mM 
DTT      1.0 mM 
PMSF      0.2 mM 
RNasin     40.0 U/ml 
Physiological buffer with BrUTP: 
Adenosine triphosphate (ATP)  2.0 mM 
Guanosine-5'-triphosphate (GTP)  0.4 mM 
Cytosinetriphosphate (CTP)   0.4 mM 
BrUTP     0.4 mM 
MgCl2      2.0 mM 
All chemicals were dissolved in physiological buffer. 
20x Saline sodium citrate (SSC) buffer: 
NaCl    3.0 M 
Na3C6H5O7   0.3 M  
pH 7.3  
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2.2.3 Hormones 
PMSG (Intergonan; MSD) 
hCG (Ovogest; MSD) 
Cetrorelix (Cetrotide; Merck-Serono) 
2.2.4 Media 
For isolation of oocytes and 2-cell embryos the HEPES buffered M2-Medium (Sigma 
Aldrich) was used. Embryos were cultivated to the 8-cell stage in KSOM medium 
(GlobalStem). 
2.2.5 Antibodies 
Monoclonal mouse anti-BrU (1:50; Roche) 
Polyclonal rabbit anti-H3K9me3 (1:40; Epigentek) 
Polyclonal goat anti-Ybx2 (1:300; Santa Cruz) 
Polyclonal rabbit anti-goat IgG-Cy3 (1:200; Sigma Aldrich) 
Monoclonal goat anti-rabbit IgG-TRITC (1:40; Epigentek) 
2.2.6 Oligonucleotides, UPL-Probes, Taqman assays and DNA marker 
Random hexamer primers and oligo(dT)16 primers for reverse transcription were obtained 
from Life Technologies. Oligonucleotides and UPL-Probes for qRT-PCR analysis were 
designed using the Universal ProbeLibrary Assay Design Center (Roche; 
https://lifescience.roche.com/webapp/wcs/stores/servlet/CategoryDisplay?tab=Assay+Design
+Center&identifier=Universal+Probe+Library&langId=-1). Oligonucleotides were obtained 
from Biomers and UPL-Probes from Roche. Pre-designed Taqman assays for qRT-PCR 
analysis were obtained from Life Technologies. All assays are listed in Supplementary 
Table S1. 
For the ePAT analysis an anchor primer containing a poly(A) stretch at the 3’end and gene 
specific forward primers were ordered from Eurofins. Oligonucleotide sequences are listed in 
Supplementary Table S2.  
Oligonucleotide sequences for Sanger or Bisulfite Sequencing were previously described in 
(El Hajj et al. 2011) and ordered from Metabion (Supplementary Table S3).  
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The pUC19 DNA/MspI (HpaII) Marker (Thermo Scientific) was used for size determination 
of the PCR product length by agarose gel electrophoresis. This marker has a range from 34 bp 
to 501 bp. 
2.2.7 Enzymes 
DNase I (Qiagen) 
ExoSAP-IT (Affymetrix) 
HotStarTaq DNA Polymerase (Qiagen) 
Hyaluronidase (Sigma Aldrich) 
Klenow Fragment (New England Biolabs) 
Pronase E (Sigma Aldrich) 
RiboLock RNase Inhibitor (Thermo Scientific) 
2.2.8 Kits 
Agencourt AMPure XP System (Beckman Coulter) 
Agilent DNA 1000 Kit (Agilent Technologies) 
Agilent High Sensitivity DNA Kit (Agilent Technologies)  
Agilent RNA 6000 Pico Kit (Agilent Technologies)  
Arcturus Pico Pure RNA Isolation Kit (Life Technologies) 
BigDyeTerminator v1.1 Cycle Sequencing Kit (Life Technologies) 
EZ DNA Methylation-Direct Kit (Zymo Research) 
GeneAmp RNA PCR Core Kit (Life Technologies) 
Multiplex PCR Kit (Qiagen)  
Ovation Single Cell RNA-Seq System (NuGEN)  
QiaShredder (Qiagen) 
ReadyMix Taq PCR Reaction Mix (Sigma Aldrich) 
RNeasy MinElute Clean up Kit (Qiagen) 
Superscript III Reverse Transkriptase (Life Technologies) 
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2.2.9 Mouse strains 
C57Bl/6J inbred female mice (Mus musculus) were used for all experiments, except for the in 
vitro follicle culture. The benefit of using an inbred strain is the homogeneous genetic 
background. This should provide low genetic variability within one experimental group and 
therefore lower the amount of replicates (animals) needed. The disadvantage is the inbred 
depression, which reduces fertility of animals from the C57Bl/6J strain. For in vitro follicle 
culture C57Bl/6J mice were therefore mated with animals from the CBA inbred strain and 
follicles were isolated from the hybrid C57Bl/6J x CBA females obtained out of this breeding.  
For the generation of 2-cell embryos to study BrUTP incorporation, C57Bl/6J female mice 
were mated with C57Bl/6J x CBA hybrid males to increase the reproductive success. DNA-
methylation analysis was carried out with 8-cell embryos derived from C57Bl/6J female mice 
mated with CAST/EiJ male mice. CAST/EiJ (M. m. castaneous) is also an inbred strain but it 
is not as closely related to C57Bl/6J as the CBA strain. Therefore, heterozygous single 
nucleotide polymorphisms (SNPs) can be found in the offspring allowing the differentiation 
between maternal and paternal allele during DNA-methylation analysis.  
All strains were bred in the Central Animal Facility of the University Hospital Essen. 
Founding animals of the C57Bl/6J and CBA strains were obtained from Harlan Laboratories. 
CAST/EiJ breeding founder pairs were kindly provided by Prof. Ulrich Zechner, University 
of Mainz, Germany. All mice were housed under standard conditions (food and water ad 
libitum, 12:12 h dark-light cycles). Cages were supplied with bedding and nesting material. 
Breeding pairs additionally obtained a house of red acrylic glass.  
2.3 Methods 
2.3.1 Generation and collection of preovulatory-aged oocytes 
2.3.1.1 In vivo maturation and preovulatory aging of oocytes 
For in vivo growth and maturation of MII oocytes, female 4-6 weeks old C57Bl/6J mice were 
stimulated hormonally to induce superovulation (Figure 4A). On day 0 all mice were injected 
intra peritoneal (i.p.) with 10 IU pregnant mare serum gonadotropin (PMSG) to stimulate 
follicle growth and maturation. PMSG is a gonadotropic hormone, produced by pregnant 
mares during gestation and shows similar activity as FSH in mice. Intrinsic hormones were 
suppressed by daily subcutaneous (s.c.) application of 50 mg cetrorelix during the phase of 
oocyte growth and maturation starting from day 0. For the collection of control oocytes 10 IU 
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human chorionic gonadotropin (hCG) was applied i.p. 48 h later at day 2 of stimulation to 
induce ovulation. These 48 h represent the intrinsic cycle of the mouse. Human CG is 
produced during human pregnancy in the placenta and mimics the effect of LH by inducing 
ovulation.  
Due to inhibition of the intrinsic hormone levels with cetrorelix it was possible to delay 
ovulation and age oocytes for 3 or 4 days (d) in vivo. Ovulation of preovulatory-aged oocytes 
(PreOA) was induced at day 5 or 6. To ensure that PMSG levels stayed high during the course 
of aging, PMSG was applied every 2 d. Fifteen hours after hCG injection on day 3 (control), 6 
or 7 (PreOA), mice were anesthetized with 1-2 ml isoflurane in a bell jar for 30-60 seconds (s) 
and then sacrificed by cervical dislocation. Mice were dissected to isolate the female 
reproductive tract, including the uterus, fallopian tubes and ovaries. These organs were then 
further dissected using a binocular, to collect the oviduct, which was transferred into a 25 µl 
drop of M2-medium. The oviductal ampulla was then torn using forceps, releasing the 
cumulus-oocytes-complex (COC). To dissociate the cumulus cells from the oocytes, the COC 
was transferred into another 25 µl drop of M2-medium, which was enriched with 2 µl 
(10 mg/ml) hyaluronidase. The oocytes were afterwards washed 3-4 times in M2-medium to 
remove all cumulus cells and stored at -80 °C until further use.  
2.3.1.2 In vitro growth and preovulatory aging of oocytes 
The follicle culture system used for in vitro preovulatory aging (Figure 4B) was established in 
the Department of Gene Technology and Microbiology at the University of Bielefeld. Oocytes 
were grown, maturated and preovulatory-aged for 3 or 4 d in vitro by Dr. Tom Trapphoff and 
Martyna Heiligentag under the supervision of Prof. Ursula Eichenlaub-Ritter and send to our 
laboratory for further analysis. The follicle culture system has been described in Traphoff et 
al. (2010), Demant et al. (2012) and Wigglesworth et al. (2012). Briefly, preantral follicles 
were isolated from female F1 hybrid C57Bl/6J x CBA/Ca mice and grown and maturated in 
vitro. Follicle growth was stimulated with recombinant FSH (rFSH) and recombinant LH 
(rLH) for 12 d. Then ovulation was induced with recombinant epidermal growth factor 
(rEGF) and recombinant hCG (rhCG). Control MII oocytes were collected 18 h later on day 
13. To age oocytes preovulatory, the in vitro culture was prolonged for 3 or 4 d before 
application of rEGF and rhCG.  
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Figure 4: Treatment scheme of the mouse models for preovulatory oocyte aging in vivo (A) and in vitro 
(B) and postovulatory aging (C). A) Oocyte growth in vivo was induced by application of PMSG at day 0 and 
ovulation was induced at day 2 by hCG injection. Oocytes were retrieved from the oviductal ampullae the next 
morning. Delaying ovulation with the GnRH antagonist cetrorelix caused in vivo preovulatory aging for either 3 
or 4 days. B) In vitro growth and preovulatory-aging was performed using a follicle culture system. Oocyte 
growth was stimulated by application of rLH and rFSH and ovulation was induced after 12 days with rhCG and 
rEGF. Oocytes were collected 18 h later. Delaying ovulation for 3 or 4 days caused preovulatory aging of 
oocytes in vitro. C) Growth and ovulation of postovulatory-aged oocytes was performed as described in A. After 
oocyte collection, oocytes were incubated in M2-medium for an extra day, causing postovulatory aging. This 
figure was modified from Dankert et al. (2014). 
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2.3.2 Generation and collection of postovulatory-aged in vivo-maturated oocytes 
For the generation of postovulatory-aged oocytes (PostOA), C57Bl/6J female mice were 
stimulated hormonally to induce superovulation, similar as described above (2.3.1.1). Mice 
received PMSG to stimulate follicle growth and oocyte maturation. Ovulation was induced by 
hCG application 48 h later. MII oocytes were collected 15 h after hCG injection from the 
oviductal ampullae as described above. After removal of the cumulus cells, oocytes were 
either frozen at -80 °C (controls) or aged for 24 h in 100 µl M2-medium covered by mineral 
oil at 37 °C and 5% CO2 (PostOA). After 24 h, aged oocytes were also stored at -80 °C until 
further use.  
2.3.3 Generation and collection of embryos derived from preovulatory-aged oocytes 
To generate embryos from control and preovulatory-aged oocytes, female C57Bl/6J mice 
(> 8 weeks) were stimulated hormonally (2.3.1.1). After induction of ovulation by application 
of hCG females were mated over night with either C57Bl/6J x CBA hybrid males or 
CAST/EiJ males. The next morning males and females were separated and females were 
checked for the presence of a vaginal plug. Twenty-four hours later plugged females were 
sacrificed by cervical dislocation and the oviducts were isolated. Two-cell embryos were 
collected in M2-medium by flushing the oviduct with DPBS using a syringe. After subsequent 
washing of the embryos in M2-medium, the 2-cell embryos were either used immediately for 
immunohistochemical analyses or further cultured to the 8-cell stage in 100 µl KSOM under 
mineral oil at 37 °C and 5% CO2 for 24 h. Eight-cell embryos were frozen individually in 
10 µl DPBS at -80 °C.  
2.3.4 RNA isolation from oocytes 
Total RNA was isolated from oocytes using the Arcturus PicoPure RNA Isolation Kit 
according to manufacturer instructions with small adaptations. For homogenization of 
samples, cell mixtures were transferred into a QIAshredder column and centrifuged at full 
speed (20108xg) for 5 min. Any residual DNA, which might interfere with later analysis was 
removed by DNase I treatment according to the guidelines of the kit. RNA was eluted in 
14 µL elution buffer, which was applied directly to the membrane. Elution buffer was 
incubated for 1 min followed by two centrifugation steps; 1 min at 8000xg and 1 min at 
16,000xg. RNA was stored at -80 °C until further use. 
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2.3.5 RNA expression analysis 
To analyze RNA expression and relative polyadenylation of transcripts of genes in 
preovulatory-aged and control oocytes, RNA from pooled oocytes was reverse transcribed 
(RT) into cDNA and analyzed by quantitative real-time polymerase chain reaction (qPCR). 
For all experimental groups 3 samples of 20 pooled oocytes each were analyzed. For reverse 
transcription of total RNA or poly(A) mRNA in oocytes, cDNA was either primed with 
random hexamers or with oligo(dT)16primers.  
2.3.5.1 Reverse transcription of RNA 
For the reverse transcription of oocyte RNA into cDNA, the GeneAmp RNA PCR Core Kit 
was used. Reactions were prepared as shown in Table 1. To control for successful DNA 
digestion during RNA preparation in subsequent PCR reactions a -RT control reaction lacking 
the reverse transcriptase was included. Samples were incubated in a thermocycler for 10 min 
at 21 °C followed by cDNA synthesis for 30 min at 42 °C and reverse transcriptase inhibition 
for 5 min at 99 °C.  
Table 1: Reverse transcription reaction. 
Sample +RT -RT 
Total RNA 9.00 µl 2.25 µl 
MgCl2 (25 mM) 8.20 µl 2.05 µl 
10x PCR Buffer II 5.00 µl 1.25 µl 
dGTP 5.00 µl 1.25 µl 
dATP 5.00 µl 1.25 µl 
dTTP 5.00 µl 1.25 µl 
dCTP 5.00 µl 1.25 µl 
Primer (10 µM) 2.50 µl 0.63 µl 
RNase inhibitor (20 U/µl) 2.50 µl 0.63 µl 
MuLV Reverse Transcriptase (50 U/µl) 2.50 µl - 
RNase free water add to 50 µl add to 12.5 µl 
 
2.3.5.2 Quantitative real-time PCR 
Real-time qPCR is a PCR method used to quantify specific DNA elements amplified during 
PCR by analyzing fluorescent intensity during each amplification cycle. Here, the technology 
was utilized for relative quantification of RNA expression by amplification of cDNA after 
reverse transcription. Samples were amplified and quantified on the LightCycler 480 II 
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(Roche) using the assays designed by the Universal Probe Library (UPL) design center. The 
UPL probes consist of a short sequence (8-9 bp) labeled at the 5’ end with the fluorophore 
FAM (fluorescein amidite) and at the 3’ end with a dark quencher dye. The UPL probe binds 
to the amplified sequence in between the primer pair. During amplification, the probe is 
digested by the 5’-3’-exonuclease activity of the DNA polymerase resulting in the separation 
of the quencher and the FAM dye. As a result of amplification, the quencher will no longer 
suppress FAM fluorescence, which will be measured by the LightCycler in each amplification 
cycle. The intensity of fluorescence is proportional to target amplification.  
An internal reference gene, also known as housekeeping gene, is commonly used for 
quantitative analysis of relative RNA-levels. It is unclear whether murine housekeeping genes 
are affected by preovulatory aging. A previous study investigated several housekeeping genes, 
including GAPDH, ACTB, Histone H2A and 18S rRNA in bovine oocytes, during 
development (Robert et al. 2002). They showed that housekeeping genes are affected by the 
general maternal RNA-decay seen during oocyte maturation and early embryonic 
development. It is likely that a similar effect might be happening in the mouse oocyte. 
Therefore, Luciferase mRNA was spiked into the oocyte pools before RNA isolation 
(1 pg/oocyte), to serve as an external reference for analysis of candidate maternal effect (ME) 
genes. Investigation of Ybx2 transcript levels was normalized using a Luciferase standard 
curve. 
UPL assays were used for the investigation of Ybx2, 7 ME genes (Brg1, Tet3, Trim28, Zfp57, 
Nlrp14, Pou5f1, Zar1) and Luciferase. Dnmt1, Nlrp2 and Nlrp5 were analyzed using pre-
designed Taqman assays, which are based on the same principle as the UPL asssays and 
include a primer pair and a hydrolysis probe. All primers and UPL-probes are summarized in 
Supplementary Table S1. 
Table 2 shows the preparation of a 20 µL qRT-PCR reaction mix using either UPL or Taqman 
assays. All samples were analyzed in technical triplicates, a sample containing water instead 
of cDNA and a sample containing the –RT control were used as negative controls.  
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Table 2: qRT-PCR reaction. 
Assay   UPL  Taqman 
cDNA   1.0 µl    1.0 µl 
2x Light Cycler Master Mix 10.0 µl 10.00 µl 
Fwd Primer (10 µM)   0.8 µl      - 
Rev Primer (10 µM)   0.8 µl      - 
UPL Probe   1.6 µl      - 
Taqman Assay      -    1.0 µl 
Water   5.8 µl    9.0 µl 
 
The following PCR conditions were applied: 
95 °C  10 min 
95 °C  10 s 
60 °C  30 s  50 cycles 
72 °C    1 s 
 
The fold change of each ME gene in preovulatory-aged oocytes compared to control oocytes 
was calculated for both random-primed and oligo(dT)-primed cDNA using the Ct-value and 
the 2-ΔΔCt method. The Ct-value is the cycle number where the fluorescent signal intensity 
starts to rise exponentially. To eliminate possible outliers, the median Ct of each triplicate was 
taken for analysis. First, the Ct-value of both aged and control oocytes for each ME-gene 
(target) had to be normalized against Luciferase expression (reference) for each of the 3 
biological replicates (oocyte pools) per condition: 
∆𝐶𝐶 = 𝑚𝑚𝑚𝑚𝑚𝑚𝐶𝐶(𝑇𝑚𝑇𝑇𝑚𝐶) − 𝑚𝑚𝑚𝑚𝑚𝑚𝐶𝐶(𝑅𝑚𝑅𝑚𝑇𝑚𝑚𝑅𝑚) 
To calculate the difference in expression between aged and control oocytes, the mean ΔCt of 
the 3 control replicates was calculated and then subtracted for each single ΔCt-value: 
∆∆𝐶𝐶 = ∆𝐶𝐶 − 𝑚𝑚𝑚𝑚∆𝐶𝐶(𝐶𝐶𝑚𝐶𝑇𝐶𝐶) 
Then, the fold change was calculated:  
𝐹𝐶𝐶𝑚 𝑅ℎ𝑚𝑚𝑇𝑚 = 2−∆∆𝐶𝐶 
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Last, the fold change was normalized against controls:  
𝑁𝐶𝑇𝑚𝑚𝐶𝑚𝑁𝑚𝑚 𝐹𝐶𝐶𝑚 𝑅ℎ𝑚𝑚𝑇𝑚 = 𝐹𝐶𝐶𝑚 𝑅ℎ𝑚𝑚𝑇𝑚
𝑚𝑚𝑚𝑚 𝐹𝐶𝐶𝑚 𝑅ℎ𝑚𝑚𝑇𝑚(𝐶𝐶𝑚𝐶𝑇𝐶𝐶) 
The mean of the normalized fold change of preovulatory-aged oocytes was compared to 
control oocytes after random hexamer priming to determine possible effects of aging on total 
transcript levels. A change in poly(A) content was defined as a significant difference in fold 
changes between random hexamer-primed and oligo(dT)-primed cDNA.  
2.3.6 Agarose gel electrophoresis 
Agarose gel electrophoresis was used to determine the size of DNA fragments. During gel 
electrophoresis, DNA samples are added to an agarose gel to which an electric field is 
applied. The negatively charged nucleic acids will migrate through the gel towards the anode 
and are separated by size (smaller fragments move faster than larger fragments). A DNA 
marker with DNA fragments of known size was used as reference for size determination. 
1-2% agarose gels were prepared in 1x TAE buffer and enriched with 4 µg/ml ethidium 
bromide (EtBr). EtBr intercalates into DNA and can be visualized under ultra violet (UV) 
light of 302 nm. DNA fragments were transferred to the gel with 1x Loading Dye. The 
pUC19 DNA/MspI (HpaII) Marker was used as reference for size determination. 
Electrophoresis was carried out at 100-120 V.   
2.3.7 Immunofluorescent analysis of oocytes and embryos 
Immunofluorescent (IF) analysis was used to analyze the histone modification H3K9 
trimethylation (H3K9me3) and Ybx2 protein expression of in vivo preovulatory-aged and 
control oocytes. Also, BrUTP incorporation in two-cell embryos derived from either in vivo 
preovulatory-aged or control oocytes was detected using IF. This technique uses the antigene-
antibody binding affinity to visualize epitopes in a cell or tissue. A primary antibody specific 
for an antigen, in this case the histone methylation H3K9me3 or the protein Ybx2, first binds 
to the epitope. To visualize this bond a secondary antibody that is specific for the primary 
antibody and carries a fluorophore is added. The secondary antibody has to be raised against 
the IgG of the host animal species in which the primary antibody was raised. The fluorescent 
label of the secondary antibody can be detected using a light microscope. The protocols for 
detection of H3K9me3 and Ybx2 expression in embryos were established by the group of 
Prof. Ursula Eichenlaub-Ritter.  
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2.3.7.1 Coating of microscope slides with poly-L-lysin 
For analysis, all oocytes were applied to poly-L-lysin coated microscope slides after the IF 
reaction. Poly-L-lysin is positively charged and surfaces covered with it support binding of 
the mainly negatively charged cell membranes. This allows binding of oocytes to the 
microscope slide. To coat the slides with poly-L-lysin, first a ring of vulcanized rubber was 
applied to the slides. After the ring had dried a poly-L-lysin solution in water (0.1 mg/mL) 
was applied to the surface of the slide within the ring. After drying of the poly-L-lysin 
solution the slides were rinsed with demineralized water and dried again. The oocytes were 
placed inside the ring after the IF reaction, which protected them from being crushed 
underneath the cover slip. After mounting, the rim of the cover slip was fixed using nail 
polish.   
2.3.7.2 Ybx2 expression in oocytes 
Oocytes were isolated as described previously (2.3.1.1) and placed into a Terasaki plate. Each 
well contained 13 µl of a buffer, solution or antibody. Oocytes were transferred from one well 
to the next. All following steps occurred at room temperature. The first well contained 
4% PFA in DPBS in which the oocytes were fixed for 1 h. Afterwards, the plasma membrane 
was permeabilized in 0.5% Triton X-100 and oocyte were then transferred into a first well of 
blocking buffer to wash the oocytes briefly. In a second well of blocking buffer, blocking 
occurred during a 30 min incubation period. Oocytes were transferred into a well containing 
the primary antibody goat anti-Ybx2 in blocking buffer (1:300) and incubated for 1 h. Then 
oocytes were washed 4 times in subsequent wells in blocking buffer for 10 min each and 
transferred into the secondary antibody rabbit anti-goat IgG-Cy3 in blocking buffer (1:200) 
for 1 h. Oocytes were washed again 4 times in blocking buffer for 10 min each and transferred 
into the ring on the poly-L-lysin coated slides. Oocytes were mounted with Vectashield 
containing DAPI, which is a fluorescent stain that intercalates into the DNA and therefore 
visualizes cell nuclei. 
2.3.7.3 H3K9me3 expression in oocytes 
The protocol of H3K9me3 IF was very similar to Ybx2 analysis. The beginning of the 
protocol was different because the zona pellucida needed to be removed to allow better 
penetration of the antibody into the cell. After removal of the cumulus cells with 
hyaluronidase the zona was digested in pronase at 37 °C under constant visual monitoring. 
After the zona had dissolved, the oocytes were washed in two drops of M2-medium and then 
fixed in PFA, permeabilized in Triton X-100, and blocked in blocking buffer for 30 min. 
Oocytes were then transferred into the primary antibody rabbit anti-H3K9me3 in DPBS (1:40) 
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and incubated for 1 h. After a brief washing and blocking for 30 min in two subsequent wells 
of blocking buffer, oocytes were incubated for 1 h in the secondary antibody goat anti-rabbit 
IgG-TRITC in DPBS (1:40). Oocytes were washed twice shortly in blocking buffer and then 
transferred into DAPI for 15 min. Last, the oocytes were transferred into blocking buffer 
again, transferred into the ring on the poly-L-lysin coated microscope slides and mounted 
with DABCO.  
2.3.7.4 BrUTP incorporation in two-cell embryos 
To assess the embryonic genome activation at the two-cell stage of embryos derived from 
either preovulatory-aged or control oocytes, incorporation of bromouridine-triphosphate 
(BrUTP) into the cell nuclei was detected using IF. The protocol was adapted from Aoki et al. 
1997 by Dr. Debora Dankert at the Institute of Anatomy, University Hospital Essen. Embryos 
were incubated in BrUTP, which is a nucleotide analogue that is incorporated into the RNA 
during transcription (Jackson et al. 1993). There it is converted into Bromouridine (BrU), 
which can be detected with an antibody by IF. Instead of an indirect visualization using a 
secondary antibody, the primary antibody was directly labeled with a fluorescent dye (FITC).  
In detail, after flushing the two-cell embryos out of the fallopian tube, they were transferred 
into a Terasaki plate and washed in DPBS. The membrane was permeabilized for 1-2 min in 
0.05% Triton X-100 in physiological buffer (PB) until a slight swelling of the cells was 
observed. Embryos were washed 3 times in PB and then incubated in BrUTP solution for 
10 min at 33 °C. All BrU that did not incorporate into the RNA was washed out in 3 
subsequent wash steps in PB. Then, embryos were incubated in 0.2% Triton X-100 in PB for 
3 min to permeabilize the nuclear membrane. Embryos were washed 3 times in PB and then 
fixed in 4% PFA in PB for 30 min at room temperature or overnight at 4 °C.  
For IF analysis of BrUTP incorporation the primary antibody was labeled with FITC. For this, 
10 µl FITC-solution (10 mg/mL) was added to 300 µl mouse anti-BrU (300 ng/µl) and diluted 
with 1690 µl sodium carbonate buffer to a total volume of 2 ml. This mixture was incubated 
for at least 1 h at room temperature or overnight at 4 °C, to allow binding of FITC to the 
antibody. To concentrate the antibody, the mixture was transferred to a Vivaspin 6 
ultrafiltration spin column (Sartorius) and filled up with 4 ml DPBS. To wash out all unbound 
FITC and concentrate the primary antibody, the spin column was centrifuged for 5-7 min at 
3600xg until 300-400 µl of the antibody mixture in the spin column were left. The supernatant 
was discarded.  
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After preparation of the primary antibody, embryos were washed 5 times in blocking buffer 
over a time period of 15 min. Then, the primary antibody in PB (1:50) was added and 
incubated for 1 h. The embryos were washed twice in blocking buffer and mounted with 
Vectashield containing DAPI as described above.  
2.3.7.5 Analysis of fluorescence intensity 
H3K9me3 and BrU IF reactions of oocytes and embryos were analyzed by quantification of 
fluorescence intensity of the samples. Detection of fluorescence was done with a LEICA 
DM4000B microscope. Ybx2 IF was analyzed by Dr. Tom Trapphoff by confocal laser 
scanning microscopy (CLSM). Intensity of fluorescence was quantified with the software 
Image J. Fluorescence intensity of the region of interest (IROI; e.g. the cell nucleus for 
H3K9me3 and BrUTP) was normalized against the background intensity (IBackground; e.g. 
cytoplasm). The ratio between normalized intensity (ΔI) of aged embryo and control embryos 
was calculated as follows: 
 
ΔI = IROI- IBackground 
𝑅𝑚𝐶𝑚𝐶𝑚𝑅𝑚 𝐼𝑚𝐶𝑚𝑚𝐼𝑚𝐶𝐼 = ∆𝐼(𝐸𝑚𝐸𝑇𝐼𝐶)
𝑚𝑚𝑚𝑚∆𝐼(𝐶𝐶𝑚𝐶𝑇𝐶𝐶 𝐸𝑚𝐸𝑇𝐼𝐶𝐼)  
2.3.8 Poly(A) tail dependent fractionation of mRNA 
To analyze the effect of postovulatory aging on the poly(A) tail on a transcriptome-wide level, 
mRNA was separated into fractions of different poly(A) tail lengths (Figure 5). The method is 
based on magnetic oligo(dT)25 Dynabeads, that bind to poly(A) mRNA and was adapted from 
Meijer et al. (2007). The +Poly(A) mRNA bound to the beads can be separated from the 
unbound mRNA, containing the -Poly(A) mRNA fraction (fraction 1) and all other RNAs that 
do not contain poly(A) stretches (e.g. rRNA). The +poly(A) mRNA binds to the beads at a 
high salt concentration. The longer the poly(A) tail, the stronger the binding to the beads will 
be. A stepwise lowering of the salt concentration of the buffer will result in fractionated 
elution of transcripts differing in poly(A) tail length from short (fraction 2, medium salt 
buffer) to long (fraction 3, water). So after poly(A) mRNA fractionation there will be 
one -Poly(A) RNA fraction and several +Poly(A) mRNA fractions with increasing poly(A) 
tail length. 
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Figure 5: Fractionation of mRNA depending on the poly(A) tail length. Total RNA containing mRNAs with 
different poly(A) tail length were hybridized to oligo(dT) beads at high salt concentration (9x SSC buffer). 
Unbound RNA, containing –Poly(A) mRNA was separated (fraction 1). With decreasing salt concentrations, 
mRNAs with increasing poly(A) tail length were eluted. First, oligoadenylated mRNA (fraction 2) was eluted in 
0.075x SSC buffer and second polyadenylated mRNA (fraction 3) was eluted in water. The method and this 
figure are based on Meijer et al. 2007 (ORF: open reading frame; UTR: untranslated region).  
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2.3.8.1 Poly(A)-mRNA fractionation 
First, the oligo(dT) beads were adapted to room temperature for at least 30 min and then 
washed 3 times in 200 µl 0.5xSSC buffer. For fractionation a pool of 200 in vivo 
postovulatory-aged and 200 control oocytes was used. Oocytes were incubated in 10 µl 
Pronase for 10 min at 37 °C to digest the zona pellucida. RNA was extracted from oocytes by 
mixing them with 30 µl GTC buffer and incubation for 5 min at room temperature. After 
adding 100 µl dilution buffer (salt concentration: 9xSSC), the mixture was incubated for 
5 min at 70 °C to denature RNA and remove any secondary structures, which might interfere 
with binding to the oligo(dT) beads. The RNA mixture was applied to the oligo(dT) beads, 
placed on a rotator and incubated for 30 min at room temperature to allow RNA binding to the 
beads. Rotation prevented sedimentation of the beads and therefore intermixture of RNA and 
oligo(dT) beads during binding. The tube was then placed onto the magnet for 1 minute to let 
the beads with the bound +Poly(A) mRNA bind to the magnet. The supernatant, containing 
fraction 1 (-Poly(A) mRNA), was removed and saved. Beads were washed 3 times in 200 µl 
0.5xSSC buffer. The +Poly(A) mRNA was eluted in two steps, in decreasing salt 
concentrations. For this, beads were first resuspended in 100 µl 0.075xSSC buffer and 
incubated for 5 min at room temperature. The sample was then transferred to a magnet, 
incubated for 1 min and the supernatant containing fraction 2 (oligoadenylated mRNA) was 
removed and saved. The second elution step was conducted using 100 µl RNase free water for 
elution of fraction 3 (polyadenylated mRNA).  
2.3.8.2 RNA cleanup and concentration 
After fractionation, the 3 fractions were all suspended in different buffers with varying salt 
concentrations. To clean up and concentrate the RNA the RNeasy MinElute Cleanup Kit was 
used according to manufacturer’s instructions. Before cleanup, Luciferase RNA was spiked 
into each fraction as an external reference for normalization of later analysis. This was not 
done before fractionation since Luciferase RNA has a poly(A) tail of 30 adenosines and 
would have been fractionated. An on-column DNA-digestion was carried out using DNase I 
as described in the kits user instructions. RNA was eluted in 14 µl RNase-free water.  
The RNA quantity and quality was assessed by capillary electrophoresis on the Agilent 2100 
Bioanalyzer (Agilent Technologies) using the RNA 6000 Pico Chip and following the 
manufacturer’s user manual.  
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2.3.9 Transcriptome-wide RNA-sequencing analysis 
The 3 mRNA fractions of both, postovulatory-aged and control oocytes were analyzed by 
transcriptome-wide RNA-sequencing on the Illumina HiSeq 2000. As a control, non-
fractionated total RNA of 20 postovulatory-aged and 20 control oocytes was used to 
determine loss of RNA during the mRNA fractionation. If no RNA would have been lost the 
sum of all fractions would add up to the total RNA control. As a second control, 3 µL RNA 
from each of the 3 fractions was pooled together to check for biases during library preparation 
and sequencing process, which might occur since the fractions do not contain the same type of 
RNA: the unbound fraction contains other RNA types such as rRNA and tRNA next to 
mRNA, whereas the other fractions contain pure mRNA, which differ in length of the poly(A) 
tail. If these differences in RNA do not affect the RNA-sequencing, then the pool of fractions 
should be identical with the sum of the single fractions.  
2.3.9.1 Library preparation 
The sequencing libraries were prepared using the Ovation Single Cell RNA-Seq system, 
which is designed for very low amounts of total RNA, following the recommendations of 
NuGEN (User Guide “Ovation Single Cell RNA-Seq system”, Version M01363 v6). Briefly, 
the RNA fractions were first reverse-transcribed into single stranded antisense cDNA. The 
cDNA was then processed with a restriction enzyme into fragments of approximately 300 bp. 
A forward adaptor with a semi random primer attached was ligated to the 3’end of the 
fragments. The semi random primer mix was specific for mRNA to enrich for transcripts in 
the library. This was followed by second strand synthesis and end repair. Last, a reverse 
primer was ligated to the 5’end of the double stranded fragments and the library was 
amplified and enriched in two subsequent PCR steps. The reverse primer contained a 6 bp 
barcode that allowed identification of the sample during the sequencing analysis. Each sample 
got its own barcode enabling pooling of all samples together in one flow cell during 
sequencing. The fragment length, library quality and quantity were analyzed on a High 
Sensitivity DNA chip on the Agilent Bioanalyzer 2100.  
2.3.9.2 RNA-sequencing on the Illumina HiSeq 
Sequencing of the cDNA library was conducted on the Illumina HiSeq 2000 in the Biochip 
Laboratory of the University Hospital Essen by PD Dr. Ludger Klein-Hitpass and Claudia 
Haak. The HiSeq 2000 is an ultra-high-throughput next generation sequencing system, based 
on a four-colour cyclic reversible terminator system. During sequencing, each of the four 
nucleotides is labeled with its own fluorescent dye, which emits a signal when incorporated 
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into the DNA template. The fluorescent signals are captured in so-called flowgrams and 
converted into sequences. 
The library was automatically clustered and amplified on the cBot (Illumina) using the HiSeq 
Cluster Kit v4 (Illumina). The cDNA molecules of the library all contain a forward and 
reverse primer, which both include an adaptor sequence (dual-indexed). The molecules are 
captured by covalent binding to oligonucleotides that are complementary to the adaptor 
sequence and attached to the flow cell. A clonal cluster of each of these cDNA molecules 
arises by solid-phase bridge amplification on the flow cell. One flow cell contains 8 lanes. All 
samples (fractions and controls) were pooled and loaded to 1 lane of the flow cell. The flow 
cell was then transferred to the HiSeq 2000, which was loaded with the HiSeq SBS Kit v4. A 
dual-indexed paired-end sequencing protocol was applied, in which 100 bp sequences were 
generated.  
2.3.9.3 Analysis of RNA-Seq data 
The data produced by the Illumina HiSeq were transferred to the Department of Genome 
Informatics of the University Hospital Essen, where they were analyzed by Prof. Sven 
Rahmann, Dr. Daniela Beißer and Dr. Inken Wohlers. First, reads were mapped against the 
mouse transcriptome with Tophat2. Short reads and duplicate reads were excluded. Then the 
data were filtered by searching for genes with HTSeq-Count. Fractions were normalized 
against the two control groups (total RNA and pooled fractions). Luciferase RNA that was 
spiked into each sample as external control was also included into the normalization. Genes 
represented in the control and postovulatory-aged fractions with over 500 counts were 
included into the analysis. A so called delta-score was determined to investigate changes in 
poly(A) tail length between the control and aged group. For this, first the proportion of reads 
per fraction (f1, f2 and f3) was calculated for each of the two groups separately. Then the 
score was determined with the following equation: 
𝐷𝑚𝐶𝐶𝑚 =  �𝑅1(𝐶𝐶𝑚𝐶𝑇𝐶𝐶) − 𝑅1(𝑃𝐶𝐼𝐶𝑃𝑃)� − (𝑅3(𝐶𝐶𝑚𝐶𝑇𝐶𝐶) − 𝑅3(𝑃𝐶𝐼𝐶𝑃𝑃))2  
Genes with |Delta| ≥ 0.2 were defined as having a differentially changed poly(A) tail length. 
Fraction 2 was excluded from this analysis to increase the robustness of the score. 
A gene ontology analysis was conducted with all genes that showed either differential 
deadenylation or polyadenylation using the Panther Classification System 
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(http://pantherdb.org/). A statistical overrepresentation test using default settings was 
performed searching for biological processes, molecular function and cellular compartments. 
2.3.10 Analysis of poly(A) tail length by ePAT 
The extension poly(A) test (ePAT) is a method to determine the poly(A) tail length of a 
transcript. It was first described by Jänicke et al. (2012) and established here in the institute 
by Dr. Debora Dankert. This technique is based on adding an anchor primer to the total RNA, 
which contains an oligo(dT) stretch. Klenow fragment of polymerase I ligates the primer to 
the 3’ end of adenylated mRNA transcripts. Reverse transcription starting with the anchor 
primer is then used to transcribe the transcript including the poly(A) tail into cDNA. A 
subsequent PCR with the anchor primer and a gene specific primer then generates fragments 
of different size dependent on the poly(A) tail length.  
Total RNA was extracted from 200 control and 200 postovulatory-aged oocytes as described 
above (2.3.4). RNA (7 µl from a 12 µl elution during RNA isolation) was mixed with 1 µl 
anchor primer (100 µM) and incubated for 5 min at 80 °C. The ePAT reaction was set up 
according to Table 3, incubated for 1 h at 37 °C and inactivated for 10 min at 80 °C. The 
reaction was then cooled to 55 °C and 1 µl Superscript II Reverse Transcriptase was added, 
incubated for 1 h and inactivated at 80 °C for 10 min.  
Table 3: ePAT reaction. 
Chemical  Volume 
RNA-anchor-primer mix   8.0 µl 
5x Superscript III Buffer   4.0 µl 
DTT (100 mM)   1.0 µl 
RiboLock RNase Inhibitor (1 U/µl) 1.0 µl 
Klenow fragment (5 U/µl)   1.0 µl 
Water 12.0 µl 
 
 
Next a PCR reaction was set up using a gene specific primer in combination with the anchor 
primer. The optimal primer annealing temperature was determined using a temperature 
gradient PCR (55 °C – 65 °C). The PCR was set up using the ReadyMix Taq PCR Reaction 
Mix (Table 4). 
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Table 4: PCR-reaction for ePAT. 
Sample +DNA -DNA 
2x ReadyMix Taq PCR Reaction Mix  10.0 µl 10.0 µl 
Anchor primer (5 µM)   2.0 µl   2.0 µl 
Gene specific primer (5 µM) 2.0 µl 2.0 µl 
Template from ePAT reaction 2.0-10.0 µl - 
Water Ad to 20 µl Ad to 20 µl 
 
 
The following PCR conditions were applied: 
 
93 °C     5 min 
93 °C     30 s 
Primer annealing temperature 60 s  35 cycles 
72 °C     60 s 
72 °C     7 min 
 
PCR products were verified by Sanger sequencing and then analyzed on a 1000 DNA Chip 
using the Agilent Bioanalyzer 2100 according to manufacturer’s instructions.  
2.3.11 Sanger sequencing 
The didesoxy chain terminating sequencing technique described by Sanger et al. (1977) was 
used to validate the sequence of DNA amplicons. During the sequencing reaction, the 
incorporation of fluorescence-labeled didesoxynucleotides induces chain termination. This 
can happen at any point of the sequence and leads to fragments with different sizes. An 
automated sequencer separates these fragments based on their size by electrophoresis and 
detects the fluorescent signals.  
2.3.11.1 ExoSAP-IT 
For analysis of PCR-products using Sanger sequencing, all free nucleotides and primer dimers 
had to be removed from the sample, since this would disturb the sequencing reaction. The 
USBExoSAP-ITPCR Product Cleanup kit was used for this. 5 µl PCR-product were mixed with 
2 µl ExoSAP-IT and incubated in a thermocycler for 15 min at 37 °C. The reaction was stopped 
by heating the sample to 80 °C for 15 min.  
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2.3.11.2 Sequencing reaction 
The BigDyeTerminator v1.1 Cycle Sequencing Kit was used to set up a 10 µl sequencing 
reaction: 
Template DNA Bis-DNA 
PCR-Product 1.0 µl 1.0 µl 
BigDye 2.0 µl 4.0 µl 
BigDye Buffer 1.0 µl - 
Primer (5 µM; FWD or REV) 1.0 µl 1.0 µl 
Water 5.0 µl 4.0 µl 
 
The following program was applied for the sequencing reaction:  
96 °C     1:00 min 
96 °C     0:10 min 
Primer annealing temperature 0:05 min  35 cycles 
60 °C     2:50 min 
 
After the sequencing reaction, 10 µl water was added to each sample. Free didesoxynucleotides 
were removed by sephadex gelfiltration. Then samples were mixed with 10 µl formamide and 
sequenced on the ABI PRISM 3130XL Genetic Analyzer (Life Technologies). Data analysis was 
carried out employing the Sequencing Analysis (Life Technologies) and Geneious (Biomatters) 
software.  
2.3.12 DNA-methylation analysis of 8-cell embryos 
DNA-methylation of imprinted genes in single 8-cell embryos was assessed using deep 
bisulfite next-generation amplicon sequencing. For this sequencing technology, DNA is first 
treated with bisulfite, which converts unmethylated cytosine bases into uracil. If a cytosine 
base is methylated, it is protected against this conversion. In a subsequent PCR step the uracil 
bases are replaced by thymidine bases. After sequencing the bisulfite strand is compared to a 
reference strand. At CpG positions in the reference strand, a T is found in the bisulfite strand, 
except for methylated CpGs that were protected from bisulfite conversion and still contain a 
C. Next-generation sequencing allows a resolution of the methylation status of single 
amplicon copies.  
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2.3.12.1 DNA extraction and bisulfite conversion 
The DNA of single 8-cell embryos was extracted and treated with bisulfite using the EZ DNA 
Methylation-Direct Kit according to the manufacturer’s manual. Briefly, DNA was extracted 
from the cells with Proteinase K. DNA denaturation and bisulfite treatment were combined 
into a single step in which DNA was incubated in conversion reagent for 3.5 h at 64 °C. After 
bisulfite conversion the DNA was purified on a spin-column and eluted in 10 µl elution 
buffer. 
2.3.12.2 Generation of amplicon libraries 
Three imprinted genes (H19, Snrpn and Igf2r) and 1 control gene (Pou5f1) were analyzed by 
bisulfite sequencing. To generate the amplicon libraries a 3-step protocol was established, 
each step containing a PCR. The first 2 PCR steps were based on a nested PCR protocol to 
amplify DNA from such limited material as single 8-cell embryos. For the outer PCR a 
multiplex protocol was used with a primer pool for all 4 loci. For the inner PCR all 4 loci 
were amplified separately. The primer sequences for the inner PCR contained of a specific 
and a universal tag-sequence. In the third step, a so-called Re-PCR, primers binding to the 
tag-sequence of the amplicon were added. These primers contained sample-specific barcodes 
(multiplex identifiers, MIDs), a 4 bp key and adaptor sequences A or B. These primers are 
used for clonal amplification of the sequences in an emulsion PCR (emPCR). The MIDs 
allow multiplexing of samples during sequencing and the key sequences are needed for 
filtering during data analysis.  
All primer sequences are summarized in Supplementary Table S3. Primers for the nested PCR 
have previously been described by El Hajj et al. (2011). For the outer PCR the Multiplex PCR 
kit was used and a 25 µl reaction was set up with a 10x primer mix (2 µM per primer):  
 
 
Table 5: Outer PCR reaction. 
Sample +DNA -DNA 
2x Multiplex PCR Mastermix  12.5 µl 12.5 µl 
10x Primer mix   2.5 µl   2.5 µl 
Bisulfite converted DNA  10.0 µl - 
RNase free water - 10.0 µl 
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The following PCR conditions were applied: 
95 °C  15 min 
94 °C  30 s 
52 °C  90 s  30 cycles 
72 °C  45 s 
72 °C  10 min 
The HotStarTaq Mastermix was used to set up a 25 µl inner PCR reaction, as shown in Table 
6. 
Table 6: Inner PCR reaction. 
Sample +DNA -DNA 
2x HotStarTaq Mastermix  12.5 µl 12.5 µl 
FWD Primer (5 µM)   2.5 µl   2.5 µl 
REV Primer (5 µM)   2.5 µl   2.5 µl 
Outer PCR product   3.0 µl - 
RNase free water   4.5 µl 7.5 µl 
 
A touchdown PCR protocol was employed to increase primer specificity. A touchdown 
protocol starts at a high primer annealing temperature. During the first cycles this temperature 
is reduced in each step. In this protocol the annealing temperature was reduced by 0.5 °C in 
each cycle for 14 cycles from 64 °C to 57 °C: 
 
95 °C  15 min 
94 °C  30 s 
64 °C  30 s  14 cycles: Δ -0.5 °C 
72 °C  45 s 
94 °C  30 s 
57 °C  30 s  25 cycles 
72 °C  45 s 
72 °C  10 min 
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PCR-products were visualized by agarose gel electrophoresis. Products with a fragment of the 
expected size were further analyzed by Sanger sequencing to validate the sequence. A 50 µl 
Re-PCR reaction was set up with all validated inner PCR-products using the HotStarTaq 
Mastermix: 
Table 7: Re-PCR reaction. 
Sample +DNA -DNA 
2x HotStarTaq Mastermix  25.0 µl 25.0 µl 
FWD Primer (20 µM) 0.5 µl 0.5 µl 
REV Primer (20 µM) 0.5 µl 0.5 µl 
Inner PCR product   3.0 µl - 
RNase free water 21.0 µl 24.0 µl 
 
Amplification took place applying the following PCR-conditions: 
95 °C  15 min 
95 °C  30 s 
72 °C  60 s 
72 °C  10 min 
The PCR-product was again visualized by agarose gel electrophoresis for size-validation. 
22.5 µl of validated products were diluted 1:1 with water and used for further sequencing 
analysis.  
2.3.12.3 Next-generation bisulfite sequencing 
For DNA-methylation analysis quantitative deep bisulfite sequencing on the 454/Roche 
genome sequencer (GS) Junior system was employed. Preparation of the samples and loading 
of the sequencer was conducted by Sabine Kaya at the Institute of Human Genetics of the 
University Hospital Essen according to the Roche emPCR Amplification Method Manual – 
Lib-A and the Roche Sequencing Method Manual.  
Amplicon libraries were purified, according to recommendations by Roche, using the 
Agencourt AMPureXP System and quantified on the Nanodrop ND-1000 Spectrophotometer 
(Thermo Scientific). Samples were diluted depending on their concentration, pooled and 
amplified in a clonal emPCR (GS Junior Titanium emPCR Kit – Lib-A; Roche). This PCR 
takes place in an emulsion in which each droplet represents an individual reaction chamber 
35 cycles 
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for clonal amplification of a single amplicon bound to a DNA capture bead. Each droplet 
contains Primer A and B that bind to the adaptor sequence of the primer that was added to the 
amplicon in the Re-PCR (Table 7). DNA capture beads containing amplified single-strand 
DNA sequences were washed, recovered and enriched. The enriched DNA capture beads 
were then transferred to a microtiter plate, where each well has place for one bead to avoid 
contaminations (GS Junior Titanium PicoTiterPlate Kit; Roche). The microtiter plate was 
loaded onto sequencing platform for analysis (GS Junior Titanium Sequencing Kit; Roche). 
The sequencing reaction on the 454/Roche GS Junior platform is similar to the Illumina HiSeq 
(2.3.9.2 RNA-sequencing on the Illumina HiSeq) except that the Roche is a single-colour 
fluorescent system. So each base has the same fluorescent label and has to be added separately in 
subsequent steps. 
2.3.12.4 Sequencing data analysis 
Data analysis was conducted using the Amplikyzer Software (Rahmann et al. 2013) with default 
settings based on the .ssf files generated by the 454/Roche GS Junior system. Due to the 
destruction of DNA during bisulfite treatment and the low input amount, it was not always 
possible to obtain reads for both, the maternal and the paternal allele. The parental alleles were 
distinguished by SNPs. The methylation level of the maternal and paternal allele was determined. 
In the case that both alleles were present for analysis the mean methylation level of the two alleles 
was calculated, which was expected to be 50% for imprinted genes and 0% for the Pou5f1 control 
gene. A deviation of >10% was defined as aberrant methylation of the embryo at a specific locus. 
If only one allele was sequenced, a methylation failure was defined as a deviation of >10% from 
the expected methylation level of a certain allele (0 or 100%).  
2.3.13 Statistical analysis  
Statistical analysis was conducted with the SigmaPlot 12.5 software (Systat Software, Inc). A 
two-tailed Student t-test was performed to analyze the statistical significance of differences 
between RNA-expression of aged and control oocytes and comparisons of fold change (2-ΔΔCt) 
of oligo(dT)16-primed cDNA with random hexamer-primed cDNA. The normal distribution of 
data was validated using the Shapiro-Wilk Normality test. When this test failed, as was the 
case for the number of oocytes retrieved per mouse, H3K9me3, Ybx2, BrUTP-incorporation 
and DNA-methylation analysis, a Mann-Whitney U Rank Sum test was applied instead. The 
α-level was set at 0.05 to determine statistically significant differences.  
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3 Results 
 
3.1 Oocyte retrieval after preovulatory aging 
The number of oocytes isolated per mouse was counted in the control group and after 3 and 
4 d of preovulatory in vivo aging (Figure 6A). All mice, also control mice, received the GnRH 
antagonist cetrorelix (control +cetro). An additional control group that did not receive 
cetrorelix (control –cetro) was included in the analysis to see if the cetrorelix itself had an 
impact on oocyte output.  
An average of 25.16 oocytes per mouse was isolated from control –cetro mice. When 
applying cetrorelix to control mice during oocyte maturation, this number decreased 
significantly to 17.92 oocytes per mouse (control –cetro: n = 68, control +cetro: n = 49, 
Mann-Whitney U test: p < 0.05). Aging reduced the oocyte number further to a mean of 
11.91 oocytes after 3 d of aging (n = 48) and 9.91 oocytes after 4 d of aging (n = 33). The 
difference between the control +cetro group and the aged groups was significant after 3 d 
(Mann-Whitney U test: p < 0.05) and 4 days (Mann-Whitney U test: p < 0.01). Thus, aging 
showed a major effect on oocyte retrieval rates. Since the GnRH treatment itself also seemed 
to affect oocyte growth and maturation rates the control +cetro group was used for all further 
experiments (in the following this group will be referred to as control).  
To investigate whether this reduced oocyte number upon aging is caused by degradation of 
oocytes, the number of degraded oocytes after ovulation was counted. The mean percentage 
of degraded oocytes relative to total oocytes per mouse was calculated for each group 
(Figure 6B). The percentage of degraded oocytes varied between the groups from 17.6% in 
3 d preovulatory-aged oocytes to 28.6% in the control –cetro group. No significant differences 
were found between the analyzed groups, indicating that the lower oocyte number after aging 
is not due to increased degradation.  
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Figure 6: Oocyte retrieval from control and preovulatory-aged mice. A) Boxplots demonstrate oocyte 
numbers isolated from mice after superovulation. Control mice are split into two groups, one that did not receive 
cetrorelix (control –cetro) and another that received cetrorelix (control +cetro). Preovulatory aging (PreOA) was 
conducted for either 3 or 4 days in the presence of cetrorelix. Cetrorelix treatment reduced oocyte numbers in 
control mice. Preovulatory aging further lowered the oocyte number. B) Graph shows the percentage of degraded 
oocytes per mouse (Mean±SEM), which did not differ significantly between the groups. Control –Cetro: n = 68, 
Control +Cetro: n = 49, PreOA 3d: n = 48, PreOA 4d: n = 33, Mann-Whitney U test: * p < 0.05; ** p< 0.01. 
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3.2 H3K9me3 histone methylation 
It is not clear what causes the observed decline in oocyte maturation rates upon preovulatory 
aging. One crucial step in oocyte maturation is the transcriptional silencing of the maternal 
genome during prophase I of meiosis. This is mediated by repressive epigenetic histone 
modifications such as the trimethylation of histone H3 lysine K9 (H3K9me3; Kageyama et al. 
2007). H3K9me3 is further important for chromosome integrity and genome stability (Peters 
et al. 2001). Therefore, the effect of preovulatory aging on the level of H3K9me3 in oocytes 
was investigated using immunofluorescence (IF) analysis. H3K9me3 was visualized in 
control (n = 106) and 4 d preovulatory-aged (n = 65) oocytes and relative signal intensity was 
compared by quantification with ImageJ (Figure 7). In both control and aged oocytes the 
H3K9me3 signal co-localized with the chromosomes in the cell nucleus (Figure 7A). Relative 
quantification of fluorescent staining intensities showed no significant difference between 
aged and control oocytes (Mann-Whitney U test: p = 0.973; Figure 7B). The mean signal 
intensity of control oocytes was set to 1 ± 0.06 a.u. (mean ± SEM) and compared to controls 
the mean signal intensity of the aged oocytes was 0.97 ± 0.05 a.u. The results indicate that 
preovulatory aging does not affect the level of H3K9 trimethylation. 
 
 
Figure 7: Immunohistochemical analysis of histone methylation H3K9me3 in control and 4 d 
preovulatory-aged (PreOA 4d) oocytes. A) Representative DAPI and anti-H3K9me3 stainings of cell nuclei of 
control and preovulatory-aged oocytes. B) Relative quantification of fluorescent signal intensities showed no 
significant difference between control and aged oocytes. Control: n = 106, PreOA 4d: n = 65; a.u.: arbitrary 
units. 
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3.3 Ybx2 transcript and Ybx2 protein expression 
For the storage of maternal transcripts and stabilization of the poly(A) tail length the Ybx2 
protein is essential (Medvedev et al. 2011). Transcript levels of Ybx2 were analyzed in 4 
control oocyte pools and in 3 pools of 4 d preovulatory-aged oocytes by qRT-PCR after 
cDNA-synthesis with random hexamer primers. Each pool contained 10 oocytes. Transcript 
levels decreased with a normalized fold change of 0.35 in aged oocytes compared to controls, 
although this decline was not significant due to high variation between the control pools (t-
test: p = 0.137; Figure 8).  
 
 
Figure 8: Transcript levels of Ybx2 in control and 4 d preovulatory-aged (PreOA 4d) oocytes. Indicated is 
the fold change of aged oocytes compared to controls, which was normalized against a Luciferase standard 
curve. The cDNA was primed with random hexamers and the two groups were compared using a t-test. No 
significant difference of transcript expression was observed. Indicated is the Mean±SEM. Control: n = 4, 
PreOA 4d: n = 3. 
 
Next the protein expression of Ybx2 was investigated using IF analysis (Figure 9). Staining of 
Ybx2 was documented by CLSM by Dr. Tom Trapphoff. In control oocytes, Ybx2 expression 
was observed throughout the whole cytoplasm, but was enriched in the subcortical RNP 
(ribonucleoprotein particles) domain (SCRD) (Figure 9A). Furthermore, expression was also 
seen in the chromosome spindle complex (arrowheads in Figure 9A’). Here, Ybx2 localized in 
the proximal kinetochore area of the chromosomes left and right to the equatorial plate in the 
spindle halves. It was absent in the area of the interpolar microtubules, in the center of the 
spindle with the chromosomes and in the polar part of the spindle and the anastral spindle 
poles.  
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After 4 d of preovulatory aging Ybx2 expression decreased in the subcortical area as well as 
in the rest of the cytoplasm (Figure 9B). Also, the spindle complex surrounding the 
chromosomes showed less Ybx2 signal after aging (Figure 9B’). The signal intensity of Ybx2 
was quantified by X-axis profiling of the relative Ybx2 mean abundance through a cross-
section of the entire cell (Figure 9C). This demonstrated enrichment of Ybx2 in the cortex of 
control and aged oocytes and also a decline in transcript abundance after aging. This uniform 
decline was also confirmed by determination of the relative staining intensity of the overall 
ooplasm, or the subcortical and the inner cytoplasmic regions separately (Figure 9D). Staining 
intensity of 83 control oocytes was compared to that of 120 aged oocytes after normalization 
against background staining. In the SCRD and in the inner cytoplasm Ybx2 expression was 
significantly lower in aged oocytes relative to controls (Mann-Whitney U test: p < 0.001 for 
both regions; Figure 9E). It is therefore not surprising that also a highly significant decrease in 
protein level in the total cytoplasm was observed after preovulatory aging (Mann-Whitney U 
test: p < 0.001). The decrease in transcript and protein levels of Ybx2 might have 
implications for RNA stability in the oocyte.  
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Figure 9: Ybx2 protein localization and relative protein abundance in control and 4 d preovulatory-aged 
(PreOA 4d) oocytes investigated by confocal laser scanning microscopy. Representative figures of Ybx2 
expression in control (A) and aged oocytes (B). A, A’) Ybx2 protein is enriched in the subcortical RNA domain, 
but also detectable in the cytoplasm, as well as in the spindle chromosome complex (arrowheads in close-up A’). 
B, B’) Reduced staining for Ybx2 was observed in preovulatory-aged oocytes and no enrichment in the spindle 
of the aged oocyte. C) X-axis-scanning through an entire cell revealed an even decline in protein abundance in 
aged oocytes in comparison to controls. D, E) This decrease in overall protein abundance was confirmed by 
semi-quantification of relative fluorescence intensity of the subcortical and inner cytoplasmatic region as well as 
total ooplasm, normalized against background fluorescence (BGR). Scale bar in D also applies to A and B and 
scale bar in B’ also to A’. Control: n = 83, PreOA 4d: n = 120, Mann-Whitney U test: *** p < 0.001.  
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3.4 Transcript levels and poly(A) content of maternal effect genes 
Since Ybx2 levels are reduced in oocytes after preovulatory aging, the effect on mRNA level 
and poly(A) tail stability of transcripts of maternal effect (ME) genes was assessed. ME genes 
are of crucial importance for early embryonic development (Li et al. 2010). It was analyzed 
by qRT-PCR if 3 d of preovulatory aging affects the expression of 10 selected candidate ME 
genes (Figure 10). Three pools of 20 oocytes each were analyzed for every experimental 
group. Preovulatory aging in vivo as well as in follicle culture was assessed. For cDNA 
synthesis total RNA was either primed with random hexamers or with oligo(dT) primers. This 
allows investigation of the poly(A) content of the ME transcripts, which is interesting because 
poly(A) tail length is an important regulator of translation efficiency in the oocyte (Clarke 
2012). Changes in total transcript levels can be visualized by the fold change of the random 
primed cDNA. The oligo(dT) primers bind to the poly(A) tail of a transcript. Therefore, 
comparison of oligo(dT)-primed cDNA to random-primed cDNA provided information about 
the poly(A) content of the transcripts: If the poly(A) content stays stable during aging, the 
fold change of oligo(dT)-primed cDNA should change in a similar amount as the fold change 
of random-primed cDNA (e.g. Zfp57 in Figure 10B). If however, the length of the poly(A) tail 
of a transcript changes, this can be observed as a difference in fold change between random- 
and oligo(dT)-primed cDNA (e.g. Smarca4 in Figure 10A).  
After oocyte maturation and 3 d of preovulatory aging in vivo, the mean transcript levels of 
Smarca4 and Tet3 decreased significantly by approximately two-fold compared to controls 
(Figure 10A; Smarca4: Fold change = 0.53, t-test: p < 0.01; Tet3: Fold change = 0.48, t-test: 
p < 0.05), as indicated by the normalized fold change of random hexamer-primed cDNA. 
Zfp57 transcript levels also tended to decrease after aging (Fold change = 0.54, t-test: 
p = 0.0602). The other analyzed genes, Trim28, Dnmt1, Nlrp2, Nlrp5, Nlrp14, Pou5f1 and 
Zar1 did not show significant changes in total transcript levels in aged oocytes compared to 
controls. When comparing the fold change of random- and oligo(dT)-primed cDNA, Smarca4 
showed a trend towards an increased poly(A) content (Oligo(dT) fold change = 1.42, t-test: 
p = 0.0567). The other ME-genes did not show significant differences between random- and 
oligo(dT)-primed cDNA. The tendency towards an increased poly(A)content was visible for 
all genes though.  
  
 Results 
62 
 
 
 
Figure 10: Transcript levels and poly(A) content of ME genes of 3 d in vivo (A) or in vitro (B) 
preovulatory-aged oocytes compared to controls. Indicated is the normalized fold change of 10 ME genes of 
aged oocytes compared to control oocytes. cDNA of oocytes was either primed with random hexamers to show 
total transcript levels or with oligo(dT) primers. Comparing the fold change of random- and oligo(dT)-primed 
cDNA indicates the poly(A) content of transcripts. A) In vivo aging of oocytes led to significantly reduced 
transcript levels of Smarca4 and Tet3 and a general tendency of poly(A) content increase. B) In vitro aging 
caused transcript decline of Trim28, Nlrp2, Nlrp14 and Zar1. Indicated is the Mean±SEM. Three pools of 20 
oocytes were analyzed for each group; t-test: t: p < 0.10, * p < 0.05, ** p < 0.01. This figure was modified from 
Dankert et al. 2014.  
 
Mean transcript levels of in vitro preovulatory-aged oocytes were significantly lower 
compared to controls for Trim28 (Fold change = 0.51, t-test: p < 0.05), Nlrp2 (Fold 
change = 0.58, t-test: p < 0.05), Nlrp14 (Fold change = 0.56, t-test: p < 0.05) and Zar1 (Fold 
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change = 0.46, t-test: p < 0.05; Figure 10B). A trend towards decreased transcript levels in 
aged oocytes compared to controls was also observed for Nlrp5 (Fold change = 0.49, t-test: 
p = 0.0541). Comparing random- and oligo(dT)-primed cDNA of in vitro-aged oocytes 
showed a trend of increased poly(A) content of Zar1 (Oligo(dT) fold change = 0.82, t-test: 
p = 0.752). Again this tendency was also observed for other analyzed genes, although not as 
pronounced as for in vivo-aged oocytes.  
Overall, the results show a decrease of transcript level for certain genes after preovulatory 
aging, although different genes were affected in vivo than in vitro. The poly(A) content of 
transcripts tends to increase upon aging, although only few significant changes were 
observed, due to high variation between samples.  
3.5 Transcriptome-wide analysis of poly(A) tail length 
After having seen effects of preovulatory aging on poly(A) tail length in some of the 
investigated candidate genes, the poly(A) tail length during aging was analyzed on a 
transcriptome-wide level. Total RNA was fractionated into 3 fractions with different poly(A) 
tail length. Establishment of the method was carried out using postovulatory-aged oocytes 
instead of preovulatory-aged oocytes because these oocytes are easier and cheaper to obtain. 
Poly(A) tail length of postovulatory-aged oocytes was compared to control oocytes. 
Successful poly(A) fractionation was verified for Dnmt1 and Zar1 with an extension poly(A) 
test (ePAT) by Dr. Debora Dankert (Dankert 2015). 
3.5.1 Poly(A)-sequencing analysis 
All fractions where sequenced on the Illumina HiSeq 2500 and reads were mapped against the 
mouse transcriptome. The number of mapped reads lay between 918,565 and 22,791,961 
reads depending on group and fraction, which corresponded to 27-79% of total read number 
(Supplementary Table S4). More reads were found in the control group in comparison to the 
postovulatory-aged oocytes. The duplicate rate was relatively high, varying between 58 and 
84%. The number of reads which coded for known genes was determined (counts). Fraction 1 
contained the majority of counts (Control: F1 = 11,625,270 counts; PostOA: F1 = 13,480,406 
counts) and in Fraction 2 and 3 less than half of the counts were found (Control: 
F2 = 7,319,693 counts, F3 = 3,814,821 counts; PostOA: F2 = 807,163 counts, F3 = 664,657 
counts). Most of these counts encoded protein-coding genes (between 75 and 99%).  
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Figure 11: Poly(A)-sequencing analysis of control and postovulatory-aged (PostOA) oocytes. A delta-score 
showing the change in poly(A) tail length between control and PostOA oocytes is visualized. A) The number of 
genes which had a differential poly(A) tail length is shown in relation to their delta-score, demonstrating that the 
majority of genes with a change in poly(A) tail length show deadenylation in aged oocytes. B, C) The ratio 
between counts without and with a poly(A) tail are shown for Nupr1, a gene with a delta-score indicating loss of 
poly(A) tail length (B) and for Btf3, which shows polyadenylation in PostOA oocytes (C). Differential poly(A) 
tail length: delta value < -0.2 or delta value >0.2.  
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The delta-score was used to compare control and postovulatory-aged oocytes and to 
determine poly(A) tail changes between the two groups. Fraction 2 and 3 were combined and 
it was just distinguished between mRNA without and with poly(A) tail (-poly(A) fraction and 
+Poly(A) fraction), to improve the robustness of the analysis. In total, 183 genes with a 
differential poly(A) tail length where found, of which 130 showed a loss of poly(A) tail and 
53 genes showed a gain in polyadenylation (Figure 11A and Supplementary Table S5). In 
Figure 11B and C examples of genes where the delta-score indicated a clear loss or gain of the 
poly(A) tail length are shown. For Nupr1 (delta -0.435) 71% of counts in control oocytes 
were found in the +poly(A) fraction and after postovulatory aging, only 29% of counts had a 
poly(A) tail. The opposite was found for Btf3 (delta 0.421), where the +poly(A) fraction 
increased after postovulatory aging from 23% to 68% of total counts. A gene ontology 
analysis did not find any biological processes, molecular functions or cellular compartments 
enriched within these gene groups, which could indicate that it is not a specific process, 
function or location that is affected by poly(A) tail changes due to postovulatory aging. All 
interpretations should be taken with caution since it was not possible to repeat this experiment 
and analysis. Three subsequent trials failed due to low sequencing library quality or because it 
was not possible to normalize the data to the Luciferase RNA or to the controls (total RNA 
and pool of F1-F3). 
3.5.2 ePAT analysis 
To verify the results obtained from the single poly(A) sequencing analysis, an ePAT was 
performed allowing the investigation of the poly(A) tail length for individual genes. Since the 
ePAT showed unspecific fragments during agarose gel electrophoresis, the fragment of the 
expected size was eluted and verified by Sanger sequencing. After this validation, the ePAT 
of 4 genes (Btf3, Prdx2, Ddx3x and Nupr1) was assessed on an Agilent DNA 1000 or DNA 
High Sensitivity chip. A region of interest containing the peak with the expected fragment 
size was defined and the concentration and average fragment size within this region was 
determined. The ePAT of Btf3, which in the sequencing analysis showed a decline in poly(A) 
content after postovulatory aging, showed a decrease in transcript levels after postovulatory 
aging from 8.85 ng/µl to 6.88 ng/µl (Supplementary Table S6). It was not possible to see a 
clear shift in the peak size between control and postovulatory-aged oocytes, indicating no 
change in poly(A) tail length (Figure 12A). This is not in accordance with the RNA 
sequencing results. Another example for polyadenylation, Prdx2 was investigated, which had 
a delta value of 0.244 during the poly(A) sequencing analysis. This gene showed no clear 
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decline in transcript levels (control: 1.08 ng/µl; PostOA: 1.01 ng/µl). The peak size changed 
from an average size of 429 bp in control oocytes to 471 bp in aged oocytes, indicating an 
increase in poly(A) tail length in agreement with the sequencing results (Figure 12B). Ddx3x 
showed no change in poly(A) tail length during the sequencing analysis (delta value: 0.090). 
The ePAT confirmed this result, since there was no visible shift in peak size between control 
and postovulatory-aged oocytes (Figure 12C). It also showed a decrease in transcript level of 
aged oocytes (control: 2.55 ng/µl; PostOA: 2.40 ng/µl). Nupr1 showed deadenylation after 
aging during the sequencing experiment. We were not able to detect a signal for this transcript 
after postovulatory aging in two trials with 200 pooled oocytes each, probably due to a severe 
transcript decline upon aging (Figure 12D). Of the other 3 genes only 2 confirmed the 
sequencing data. Taken together with the 3 unsuccessful trials to reproduce the poly(A) 
sequencing experiment, it seems that this method is not reliable with the experimental set up 
used here. This is possibly due to the low input amount when using mammalian oocytes. 
Therefore, the transcriptome-wide approach was not used to investigate poly(A) tail length in 
preovulatory-aged oocytes.  
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Figure 12: Poly(A) tail length of 200 pooled control and 200 pooled postovulatory-aged (PostOA) oocytes 
as determined by ePAT of the transcripts Btf3 (A), Prdx2 (B), Ddx3x (C) and Nupr1 (D). Shown is the 
fluorescence intensity of DNA fragments as measured with an Agilent DNA 1000 chip (Btf3, Ddx3x, Nupr1) or 
DNA High Sensitivity chip (Prdx2). The peaks for the upper and lower marker are indicated by the arrows and 
the region of interest (green), containing the amplicon peak with the possible poly(A) tail. A shift in poly(A) tail 
length was observed only for Prdx2.  
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3.6 Fertilization rates after preovulatory aging 
To analyze the developmental capacity of preovulatory-aged oocytes in comparison to control 
oocytes, female C57Bl/6J mice were mated either with C57Bl/6JxCBA hybrid males or 
CAST/EiJ males (see also 2.2.9). The hybrid males were used for mating instead of C57Bl/6J 
males to avoid inbred depression, which was shown to affect the fertilization rates of IVF 
(Dankert 2015). A mating was counted successful when the female had a vaginal plug the 
next morning after mating and 2-cell embryos were found in the oviduct 36 h after mating. 
The number of 2-cell embryos and unfertilized oocytes of every mating was recorded. The 
ratio of 2-cell embryos to total oocyte number found in the oviduct was defined as fertilization 
rate. 
 
 
Figure 13: Two-cell rate as indicator of fertilization rate (A) and absolute number of 2-cell embryos (B) 
after mating of C57Bl/6J females with C57Bl/6JxCBA hybrid males. Fertilization of oocytes after 3 d of 
preovulatory aging (PreOA 3d) was significantly reduced after aging compared to controls as demonstrated by 
the decreased 2-cell rate. Also, the total number of 2-cell embryos decreased after aging. Indicated is the 
Mean±SEM. Control: n = 10, PreOA: n = 5, t-test: * p < 0.05. 
 
In total, 10 of 18 control females were effectively mated with C57Bl/6JxCBA hybrid males. 
In contrast, only 5 of 16 matings with females with 3 d preovulatory-aged oocytes were 
successful. The fertilization rate of control mice lay at 76% (n = 10, SEM = 6.93; 
Figure 13A). After preovulatory aging the fertilization rate dropped significantly to 46% 
(n = 5, SEM = 10.45, t-test: p = 0.0299). This is a drop of almost one third. When looking at 
 Results 
69 
 
total number of embryos that derived from each mating the difference between control and 
preovulatory oocytes was even greater: the mean embryo number derived from control 
embryos was 16.6 (SEM = 3.58; Figure 13B) and after preovulatory aging the number 
declined to an average of 5.2 (SEM = 2.54; t-test: p = 0.0563). This is a decrease of more than 
two third. The low number of embryos can be explained by a combination of low fertilization 
rates and a reduced oocyte number after preovulatory aging in vivo (see 3.1). So there are 
fewer oocytes available for fertilization after preovulatory aging and these oocytes seem more 
difficult to fertilize. Taken together, the data point to a reduced developmental competence of 
oocytes after 3 d of preovulatory aging.  
To distinguish between paternal and maternal genetic background during the DNA 
methylation analysis of 8-cell embryos, males of the CAST/EiJ mouse strain were used for 
mating with C57Bl/6J females. Two-cell embryos were collected from the oviduct 36 h after 
mating. In general, the mating rate was very low: 3 out of 8 control matings and only 3 out of 
21 matings after aging were successful. The fertilization rate was similar to C57Bl/6JxCBA 
hybrid males (control: 83% ± 11.5 SEM and PreOA 54% ± 4.1 SEM). Due to the low number 
of trials the difference was not significant. The number of embryos retrieved per mating was 
similar between the control and aged group. From control mice an average of 13 ± 3.8 SEM 
embryos was retrieved and after preovulatory aging the number dropped to 10 ±1.0 SEM 
embryos. Embryos were further cultured in vitro to the 8-cell stage. The developmental rates 
did not differ greatly between the 2 groups (control: 84.0%; PreOA: 88.9%). In summary, it 
seems that preovulatory-aged oocytes are more difficult to fertilize, but that those that are 
successfully fertilized develop in a similar rate as controls.  
3.7 Transcription onset in 2-cell embryos 
To investigate the embryonic genome activation, transcriptional activity of embryos at the 2-
cell stage was assessed. At this time point the first major wave of embryonic genome 
activation should occur (Schultz 1993; Hamatani et al. 2004; Wang et al. 2004). Two-cell 
embryos derived from control and 3 d in vivo preovulatory-aged oocytes were incubated in 
BrUTP. During transcription BrUTP is incorporated into nascent RNA and is converted to 
BrU. The BrUTP incorporation into 2-cell embryos was visualized with a FITC-labeled 
antibody against BrU (Figure 14A). BrU was mainly present in the cell nuclei of control and 
aged embryos, where it was enriched in nucleoli-like structures. In embryos derived from 
preovulatory-aged oocytes, the BrU signal was more intense than in control embryos. The 
fluorescent signal of the cell nucleus was semi-quantified by Image J, normalized against 
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background staining and a fold change of embryos from aged oocytes in comparison to 
control embryos was calculated (Figure 14B). A total of 61 control embryo cells and 43 cells 
from embryos derived after oocyte aging were analyzed. Embryos from preovulatory aged 
oocytes showed a highly significant increased fold change of 2.85-fold in comparison to 
control embryos (Mann-Whitney U test: p < 0.001). This indicates a higher transcription rate 
in 2-cell embryos derived from aged oocytes.  
 
 
Figure 14: BrUTP incorporation in 2-cell embryos derived from control or 3 days preovulatory-aged 
(PreOA 3d) oocytes. A) Shown are representative 2-cell embryos derived from either control embryos or after 
preovulatory oocyte aging, which had been incubated in BrUTP. BrUTP is incorporated into nascent RNA 
during transcription and converted into BrU. DNA was stained with DAPI and BrUTP incorporation with a 
FITC-labeled antibody against BrU. B) The normalized fluorescence intensity shows a significant increase in the 
PreOA group in comparison to controls. Control: n = 61, PreOA: n = 43;Mann-Whitney U test: *** p < 0.001.  
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3.8 DNA methylation of imprinted genes in 8-cell embryos 
Differential DNA methylation of imprinted genes is maintained throughout embryonic 
reprogramming. Imprint maintenance was assessed of 15 control and 14 embryos derived 
from preovulatory-aged oocytes by analyzing DNA methylation levels of 3 imprinted loci at 
the 8-cell stage (H19, Snrpn, Igf2r). At this time point in embryonic development all cells are 
still pluripotent, but the embryonic genome is already fully active. Pou5f1 was analyzed as a 
control gene that should undergo reprogramming and should be fully demethylated at the 8-
cell stage (El Hajj et al. 2011). Deep-amplicon bisulfite sequencing of single embryos showed 
indeed methylation levels of nearly 0% for Pou5f1 for most control and preovulatory-aged 
embryos on both the maternal and paternal allele (Figure 15A, Supplementary Figures S1 and 
S2, Supplementary Table S7). Of the 3 imprinted loci analyzed H19 is the only one with 
imprint methylation on the paternal allele, which was indeed observed (Figure 15B, 
Supplementary Figures S3 and S4, Supplementary Table S8). The amplicon included 4 CpGs, 
but the methylation on the paternal allele of the first CpG was unstable in both control and 
preovulatory-aged embryos, so it was excluded from the analysis. As expected, Snrpn and 
Igf2r both showed methylation of the maternal and not the paternal allele (Figure 15C and D, 
Supplementary Figures S5-S8, Supplementary Table S9 and S10). PCR template switching 
was observed on the Snrpn locus and, although to a lesser extent, the H19 locus. It was not 
possible to observe fully methylated and fully unmethylated alleles for these loci. Therefore, 
for the further analysis the mean methylation levels of the maternal and paternal alleles were 
analyzed to compensate the template switches. In Figure 15E an example of an embryo with 
aberrant methylation is shown for the Igf2r locus. In this example the maternal allele is 
hypomethylated, while the paternal allele shows low methylation as expected. This 
hypomethylation of the maternal allele could indicate failure in imprint setting or an 
impairment of imprint maintenance during embryonic development.  
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Figure 15: DNA methylation on the maternal and paternal allel for representative single 8-cell control 
embryos assessed by deep amplicon bisulfite-sequencing. Individual reads are shown in rows, single CpG 
sites are shown in columns. Methylation status for each CpG is indicated in red (methylated) or blue 
(unmethylated). The total number of reads and average methylation rate are shown per allele at the top of each 
figure. A) Pou5f1 is a control gene, which was expected to be fully demethylated at the 8-cell stage. B-D) Three 
imprinted genes were analyzed: H19, which was expected to be paternally methylated (B) and Snrpn and Igf2r, 
which were expected to be maternally methylated (C, D). E) An example for aberrant DNA methylation of an 
embryo is shown for the Igf2r locus where the maternal allele is hypomethylated.  
 
The mean methylation of the maternal and paternal allele of Pou5f1 was close to 0% for both 
control and preovulatory-aged embryos (Control = 6.1%; PreOA 3d = 1.4%; Figure 16A). 
Embryos derived from preovulatory-aged oocytes actually showed 0% methylation for all but 
one, whereas 8 of 15 control embryos showed methylation levels over 0%. The difference 
between control and aged embryos was not significant. All imprinted genes showed average 
methylation levels around 50% when combining the methylation levels of the maternal and 
paternal alleles. For H19 the mean methylation level of control embryos was 49.6% and 
46.4% for aged embryos (Figure 16B). Again there was no significant change between control 
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and aged embryos. Similar results were obtained for Snrpn (control = 42.9%; 
PreOA 3d = 49.8%; Figure 16C) and Igf2r (control = 47.6%; PreOA 3d = 47.5%; 
Figure 16D). 
 
 
Figure 16: DNA methylation levels in embryos of control and 3 d preovulatory-aged (PreOA 3d) oocytes. 
Boxplots indicate the mean methylation levels of the maternal and paternal allele, which for Pou5f1 (A) lies 
close to 0% and for the imprinted genes H19 (B), Snrpn (C) and Igf2r (D) around 50%. Dots visualize the mean 
methylation level for single embryos. No significant differences were observed between control and aged 
embryos for any of the investigated loci. Control: n = 15, PreOA: n = 14. 
 
 Results 
75 
 
To determine the number of embryos with aberrant methylation, mean methylation levels of 
single embryos were assessed and an embryo with over 10% divergence from the expected 
methylation was defined as having methylation impairment. For Pou5f1 3 of 15 analyzed 
control embryos and 1 of 12 analyzed preovulatory-aged embryos showed aberrant 
methylation of over 10% (Figure 17A). This is not a big difference but more control than 
preovulatory-aged embryos showed a methylation failure, which is in line with the higher 
mean methylation level observed for the control group. For H19 more embryos of aged 
oocytes with a methylation failure were detected (control: 2/13; PreOA 3d: 3/14; Figure 17B). 
Snrpn was the locus where most embryos with aberrant methylation were found: 5 of 15 
control embryos and 2 of 14 embryos from preovulatory-aged oocytes had mean methylation 
levels below 40% or above 60% (Figure 17C). No embryos of preovulatory-aged oocytes 
showed methylation abnormalities for Igf2r and only 2 of 15 control embryos displayed 
abnormal methylation on this locus (Figure 17D).  
Overall, there were no clear differences between the number of embryos with methylation 
aberrations of the control and preovulatory-aged group. This is consistent with a lack of 
significant differences in average methylation levels between the two groups. These results 
demonstrate that preovulatory aging does not affect DNA methylation of the 4 analyzed 
genes.  
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Figure 17: Number of embryos with aberrant methylation levels derived from control or 3 d preovulatory-
aged (PreOA 3d) oocytes. The number of analyzed embryos is shown, with embryos with impaired methylation 
levels indicated in grey for Pou5f1 (A), H19 (B), Snrpn (C) and Igf2r (D). No clear effect of aging on 
methylation failure can be observed. 
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4 Discussion 
Growth and maturation of the mammalian oocyte are tightly regulated and perturbations of 
these processes can have severe effects on the developmental potential of the oocyte. The 
present study focused on the molecular effects of prolonged oocyte maturation known as 
preovulatory aging. Hardly anything is known about this form of oocyte overripeness making 
this study to the most detailed analysis about the molecular mechanisms of preovulatory aging 
so far. An in vivo mouse model was used in which ovulation was delayed with the GnRH 
antagonist cetrorelix. The effects of delayed ovulation on RNA storage potential, transcript 
levels and poly(A) tail length, as well as on epigenetic histone modifications were 
investigated in oocytes. To assess the developmental capacity of the preovulatory-aged 
oocytes several aspects of early embryonic development were analyzed. It was found that 
certain but not all processes were impaired by preovulatory aging demonstrating that there is a 
distinct regulation of these processes.  
4.1 Preovulatory aging reduces oocyte number and fertilization rates 
Ovulation is a critical step in each menstrual cycle. Since preovulatory aging is caused by 
deregulation of the menstrual cycle it was interesting to see if it would interfere with oocyte 
maturation. Furthermore, fertilization rates were determined to investigate the quality and 
developmental potential of oocytes after preovulatory aging. 
4.1.1 Effects of cetrorelix on oocyte numbers during regular menstrual cycles 
The cetrorelix mouse model of the present study is the first in vivo model for preovulatory 
aging induced by hormonal manipulation of the menstrual cycle. The GnRH antagonist 
cetrorelix suppresses gonadotropins during ovarian stimulation and thus prevents a premature 
LH surge. It has found broad application in human assisted reproductive techniques (ART). 
Before the introduction of GnRH antagonists GnRH agonists were used in ART to diminish 
gonadotropins during ovarian stimulation. Over 200 studies have compared the benefits and 
disadvantages of both protocols with conflicting results. Meta-analyses found lower oocyte 
numbers as well as slightly reduced pregnancy rates using a GnRH antagonist protocol (Al-
Inany 2007; Al-Inany et al. 2011). The reduced oocyte numbers are in line with the results of 
the present study. Since the difference in pregnancy rate between the two protocols did not 
differ much, and antagonists have many benefits such as a shorter treatment period and less 
side-effects in comparison to agonists they are still widely used (Depalo et al. 2012).  
 Discussion 
78 
 
It is not known why GnRH antagonists lead to a lower number of oocytes. Since in human 
ART oocytes are not ovulated but retrieved directly from the ripe follicles, the antagonist is 
likely to affect oocyte maturation before ovulation. Antagonists bind competitively to GnRH 
receptors and directly prevent GnRH to stimulate the pituitary cells to produce gonadotropins. 
This leads to a deep suppression of LH secretion, which has been proposed to affect follicle 
maturation and oocyte ripening. Indeed, it is known for another antagonist, ganirelix, that 
with increasing antagonist dosage the LH and estrogen levels drop and implantation and 
ongoing pregnancy rates decline (The ganirelix dose-finding study group 1998). However, 
studies trying to overcome this problem by LH substitution showed no effect on oocyte 
retrieval or embryo numbers and pregnancy or delivery rate, which contradicts this hypothesis 
(Aboulghar et al. 2004; Cedrin-Durnerin et al. 2004; Baruffi et al. 2007). Another postulated 
explanation for the observed effects in humans is that not the absolute LH levels are 
associated with low pregnancy rates after GnRH antagonist treatment but the large changes in 
LH levels during treatment. Oocyte maturation could also be affected by FSH suppression 
during cetrorelix treatment. In the present study, control mice that did not receive cetrorelix 
secreted intrinsic FSH next to injected PMSG that supports follicle and oocyte development. 
In case that these intrinsic hormone levels are suppressed due to cetrorelix this might lead to 
recruitment of fewer follicles and therefore to lower oocyte numbers at the time point of 
ovulation.  
In order to study the influence of intrafollicular aging rather than suppression of LH, the 
control mice in the present study received cetrorelix but were stimulated to ovulate without 
delay. Nevertheless, it cannot be excluded that the effects seen in the in vivo model for 
preovulatory aging are at least partly an effect of prolonged cetrorelix treatment instead of 
prolonged ripening.  
4.1.2 Effects of preovulatory aging on oocyte numbers 
In line with previous studies in other vertebrate species including studies in rodents and 
humans (Smits et al. 1995), a decrease in number of ovulated oocytes after preovulatory aging 
was observed. These oocytes were of good quality as no increase in the number of 
degenerated oocytes was observed. However, degeneration of oocytes could occur before 
ovulation and lead to oocyte death in atretic follicles. Another possibility is that less oocytes 
ovulate due to maturation or growth arrest during preovulatory aging in the ovary. Both 
theories are supported by data on preovulatory aging in the in vitro follicle culture system 
revealing an increase of maturation arrest and oocyte degeneration, which correlated with a 
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decreased percentage of maturated MII oocytes (Demond et al. submitted). In comparison to 
control oocytes, more preovulatory-aged oocytes arrested in the germinal vesicle stage or 
were not able to complete germinal vesicle breakdown during meiosis I. It is likely that such a 
developmental arrest also occurs during in vivo preovulatory aging and that these arrested 
oocytes retain in the ovary upon induction of ovulation due to e.g. deregulated 
folliculogenesis, granulosa cell maturation or cumulus expansion. 
4.1.3 Effects of preovulatory aging on fertilization  
Not only ovulation but also fertilization was affected by preovulatory aging as indicated by a 
decrease of the 2-cell embryo rate after preovulatory aging from 76% to 46%. Similar results 
have been published for rats where preovulatory aging lowered the fertilization success as 
well (Fugo and Butcher 1966). The difference of total number of 2-cell embryos retrieved 
after in vivo preovulatory aging in comparison to controls was even more striking; decreasing 
from an average of 16.6 to 5.2 embryos per mouse. This major decline is likely due to a 
combination of the lower oocyte numbers that ovulate and lower fertilization rates after 
preovulatory aging.  
In addition to preovulatory aging, also postovulatory aging that starts after ovulation is known 
to affect fertilization rates. The optimal time window for fertilization in the mouse lies 
between 8 and 12 h after ovulation (Austin 1974). If fertilization is delayed the oocyte starts 
to degenerate and fertilization rates reduce. For example, in vivo fertilization of postovulatory 
aged-oocytes 21-25 h after hCG application decreased the 2-cell rate significantly (Marston 
and Chang 1964). Using in vitro fertilization, no effect on fertilization rates was observed 
after postovulatory aging for up to 8 h (Dankert 2015). However, after 13 h the fertilization 
rates had previously been shown to drop and after 24 h no fertilization seems to be possible 
(Lacham-Kaplan and Trounson 2008). The present study shows that degeneration of the 
oocyte does not only happen after ovulation but can also happen before, when ovulation is 
delayed, having similar consequences for fertilization. However, the time frame in which 
aging occurs is different before ovulation than after considering that fertilization was still 
possible after 3 d of preovulatory aging. So in the ovary the oocytes seem to be more 
protected.  
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4.2 Stable H3K9 trimethylation in preovulatory-aged oocytes 
The reduced fertilization rates after preovulatory aging point to an impaired oocyte quality 
and developmental potential. Therefore, several aspects were addressed in the following to 
search for possible causes for the reduced quality of preovulatory-aged oocytes.  
Trimethylation of H3K9 is an epigenetic histone modification which occurs during oocyte 
growth (Kageyama et al. 2007). It is a chromatin repressive mark required for genome 
stability and thought to be associated with transcriptional silencing in the maturating oocyte 
and (Peters et al. 2001, Kageyama et al. 2007). H3K9me3 was first discovered to be mainly 
present in constitutive heterochromatin but recent work has found that it plays a key role in 
cell differentiation (Becker et al. 2016). After preovulatory in vivo aging no effect on 
H3K9me3 levels was observed. This is in contrast to in vitro preovulatory aging in follicle 
culture where a decrease after aging was found (Demond et al. submitted). Also other forms 
of oocyte overripeness show effects on H3K9me3. Postovulatory aging shows a similar 
decline in H3K9me3 levels as in vitro preovulatory aging (Trapphoff et al. 2010). Maternal 
aging of mice has an even more severe impact on H3K9me3 and can lead to complete 
depletion of methylation marks (Manosalva and Gonzalez 2010; Van den Berg et al. 2011). 
Absence of H3K9me3 leads to genome instability, chromosome disruption during meiosis and 
methylation deficiency (Peters et al. 2001). It was indeed found that H3K9me3-deficient vitro 
preovulatory-aged and postovulatory-aged oocytes had an increased rate of chromosome 
misalignments (Trapphoff et al. 2015; Demond et al. submitted). For comparison, it would be 
interesting to investigate chromosome alignment and spindle formation of in vivo 
preovulatory-aged oocytes in subsequent studies. Overall the studies show differences 
between pre- and postovulatory aging and between the in vivo situation and the follicle 
culture system. Methylation of H3K9 might be better protected in the ovary than in vitro.  
4.3 Loss of Ybx2 protein levels may impair RNA storage potential 
Ybx2 is a germ cell specific RNA binding protein, required for mRNA storage and poly(A) 
tail stability in the oocyte (Gu et al. 1998; Medvedev et al. 2011). After preovulatory aging 
transcript levels of Ybx2 tended to decrease even though not significantly due to a high sample 
variation between the oocyte pools. A similar variation was observed during qPCR analysis of 
maternal effect genes. It appeared that there is a high variation between single oocytes in 
transcript levels and that it might be better to increase the oocyte number of the pools or to 
analyze more pools.  
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The tendency of decreased transcript levels was supported by a significant decline in protein 
levels of Ybx2 after preovulatory aging. Also, after postovulatory aging a decrease in Ybx2 
mRNA and protein levels has been described and a relocation of Ybx2 protein in the cell was 
observed (Trapphoff et al. 2015). Normally, Ybx2 is localized in the cytoplasm where it is 
enriched in the subcortical RNP domain (SCRD; Flemr et al. 2010). There it co-localizes with 
poly(A)-mRNA, the RNA helicase Ddx6 and Edc4, a component of cytoplasmic RNA 
granules (also known as P-bodies; Flemr et al. 2010). Ybx2 is not located in the chromosome-
spindle-complex except for the proximal kinetochore area of the chromosomes (Trapphoff et 
al. 2015). After postovulatory aging Ybx2 protein localization was disturbed and was 
enriched in the center of the ooplasm. In the current study Ybx2 did not show a reallocation 
but a general loss in protein abundance in preovulatory-aged oocytes.  
The loss in Ybx2 protein levels after preovulatory aging might have a serious impact on RNA 
storage potential. Ybx2 is one of the most abundant proteins in the oocyte and loss of Ybx2 
leads to alterations of the entire transcriptome and failure in transcriptional silencing and 
ultimately results in infertility (Yang et al. 2005; Medvedev et al. 2011). Following germinal 
vesicle breakdown during oocyte maturation Ybx2 protein is phosphorylated by the Cdc2a 
kinase, which in turn leads to mRNA instability and the maturation-associated degradation of 
mRNAs in the oocyte (Medvedev et al. 2008). This transcript instability is associated with 
translation of factors needed for the oocyte-to-embryo transition. Following fertilization the 
amounts of Ybx2 mRNA and Ybx2 protein decrease such that little Ybx2 protein is detected 
in 2-cell embryos (Yu et al. 2001). It could be possible that the observed decline in Ybx2 
protein levels in preovulatory-aged oocytes is a consequence of precocious dephosphorylation 
and degradation.  
4.4 Preovulatory aging affects poly(A) tail length and expression of 
maternal effect genes 
Disturbances of maternal effect (ME) genes affect oocyte quality. Since the reduced Ybx2 
levels might affect mRNA and poly(A) tail stability after preovulatory aging, transcript levels 
and poly(A) tail length of selected ME genes were analyzed. ME genes are of special 
importance for the developmental potential since they encode transcripts that are expressed in 
the oocyte but function in the early embryo (Li et al. 2010). Expression levels and poly(A) tail 
length of ME genes in preovulatory-aged oocytes derived in vivo and in follicle culture were 
assessed by qRT-PCR. The results of the poly(A) tail length analysis by comparison of 
random hexamer and oligo(dT)-primed cDNA was confirmed using an ePAT analysis for 
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Zar1 and Dnmt1 in postovulatory-aged oocytes (Dankert et al. 2014). In postovulatory-aged 
oocytes the poly(A) tail length of Zar1 showed no significant effect, whereas Dnmt1 showed 
a decrease in length. The results of the ePAT were in line with the qRT-PCR data, indicating 
that the method is reliable.  
4.4.1 Polyadenylation of transcripts after preovulatory in vivo aging 
After preovulatory aging of in vivo matured oocytes mRNA levels of Smarca4 and Tet3 were 
significantly reduced. This is likely to disturb protein levels that could affect chromatin 
remodeling and DNA demethylation in the course of embryonic genome reprogramming and 
activation (Bultman et al. 2006; Gu et al. 2011). Loss of transcript could therefore affect the 
embryonic genome activation. Zfp57 mRNA levels tended to decrease as well although not 
significantly. Loss of Zfp57 expression is known to interfere with DNA methylation 
maintenance of imprinted genes during epigenetic reprogramming in the preimplantation 
embryo (Li et al. 2008b). 
It was surprising to see a tendency towards increased poly(A) tail length of most investigated 
ME genes in oocytes after in vivo preovulatory aging. An increased poly(A) tail length has 
also been previously described for BUB1B and MAD2L1 transcripts in in vitro-matured 
human oocytes with a low developmental competence (Jones and Cram 2013). These two 
genes encode spindle and cell cycle regulating factors. In contrast, postovulatory aging from 
in vivo-matured oocytes is associated with a decrease in poly(A) tail length for many genes in 
both Xenopus and mice (Kosubek et al. 2010; Dankert et al. 2014). The poly(A) tail length is 
an important regulator of posttranscriptional control during oocyte maturation when 
transcription is repressed (Weill et al. 2012). During oocyte growth, mRNAs accumulate in 
the ooplasm. To store them in a dormant state, the poly(A) tail is shortened, which leads to 
translational repression of the transcripts. When the transcripts need to be recruited for protein 
translation during oocyte maturation, the poly(A) tail can be elongated again through a 
process known as cytoplasmic polyadenylation. The best investigated mechanism of 
cytoplasmic polyadenylation is mediated by CPEB, which binds to the CPE (Figure 2; 
McGrew et al. 1989, Gebauer et al. 1994). Of the 10 selected ME genes only Brg1, Tet3 and 
Dnmt1 contain a CPE in their 3’UTR (Dankert et al. 2014). Since these 3 genes all show a 
trend towards an increased poly(A) tail length after preovulatory in vivo aging, it is likely that 
CPE-dependent polyadenylation occurred in these cases. However, this cannot be the only 
mechanism working in preovulatory-aged oocytes since also other transcripts without a CPE 
showed polyadenylation.  
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The qRT-PCR analysis showed a high standard variation between the oocyte pools resulting 
in significant changes in poly(A) tail length for only few genes. But a concordant effect of 
poly(A) tail status was seen for almost all investigated genes supporting that the effects 
observed are reliable. The results indicate that prolonged meiotic arrest may cause increased 
re-adenlyation of mRNAs during preovulatory aging. This might be a signal for precocious 
recruitment of transcripts for translation in the preovulatory-aged oocytes, which would fit 
with the loss of Ybx2 protein levels. It is important to analyze in subsequent studies whether 
the increased polyadenylation after preovulatory in vivo aging also results in increased protein 
levels, which could explain the reduced oocyte quality in this mouse model.  
4.4.2 Preovulatory in vitro aging affects transcript levels 
The current results show that ME genes are distinctly regulated and transcript levels of the 
selected genes react differently to preovulatory aging in vitro. Transcript levels of Dnmt3a, 
Dnmt3l and Zfp57 have previously been shown not to be affected in in vitro-matured mouse 
oocytes (Anckaert et al. 2013b). This is in is in agreement with the present study that also did 
not show any significant changes in Zfp57 mRNA levels after preovulatory aging in the in 
vitro follicle culture system. However, in the present study the in vitro follicle culture model 
in vitro preovulatory-aged oocytes showed a significant decrease in transcript levels for 
Trim28, Nlrp2, Nlrp 14 and Zar1, and a similar trend for Nlrp5. Trim28 protein interacts with 
Zfp57 and is also required in imprint maintenance during early embryonic development 
(Messerschmidt et al. 2012). It is not exactly known how Nlrp2 and Nlrp14 function in the 
oocyte, but both are needed for embryonic development past the 2-cell stage (Horikawa et al. 
2005; Peng et al. 2012). In humans, mutations in NLRP2 and NLRP7 are responsible for 
imprinting defects (Murdoch et al. 2006; Meyer et al. 2009). It remains to be determined 
whether murine Nlrp proteins might have similar functions. 
Nlrp5 showed a decrease in total transcript levels in preovulatory-aged in vitro-grown MII 
oocytes compared to controls. A similar reduction was also observed for Nlrp5 protein 
abundance of in vitro preovulatory-aged GV oocytes (Demond et al. submitted). Although the 
abundance of this protein was not analyzed in MII oocytes, the decrease found at GV stage 
suggests a perturbation of the normal expression pattern of Nlrp5 before ovulation that may 
also affect preimplantation embryogenesis after fertilization. The same study found Smarca4 
protein levels to be altered as well. Here, an increase in protein abundance was observed at 
GV stage. In contrast, the MII transcript-data did not show an effect of preovulatory aging on 
Smarca4 mRNA levels. This could mean that transcript expression levels or polyadenylation 
 Discussion 
84 
 
status are not directly predictive for abundance of a protein, which is supported by data on 
transcript and protein expression after postovulatory aging (Dankert et al. 2014; Trapphoff et 
al. 2015). However, the comparison of GV protein levels and MII transcript levels has to be 
regarded with caution. It cannot be ruled out that transcript and protein levels change during 
the transition from GV to MII stage. It would therefore be interesting to investigate protein 
levels in MII in vitro-grown oocytes to have a direct comparison of transcript and protein 
expression after preovulatory aging in vitro.  
The present data demonstrates clear differences between in vivo and in vitro preovulatory 
aging of oocytes. This is in line with a study by Sanchéz and colleagues (2009) who found 
reduced total transcript levels for Bmp15, Gdf9, Nlrp5, Zar1 and Fgf8 in immature in vitro-
grown oocytes in comparison to in vivo-grown oocytes. The current study also analyzed Zar1 
transcript levels, which is an oocyte specific gene involved in syngamy (Wu et al. 2003). A 
decrease in total transcript levels of Zar1 was observed after preovulatory aging in vitro. 
Furthermore, Zar1 showed a trend towards an increased poly(A) tail length. This tendency 
was observed for other genes as well, which is in accordance with the data on preovulatory in 
vivo aging. However, polyadenylation was observed less consistently in vitro than in vivo and 
not for the same genes. Along with the differences in total transcript levels between the in 
vivo and the in vitro mouse model, environmental factors seem to influence mRNA stability 
and poly(A) tail length in the oocyte and are different in the ovary compared to follicle 
culture. Indeed, oocytes from follicle culture are still of lower quality than in vivo-matured 
oocytes even though culture methods improved (Smitz et al. 2010).  
4.5 Transcriptome-wide analysis of poly(A) tail dynamics 
It was aimed to establish a poly(A) RNA sequencing analysis to investigate the poly(A) tail 
dynamics during oocyte aging on a transcriptome-wide level. For this, a method described by 
Meijer and coworkers was adapted (Meijer et al. 2007). Meijer separated RNA from 10 
Xenopus oocytes into 6 fractions of increasing poly(A) tail length, which was verified by urea 
polyacrylamide gel electrophoresis. In the present study, this method was adapted for 200 
mouse oocytes using oligo(dT) Dynabeads for separation of the RNA. Elution of 200 control 
oocytes into 4 fractions was successfully analyzed by ePAT for Zar1 and Dnmt1, 
demonstrating an increase in poly(A) tail length in the fractions when eluting in buffers of 
decreasing salt concentration (Dankert 2015). Subsequently, transcriptome-wide sequencing 
analysis was used investigate an effect of postovulatory aging on mammalian oocytes. A 
transcriptome-wide decrease of polyadenylated transcripts had been previously described for 
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Xenopus but not mammalian oocytes (Kosubek et al. 2010). Since postovulatory aging 
coincides with a decrease in total RNA levels, the transcriptome was separated in only 3 
fractions with different poly(A) length (unbound -poly(A) mRNA, oligoadenylated mRNA 
and polyadenylated mRNA) to maximize the RNA amount in each fraction. As normalization 
of the data was still difficult it was only distinguished between -poly(A) RNA and +poly(A) 
RNA for the final analysis. A decrease in poly(A) tail length was observed for the majority of 
genes after postovulatory aging, which is in line with the study on Xenopus oocytes (Kosubek 
et al. 2010). It was recently described for immature bovine oocytes that transcripts required 
for early embryonic development are predominantly deadenylated (20-50 adenosines), 
whereas the majority of RNAs associated with short-term processes for meiotic resumption or 
cell survival have a long poly(A) tail of over 200 adenosines (Gohin et al. 2014). A gene 
ontology analysis of transcripts with a poly(A) tail length that changes during postovulatory 
aging did not reveal an enrichment for certain processes or biological functions in the current 
study.  
Unfortunately, it was not possible to repeat the analysis. Three consecutive trials failed due to 
low RNA quality of the libraries or because there were problems with the normalization. It is 
possible that the RNA amount of 200 oocytes is not enough when using postovulatory-aged 
oocytes, due to the loss of maternal RNAs that has been described for this form of aging 
(Kosubek et al. 2010). Indeed, the RNA sequencing analysis showed less reads in fractions 
from postovulatory-aged oocytes than controls.  
Another possibility is that the external Luciferase RNA was not an optimal reference. An 
external reference RNA was needed because internal reference genes, often referred to as 
house-keeping genes, were not suitable as a standard for two reasons: 1) the expression level 
of housekeeping RNAs might be affected by the aging process and 2) their poly(A) length 
might differ after aging, which would affect the fractionation. This is why synthetic 
Luciferase RNA with a standardized poly(A) tail length of 30 adenosines was chosen as a 
reference in the present study. To ensure that each fraction contained the same amount of 
Luciferase RNA it was added after fractionation and before the library generation. However, 
working with such limited material increases the risk for biases when adding a reference 
manually. A recent study overcame this problem by using several synthetic mRNA-like 
standards each with a different poly(A) tail length (Subtelny et al. 2014). Even though a 
different approach was used to analyze the poly(A) tail length on a transcriptome-wide level 
such a cocktail of references might have been useful for the present study as well, since it 
would be possible to add the mixture before fractionation. This might help to increase the 
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repeatability of the present experiment and with that the reliability of the results in 
combination with a higher number of oocytes as input especially after postovulatory aging.  
4.6 Preovulatory aging leads to precocious embryonic genome activation  
Since the results discussed so far showed that preovulatory aging affects RNA storage 
potential, expression and poly(A) tail length, the developmental competence of aged oocytes 
was analyzed. The results from the current as well as previous studies on fertilization rates 
already indicated that the developmental competence might be affected (see 4.1.3 and Smits et 
al. 1995). Early embryonic development depends greatly on transcripts and proteins of ME 
genes that are stored in the oocyte (Li et al. 2010). With the start of embryonic genome 
activation, these maternal factors are replaced by embryonic factors to ensure development 
beyond the 2-cell stage (Minami et al. 2007). But the first waves of embryonic genome 
activation still depend majorly on maternal factors (Hamatani et al. 2007). Tet3 and Smarca4, 
two ME genes involved in processing of the parental genomes, showed decreased transcript 
levels after preovulatory aging (Gu et al. 2011, Bultman et al. 2006). Therefore, it was 
interesting to see if the embryonic genome activation at the 2-cell stage would be also 
affected.  
Transcription at the first major wave of embryonic genome activation was assessed by BrUTP 
incorporation into 2-cell embryos. BrUTP is a nucleotide analog that is incorporated into 
nascent RNA of transcriptionally active cells. BrUTP was detected in nucleoli-like structures 
of both control and preovulatory-aged embryos. In the nucleoli rRNA is synthesized starting 
from the 2-cell stage (Knowland and Graham 1972). The majority of total RNA consists of 
rRNA, which may explain that most transcriptional activity was found in this nuclear 
compartment. The results are in conflict with a previous study that detected BrUTP mainly in 
the nucleus and observed only minor signals in the nucleoli (Inoue et al. 2012). Inoue and 
colleagues therefore suggested that BrUTP is mainly incorporated by RNA polymerase II. 
Another study though has detected incorporation of BrUTP by RNA polymerase I, which 
transcribes rRNA in the nucleoli (Wansink et al. 1993). This is in line with the present results.  
Surprisingly, an increase in transcription, as measured by BrUTP incorporation, was observed 
in 2-cell embryos that derived from preovulatory-aged oocytes compared to controls. One 
explanation could be that the cell cycle is disturbed after preovulatory aging. The initiation of 
transcription correlates with DNA replication and it was thought that embryonic genome 
activation might be triggered by DNA replication at the zygote stage (Aoki et al. 1997). 
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However, cleavage of the zygote seems to be independent of transcription since transcription 
continues to increase when cleavage is inhibited (Aoki et al. 1997). Therefore, it is more 
likely that the increase of transcription after preovulatory aging indicates a premature 
activation of the zygotic genome prior to the 2-cell stage. Similar evidence is found for 
postovulatory-aged oocytes. After 4 h of postovulatory aging an increase in transcriptional 
activity has been described (Dankert 2015). In the case of postovulatory aging more facts are 
known supporting the hypothesis of precocious transcription. It has been shown that 
postovulatory aging of 22 h leads to a transcriptional activation, resumption of the cell cycle 
and release of cortical granules in absence of fertilization (Xu et al. 1997). Furthermore, the 
protein synthesis of factors required for embryonic genome activation is increased in the 
postovulatory-aged oocyte (Wang and Latham 1997).  
Thus, after postovulatory aging the oocyte initiates events of egg activation, which might 
explain the premature transcriptional activation observed. Similar effects might occur after 
preovulatory aging, which is also supported by the altered Ybx2 protein expression and the 
polyadenylation of ME effect genes observed in the present study. Both the data on pre- and 
postovulatory aging together suggest that many processes, such as translation of transcripts in 
the oocyte or embryonic genome activation, are regulated in a continuous, time-dependent 
manner. If events such as ovulation or fertilization are delayed these processes do not adapt to 
this delay, which leads to a desynchronization and impairment of oocyte quality with 
potentially long-term effects on reproductive success and longevity of the offspring (Tarin et 
al. 2002). 
4.7 Stable imprint maintenance after preovulatory aging 
Embryonic genome activation is a highly regulated process during early embryonic 
development, which depends on reprogramming of the parental genomes (Messerschmidt 
2012). The decrease in mRNA expression of the ME genes Tet3 and Smarca4 together with 
the increased transcriptional activity provide evidence that preovulatory aging disturbs the 
epigenetic reprogramming processes. Another interesting aspect is that transcript levels of 
Zfp57 tended to decrease after preovulatory aging.  
Zfp57 is an ME gene involved in the DNA methylation maintenance of imprinted genes but 
also in the acquirement of methylation imprints (Li et al. 2008b). In humans loss-of-function 
mutations in the ZFP57 gene are associated with hypomethylation at multiple imprinted 
regions in individuals affected by transient neonatal diabetes (Mackay et al. 2008). In mice 
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maternal Zfp57 protein is present all the way throughout embryonic preimplantation 
development (Li et al. 2008b). The embryo itself also expresses Zfp57 and both the maternal 
and the embryonic protein are required for full maintenance of differential DNA methylation 
at ICRs (Li et al. 2008b). Zfp57 protein binds to a hexanucleotide sequence that is found in all 
mouse ICRs, which would explain its specific maintenance function of differentially 
methylated loci (Quenneville et al. 2011). Zfp57 seems to have a second function in imprint 
establishment, at least at the Snrpn ICR: Loss of oocyte Zfp57 in mice leads to failure in 
maternal imprint establishment during oocyte growth. This loss can be compensated by 
expression of zygotic Zfp57 leading to a gain of methylation during embryonic development 
at the ICR of Snrpn. Zfp57 protein binds directly to the Snrpn ICR (Li et al. 2008b). Thus, a 
decrease in Zfp57 expression after preovulatory aging might affect DNA methylation levels 
during preimplantation development.  
Therefore, the current study investigated the methylation levels of 3 imprinted genes (H19, 
Snrpn, Igf2r) and 1 unmethylated gene (Pou5f1) at the 8-cell stage. DNA methylation of 
single embryos was analyzed using deep-amplicon bisulfite sequencing. The data indicate a 
stable maintenance of DNA methylation at the investigated imprinted loci as well as 
successful demethylation of Pou5f1 during epigenetic reprogramming in embryos from 
preovulatory-aged oocytes. The lower transcript levels of Zfp57 after preovulatory aging seem 
not to interfere with imprint establishment or maintenance. The transcript expression of Zfp57 
was lowered by half, which might still be sufficient for stable imprint maintenance. It is also 
unknown if the decrease in transcript level of Zfp57 is reflected in protein levels. Furthermore, 
it was shown that loss of maternal Zfp57 can be partly rescued by embryonic Zfp57 (Li et al. 
2008b). Since transcription starts premature after preovulatory aging, this might further 
ameliorate the effects of decreased maternal Zfp57 expression by making embryonic Zfp57 
earlier available.  
Expression of other factors involved in imprint methylation maintenance was stable after 
preovulatory aging (Dnmt1, Trim28) and might have compensated for the loss of Zfp57. 
Trim28 protein is a co-factor of Zfp57, which binds to it and recruits heterochromatin-
inducing factors such as Hp1 and Set1b leading to the establishment of H3K9me3 during 
embryonic development (Schultz et al. 2002). Loss of Trim28 disturbs the maintenance of 
DNA methylation of imprinted genes in a random way, leading to mosaicism in the 
blastomers of 8-cell embryos (Lorthongpanich et al. 2013). A similar effect could also happen 
upon loss of Zfp57 and looking at DNA-methylation of single embryos where all 8 blastomers 
are pooled might not have a high enough resolution to detect such effects. The study of 
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Lorthongpanich and colleagues (2013) assessed DNA-methylation of single blastomers using 
a methylation sensitive restriction enzyme to digest DNA followed by a PCR. This method 
however only allows the investigation of a single CpG site. The CpGs within a CpG island 
can vary though in their susceptibility to methylation disturbances (Heinzmann et al. 2015). 
The bisulfite treatment in the current study leads to destruction of DNA making the method 
difficult to use for single cells, but the amplicon sequencing analysis enabled the investigation 
of several CpGs within a CpG island. It showed for example for H19 unstable methylation of 
one of the CpGs in the ICR in both control embryos and embryos from aged oocytes 
underlining the need to investigate more than one CpG. Recently, bisulfite sequencing of 
single oocytes has been described, which might be a good approach to investigate subtle 
changes in DNA methylation status such as mosaicism of single blastomeres within a single 
preimplantation embryo (Smallwood et al. 2014).  
This was the first study to investigate methylation levels in embryos after preovulatory aging. 
In line with the present results on preovulatory aging, previous studies on postovulatory aging 
showed no major, general effects on methylation status of imprinted genes. However, some 
studies found that certain genes are more susceptible to methylation disturbances then others 
after postovulatory aging. Mouse embryos at mid-gestation that were derived from 
postovulatory-aged oocytes showed no significant changes of methylation levels of Igf2r and 
H19. However, the placenta of these embryos was hypomethylated for H19 and increased 
transcript levels for H19 in comparison to controls were observed (Liang et al. 2008). 
Postovulatory aging showed abnormal methylation levels in mouse oocytes for the Snrpn 
DMR but not Peg1/Mest (Liang et al. 2008). In contrast, in vitro postovulatory aging of 
superovulated oocytes has shown to affect DNA methylation of the Peg1/Mest DMR in 
oocytes (Imamura et al. 2005). Whether these abnormal methylation levels are maintained 
after fertilization has not been investigated so far. Postovulatory aging of bovine oocytes 
derived from in vitro-maturated oocytes showed no significant differences in methylation 
status of bH19, bSNRPN, bZAR1, bPOU5F1 and bDNMT3A (Heinzmann et al. 2015). Only 
bDNMT3Lo showed an increase in methylation errors in oocytes and embryos after 
postovulatory aging, but only for 2 of 8 analyzed CpGs and the average methylation level did 
not change more than 20%. Even though this effect might be significant the vast majority of 
postovulatory-aged oocytes and embryos showed no methylation defects and the imprinted 
genes investigated were not affected (Heinzmann et al. 2015).  
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4.8 Conclusion 
This study used a previously established in vivo mouse model to investigate molecular effects 
of preovulatory aging on oocytes and their developmental capacity. In this mouse model it has 
been shown that preovulatory aging increases the number of embryo resorption sites and 
lowers embryonic weight during pregnancy (Bittner et al. 2011). This was a first indication 
that preovulatory-aged oocytes may be of lower quality. The present study supported this 
observation by noticing lower ovulation and fertilization rates. However, not all investigated 
processes were affected by preovulatory aging. Normal levels of the epigenetic histone 
modification H3K9me3 were observed in preovulatory-aged oocytes. Only 3 out of 10 
selected ME genes showed a decrease in RNA expression levels after aging. Embryos derived 
after preovulatory aging showed successful DNA methylation maintenance at the investigated 
imprinted genes. This demonstrates that molecular mechanisms in the oocyte and 
preimplantation embryo are distinctly regulated.  
For postovulatory aging it has been proposed that molecular processes are regulated in a time-
dependent manner and that a delay in fertilization leads to a deregulation of these processes 
(Xu et al. 1997, Kosubek et al. 2010, Trapphoff et al. 2015). The current results suggest that 
the same might occur during preovulatory aging. A premature loss of the RNA storage protein 
Ybx2 was observed, which coincided with an increase in poly(A) tail length of transcripts 
from selected ME genes. Both are indicators of a precocious recruitment of mRNAs for 
protein translation. The synthesis of proteins from stored transcripts is required for the 
initiation of transcription after fertilization in the course of embryonic genome activation 
(Wang and Latham 1997). Indeed, embryonic genome activation was premature showing an 
early increase in transcription in embryos after preovulatory aging. Taken together, it seems 
that RNA storage, poly(A) tail dynamics and embryonic genome activation are not 
(exclusively) timed by ovulation, but at least partly regulated by events in the growing or 
maturing oocyte. A delay in ovulation desynchronizes physiological processes in the oocyte, 
which may consequently affect the embryonic programs resulting in potentially long-lasting 
effects for the offspring.  
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5 Summary 
Preovulatory aging of oocytes is caused by a delay in ovulation and it is known to impair 
postimplantation embryonic development. However, hardly anything is known about the 
molecular mechanisms associated with preovulatory aging. To investigate several aspects of 
RNA dynamics in the preovulatory-aged oocytes and possible consequences on early 
preimplantation development, the present study used a mouse model in which ovulation was 
postponed with the GnRH antagonist cetrorelix.  
Preovulatory aging led to a lower number of ovulated oocytes. Furthermore, preovulatory-
aged oocytes were more difficult to fertilize, as was demonstrated by a decrease in 2-cell 
embryo rate after mating compared to controls. These results are in accordance with previous 
studies on preovulatory aging in several vertebrate models including rats and humans.  
As an indicator for transcriptional silencing and genome stability during oocyte growth, the 
epigenetic histone modification H3K9 trimethylation was analyzed using 
immunofluorescence. No effect of preovulatory aging on H3K9 trimethylation levels was 
observed. Before transcriptional silencing, mRNAs are stored in the oocyte until recruitment 
for protein translation later during oocyte maturation. One major key player in the storage and 
recruitment of maternal transcripts is the RNA-binding protein Ybx2. Immunofluorescent 
staining showed a significant decrease in Ybx2 protein abundance after preovulatory aging, 
which might have severe implications for RNA dynamics in the oocyte.  
Since the RNA-storage potential seemed impaired, transcript levels of selected maternal effect 
genes were analyzed by qRT-PCR. Maternal effect genes are of crucial importance for oocyte 
developmental potential because they function in the early embryo before transcription 
initiates again. Transcript levels of 2 out of 10 investigated ME genes (Smarca4 and Tet3) 
decreased significantly after preovulatory aging. Additionally, oligo(dT) priming allowed 
investigation of poly(A) tail length of mRNAs of the candidate maternal effect genes by qRT-
PCR. The poly(A) tail determines the translation efficiency of transcripts in the oocyte and 
early embryo. The majority of genes showed elongation of poly(A) tail length after 
preovulatory aging. Similar results were also found after in vitro preovulatory aging of 
oocytes grown in follicle culture, although not the same genes were affected than in vivo.  
Loss of Ybx2 protein and polyadenylation of maternal effect gene transcripts should occur 
later during oocyte maturation. Therefore, the results imply premature recruitment of mRNAs 
for protein translation. This assumption is supported by experiments determining the start of 
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transcription at the 2-cell stage of embryonic preimplantation development in the course of 
embryonic genome activation. Embryos were incubated in BrUTP, which intercalates into 
nascent RNA and can by visualized by immunofluorescence. Compared to controls, in 
embryos derived from preovulatory-aged oocytes an increase in transcription was observed, 
indicating a precocious start of embryonic genome activation.  
Last, DNA methylation maintenance of three imprinted genes (H19, Snrpn, Igf2r) during 
epigenetic reprogramming in the preimplantation embryo was analyzed. Deep amplicon 
bisulfite sequencing of single 8-cell embryos showed stable maintenance of DNA methylation 
at the investigated loci.  
Overall, the results show that the investigated processes are distinctly regulated in the oocyte 
and early embryo and not all of them are susceptible to preovulatory aging. Nevertheless, 
preovulatory aging impairs oocyte quality with possible long-term effects on embryonic 
development and reproductive success.  
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6 Zusammenfassung 
Eine Verzögerung des Eisprungs führt zu präovulatorischer Überreife der Oozyte und dies 
kann die Entwicklung des Embryos nach der Einnistung in die Gebärmutter beeinträchtigen. 
Über die molekularen Mechanismen, die das Entwicklungspotenzial der überreifen Oozyte 
beeinflussen und die Auswirkungen auf die frühe Embryonalentwicklung ist nur wenig 
bekannt. Mit Hilfe eines Mausmodells, in dem der Eisprung mit Hilfe des GnRH 
Antagonisten Cetrorelix hinausgezögert wurde, wurden in dieser Studie verschiedene Aspekte 
der RNA Dynamik in der überreifen Oozyte und mögliche Konsequenzen für die frühe 
Embryonalentwicklung vor der Einnistung untersucht.  
Die Verzögerung des Eisprungs führte zu einer verringerten Anzahl von ovulierten, reifen 
Oozyten. Außerdem ließen sich überreife Oozyten schlechter befruchten, was zu einer 
Abnahme der Zahl von 2-Zell-Embryonen nach Verpaarung führte. Diese Ergebnisse stimmen 
mit vorhergegangenen Studien zur präovulatorischen Überreife in verschiedenen Vertebraten, 
u.a. Ratten und Menschen, überein.  
Während des Oozyten-Wachstums wird die Transkription eingestellt. Dieser Prozess wurde 
mittels Immunofluoreszenz gegen die epigenetische Histonmodifikation H3K9-
Trimethylierung untersucht. Dabei wurde kein Effekt der präovulatorischen Überreife auf das 
Ausmaß der H3K9-Trimethylierung beobachtet. Vor dem transkriptionellen Arrest werden 
mRNAs in der Oozyte gespeichert, bis sie im späteren Verlauf der Oozyten-Reifung für die 
Translation von Proteinen rekrutiert werden. Ein wichtiger Faktor für die Speicherung und 
Rekrutierung von mRNA in der Oozyte ist das RNA-Bindeprotein Ybx2. Mittels 
Immunofluoreszenz konnte eine signifikante Abnahme der Ybx2 Proteinmenge nach 
präovulatorischer Überreife gezeigt werden. Dies könnte zu Störungen der RNA-Speicherung 
in der Oozyte führen. Um dies zu ermitteln wurde die Transkriptmenge von ausgewählten 
maternalen Effektgenen (ME-Genen) mittels qRT-PCR untersucht. Transkripte der ME-Gene 
sind entscheidend für das Entwicklungspotential der Oozyte, da sie im frühen Embryo, dessen 
Transkription noch nicht begonnen hat, wirken. Von zwei der 10 untersuchten ME-Gene 
(Smarca4 und Tet3) waren die Transkriptmengen, im Vergleich zu den Kontrollen, in 
überreifen Oozyten signifikant reduziert. Außerdem wurde die Poly(A)-Schwanzlänge von 
ME-Genen untersucht, da diese die Effizienz der Translation eines Transkriptes in der Oozyte 
bestimmt. In überreifen Oozyten zeigte der Großteil der analysierten Kandidatengene eine 
Verlängerung des Poly(A)-Schwanzes. Ähnliche Ergebnisse wurden auch bei in vitro 
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präovulatorisch überreifen Oozyten aus einer Follikelkultur beobachtet, obwohl hier nicht die 
gleichen ME-Gene beeinträchtigt waren.  
Die beobachtete Abnahme von Ybx2-Protein und die Verlängerung des Poly(A)-Schwanzes 
der ME-Transkripte sind Prozesse, die während der Eizell-Reifung eigentlich später 
stattfinden. Die Beobachtung, dass diese Prozesse bei präovulatorischer Alterung früher 
stattfinden, impliziert, dass auch die Rekrutierung von mRNA für die Proteintranslation 
verfrüht stattfinden könnte, was die Transkription im Embryo beeinflussen kann. Diese 
Annahme wird durch Analysen zur Aktivierung der Transkription im 2-Zell-Embryo 
unterstützt. Embryonen wurden in BrUTP inkubiert, welches sich während der Transkription 
in die RNA einlagert und mit Immunofluoreszenz nachgewiesen werden kann. Dieses 
Experiment zeigte, im Vergleich zu Kontrollen, eine Zunahme der Transkription in 
Embryonen von überreifen Oozyten, was auf einen vorzeitigen Start der embryonalen 
Genomaktivierung hindeutet. 
Zuletzt wurde die DNA-Methylierung von drei Genen, die dem Imprinting unterliegen (H19, 
Snrpn, Igf2r), in einzelnen 8-Zell-Embryonen analysiert. Deep amplicon bisulifte sequencing 
zeigte einen stabilen Erhalt der DNA-Methylierung nach präovulatorischer Überreife in den 
untersuchten Loci.  
Insgesamt zeigen diese Ergebnisse, dass die untersuchten Prozesse in der Oozyte und im 
frühen Embryo individuell reguliert sind und nicht alle durch präovulatorische Überreife 
gestört werden. Dennoch lässt sich sagen, dass präovulatorische Überreife die Qualität der 
Oozyte beeinträchtigt, mit möglichen Langzeiteffekten auf die Embryo-Entwicklung und den 
Reproduktionserfolg.  
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8 Supplementary data 
8.1 List of abbreviations 
°C Degrees Celcius ICR Imprinting control region 
µ Micro IF Immunofluorescence 
5hmC 5-hydroxymethylcytosine  IU International unit 
5mC 5-methyl-cytosine IVF In vitro fertilization 
A  Adenosine l Liter 
ART Assisted reproduction techniques LH Luteinizing hormone 
ATP Adenosine triphosphate lncRNA Long non-coding RNA 
BGR Background fluorescence m Milli 
bp Base pair M Molar 
BrU 5-Bromouracil ME Maternal effect 
BrUTP 5-Bromouridine-5'-triphosphate MID Multiplex identifiers 
BSA Bovine serum albumin MII Meiosis II 
cDNA Complentary DNA min Minutes 
cetro Cetrorelix mRNA Messenger RNA 
CLSM Confocal laser scanning microscopy n Nano 
COC Cumulus-oocytes-complex p Pico 
CpG Cytosine-phosphate-guanine PB Physiological buffer  
CTP Cytosine triphosphate PCR Polymerase chain reaction 
d Day PFA Paraformaldehyde 
DAPI 4′,6-Diamidin-2-phenylindol  PGC Primordial germ cell 
dATP Deoxyadenosine triphosphate PMSG Pregnant mare serum gonadotropin 
dCTP Deoxycytosine triphosphate PostOA Postovulatory aging 
dGTP Deoxyguanosine triphosphate PreOA Preovulatory aging 
DNA Desoxyribonucleid acid qRT-PCR Quantitative real-time PCR 
DPBS Dulbecco's phosphate buffered saline r Recombinant 
dTTP/dT Deoxythymidine triphosphate RNA Ribonucleid acid 
EDTA Ethylenediaminetetraacetic acid RNP Ribonucleioprotein particles 
EGF Epidermal growth factor rRNA Ribosomal RNA 
ePAT Extension poly(A) test RT  Reverse transcription 
EtBr Ethidium bromide s  Second 
FAM Fluorescein amidite s.c. Subcutaneous 
FITC Fluorescein isothiocyanate SCRD Subcortical RNP domain 
FSH Follicle stimulating hormone SEM Standard error of the mean 
g Gram SNP Single nucleotide polymorphism 
GnrH Gonadotropin releasing hormone SSC Saline sodium citrate 
GTC Guanidine thiocyanate TAE Tris acetate EDTA  
GTP Guanosine triphosphate TRITC Tetramethylrhodamine 
GV Germinal vesicle tRNA Transfer RNA 
h Hour UPL Universal Probe Library 
H3K9me3 Histone 3 Lysine 9 trimethylation UTR Untranslated region 
hCG Human chorionic gonadotropin v Volume 
i.p. Intraperitoneal xg Times gravity 
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8.4 Supplementary figures 
 
 
Figure S 1: Comparative analysis of DNA methylation levels at the Pou5f1 locus of control embryos. 
Indicated are the mean DNA methylation levels of the entire locus per embryo of the maternal allel (A) and the 
paternal allel (B). The white numbers indicate methylation levels of single CpGs. The colors represent a scale 
from red (100% methylation) to blue (0% methylation).  
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Figure S 2: Comparative analysis of DNA methylation levels at the Pou5f1 locus of 3 days preovulatory-
aged (PreOA 3d) embryos. Indicated are the mean DNA methylation levels of the entire locus per embryo of 
the maternal allel (A) and the paternal allel (B). The white numbers indicate methylation levels of single CpGs. 
The colors represent a scale from red (100% methylation) to blue (0% methylation).  
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Figure S 3: Comparative analysis of DNA methylation levels at the H19 locus of control embryos. Indicated 
are the mean DNA methylation levels of the entire locus per embryo of the maternal allel (A) and the paternal 
allel (B). The white numbers indicate methylation levels of single CpGs. The colors represent a scale from red 
(100% methylation) to blue (0% methylation).  
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Figure S 4: Comparative analysis of DNA methylation levels at the H19 locus of 3 days preovulatory-aged 
(PreOA 3d) embryos. Indicated are the mean DNA methylation levels of the entire locus per embryo of the 
maternal allel (A) and the paternal allel (B). The white numbers indicate methylation levels of single CpGs. The 
colors represent a scale from red (100% methylation) to blue (0% methylation).  
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Figure S 5: Comparative analysis of DNA methylation levels at the Snrpn locus of control embryos. 
Indicated are the mean DNA methylation levels of the entire locus per embryo of the maternal allel (A) and the 
paternal allel (B). The white numbers indicate methylation levels of single CpGs. The colors represent a scale 
from red (100% methylation) to blue (0% methylation).  
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Figure S 6: Comparative analysis of DNA methylation levels at the Snrpn locus of 3 days preovulatory-
aged (PreOA 3d) embryos. Indicated are the mean DNA methylation levels of the entire locus per embryo of 
the maternal allel (A) and the paternal allel (B). The white numbers indicate methylation levels of single CpGs. 
The colors represent a scale from red (100% methylation) to blue (0% methylation). 
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Figure S 7: Comparative analysis of DNA methylation levels at the Igf2r locus of control embryos. 
Indicated are the mean DNA methylation levels of the entire locus per embryo of the maternal allel (A) and the 
paternal allel (B). The white numbers indicate methylation levels of single CpGs. The colors represent a scale 
from red (100% methylation) to blue (0% methylation).  
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Figure S 8: Comparative analysis of DNA methylation levels at the Igf2r locus of 3 days preovulatory-aged 
(PreOA 3d) embryos. Indicated are the mean DNA methylation levels of the entire locus per embryo of the 
maternal allel (A) and the paternal allel (B). The white numbers indicate methylation levels of single CpGs. The 
colors represent a scale from red (100% methylation) to blue (0% methylation).  
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8.5 Supplementary tables 
 
Table S1: Assays for qRT-PCR analysis. 
Gene Ref-Seq  transcript ID Primer sequence (5’ – 3’) UPL-Probe 
Brg1 NM_011417.3 F cggttgtgagtgacgatgac 15 R cctcactgccacttcctga 
Tet3 NM_183138.2 F gcacgccagagaagatcaa 81 R ggacaatccacccttcagag 
Trim28 NM_011588.3  Taqman assay (Mm00495594_m1)  
Zfp57 NM_001013745.2 F aaccttcaagaacctgacatttg 15 R ccctgtgcaactggagga 
Dnmt1 NM_001199431.1  Taqman assay (Mm01151063)  
Nlrp2 NM_117690.3  Taqman assay (Mm00624616_m1)  
Nlrp5 NM_001039143.1  Taqman assay (Mm011143609_m1)  
Nlrp14 NM_001002894.2 
F gcagccacactgcaatctt 
78 R ccacaagccttactcgtgaga 
Pou5f1 NM_001252452.1 F cacgagtggaaagcaactca 82 R gctttcatgtcctgggactc 
Zar1 NM_174877.3 F ctcaggaccccggtgatt 15 R cactcggcagaactgtttga 
Luciferase M15077.1 
F gtcttcccgacgatgacg 
70 R gtctttccgtgctccaaaac 
 
 
 
Table S2: Primers for ePAT analysis of oocytes. 
Gene Ref-Seq transcript ID Primer Sequence (5’ – 3’) 
Amplicon 
length (bp) 
Annealing 
temp. (°C) 
Anchor primer gcgagctccgcggccgcg(dT)12   
Btf3 NM_001170540.1 cggacactgcagctcttttc 154 58 
Prdx2 NM_011563.5 cttggatttcacctgtgccc 353 58 
Ddx3x NM_010028.3 caaattaagcagacccggca 507 58 
Nupr1 NM_019738.1 ggcctgcttgattctttccc 236 58 
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Table S3: Primers for DNA methylation analysis of embryos. Sequences were used from El Hajj et al. 
(2011). 
Gene Ref-Seq  transcript ID Primer sequence (5’ – 3’) 
Amplicon 
length (bp) 
Annealing 
temp. (°C) 
H19 NR_130973 
Outer PCR F aaattttaattttggttgtttttgg 292 52 R aatcaattaaaaaaataataaaaccc 
Inner PCR F tggttgtttttggaatataatgtt* 167 57 R aaaaacaaaacacctatacccttc* 
Snrpn NM_033174.3 
Outer PCR F ttggtagttgttttttggtaggat 442 52 R ataaacccaaatctaaaatattttaatca 
Inner PCR F ttggtagttgttttttggtaggat* 384 57 R taaaatacactttcactactaaaatccac* 
Igf2r NM_010515.2 
Outer PCR F ggtattttgagggtgtaaattgta 295 52 R aaccctaacacaactaaacaacat 
Inner PCR F gaagggttttgtgattagggttaa* 364 57 R aaccctaacacaactaaacaacat* 
Pou5f
1 
NM_0012524
52 
Outer PCR F ttgagtgggttgtaaggatagg 329 52 R aaaaaattcacctctccctcc 
Inner PCR F gtaggggtgagaggattttgaa* 197 57 R Ccaccctctaaccttaacctct* 
*A tag-sequence was added in front of each inner PCR primer, which was used to adapt the MID-primers during 
the Re-PCR. F: cttgcttcctggcacgag; R:caggaaacagctatgac.  
 
 
 
Table S4: Read numbers of poly(A) sequencing analysis of control and postovulatory-aged (PostOA) 
oocytes. Shown are the number and percentage of mapped reads in relation to total read, the duplication rate, 
total counts of reads mapping to genes and the number and percentage of counts for protein coding genes relative 
to total counts. 
Group Fraction 
Mapped reads Duplication rate 
[%] 
Total 
counts 
Protein coding 
Number [%] Number [%] 
Control 
Total RNA 5,381,627 67 64 4,607,724 4,345,508 94 
Fraction 1 17,384,592 79 68 11,625,270 9,910,372 85 
Fraction 2 7,825,466 65 84 7,319,693 7,221,693 99 
Fraction 3 4,353,243 51 73 3,814,821 3,771,882 99 
Pool F1-F3 14,094,147 77 64 9,854,580 8,502,255 86 
PostOA 
Total RNA 3,565,365 61 61 2,919,824 2,705,953 93 
Fraction 1 22,791,961 74 68 13,480,406 10,628,766 79 
Fraction 2 1,33,769 27 74 807,163 767,737 95 
Fraction 3 918,565 27 58 664,657 641,720 97 
Pool F1-F3 8,968,297 68 60 5,581,796 4,170,924 75 
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Table S5: List of genes with a differential poly(A) tail length after postovulatory oocyte aging according to 
the poly(A) sequencing analysis. Shown are the Ensembl name and gene symbol. The delta value demonstrates 
the change in poly(A) tail length, with a negative value indicating a loss and a positive value a gain of poly(A) 
tail length. The proportion of reads without (-Poly(A)) and with (+Poly(A)) are shown for control and 
postovulatory-aged oocytes. 
Ensembl Name Gene Name Delta value 
Control 
-Poly(A) 
Control 
+Poly(A) 
PostOA 
-Poly(A) 
PostOA 
+Poly(A) 
ENSMUSG00000082841 Gm12994 -0.599 0.17 0.83 0.71 0.29 
ENSMUSG00000038400 Pmepa1 -0.571 0.33 0.67 0.94 0.06 
ENSMUSG00000030717 Nupr1 -0.475 0.22 0.78 0.71 0.29 
ENSMUSG00000022587 Ly6e -0.426 0.45 0.55 0.90 0.10 
ENSMUSG00000018677 Slc25a39 -0.414 0.45 0.55 0.91 0.09 
ENSMUSG00000067594 Krt77 -0.382 0.53 0.47 0.94 0.06 
ENSMUSG00000029166 Mapre3 -0.380 0.53 0.47 0.97 0.03 
ENSMUSG00000021576 Pdcd6 -0.359 0.60 0.40 0.96 0.04 
ENSMUSG00000028469 Npr2 -0.348 0.61 0.39 1.00 0.00 
ENSMUSG00000041423 Paqr6 -0.343 0.56 0.44 0.98 0.02 
ENSMUSG00000023336 Wfdc1 -0.333 0.49 0.51 0.88 0.12 
ENSMUSG00000090104 Slmapos2 -0.326 0.54 0.46 0.91 0.09 
ENSMUSG00000031156 Slc35a2 -0.326 0.57 0.43 0.93 0.07 
ENSMUSG00000021400 Wrnip1 -0.325 0.52 0.48 0.95 0.05 
ENSMUSG00000032551 1110059G10Rik -0.324 0.63 0.37 0.98 0.02 
ENSMUSG00000031532 Saraf -0.309 0.58 0.42 0.93 0.07 
ENSMUSG00000020321 Mdh1 -0.305 0.37 0.63 0.63 0.37 
ENSMUSG00000043556 Fbxl7 -0.305 0.56 0.44 0.89 0.11 
ENSMUSG00000026249 Serpine2 -0.305 0.49 0.51 0.82 0.18 
ENSMUSG00000063229 Ldha -0.292 0.65 0.35 1.00 0.00 
ENSMUSG00000087601 Uchl1os -0.292 0.59 0.41 0.93 0.07 
ENSMUSG00000013646 Sh3bp5l -0.291 0.64 0.36 1.00 0.00 
ENSMUSG00000024074 Crim1 -0.291 0.65 0.35 0.98 0.02 
ENSMUSG00000068154 Insm1 -0.290 0.40 0.60 0.68 0.32 
ENSMUSG00000046364 Rpl27a -0.287 0.54 0.46 0.99 0.01 
ENSMUSG00000021721 Htr1a -0.286 0.67 0.33 1.00 0.00 
ENSMUSG00000002602 Axl -0.285 0.68 0.32 0.99 0.01 
ENSMUSG00000022634 Yaf2 -0.284 0.59 0.41 0.92 0.08 
ENSMUSG00000096768 Erdr1 -0.280 0.69 0.31 1.00 0.00 
ENSMUSG00000042524 Sun2 -0.278 0.44 0.56 0.74 0.26 
ENSMUSG00000025743 Sdc3 -0.274 0.57 0.43 0.92 0.08 
ENSMUSG00000022790 Igsf11 -0.274 0.49 0.51 0.84 0.16 
ENSMUSG00000087531 Gm15606 -0.273 0.69 0.31 0.98 0.02 
ENSMUSG00000039055 Eme1 -0.272 0.52 0.48 0.94 0.06 
ENSMUSG00000018593 Sparc -0.269 0.64 0.36 0.89 0.11 
ENSMUSG00000020895 Tmem107 -0.265 0.60 0.40 0.87 0.13 
ENSMUSG00000011884 Gltp -0.265 0.57 0.43 0.88 0.12 
ENSMUSG00000031549 Ido2 -0.262 0.52 0.48 0.85 0.15 
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Ensembl Name Gene Name Delta value 
Control 
-Poly(A) 
Control 
+Poly(A) 
PostOA 
-Poly(A) 
PostOA 
+Poly(A) 
ENSMUSG00000026960 Arl6ip6 -0.260 0.61 0.39 0.89 0.11 
ENSMUSG00000022180 Slc7a8 -0.259 0.60 0.40 0.92 0.08 
ENSMUSG00000015478 Rnf5 -0.257 0.46 0.54 0.83 0.17 
ENSMUSG00000026944 Abca2 -0.256 0.51 0.49 0.86 0.14 
ENSMUSG00000097088 Gm26615 -0.249 0.55 0.45 0.97 0.03 
ENSMUSG00000033161 Atp1a1 -0.246 0.57 0.43 0.85 0.15 
ENSMUSG00000042275 Pelo -0.246 0.33 0.67 0.52 0.48 
ENSMUSG00000078566 Bnip3 -0.245 0.57 0.43 0.81 0.19 
ENSMUSG00000032198 Dock6 -0.245 0.56 0.44 0.95 0.05 
ENSMUSG00000032452 Clstn2 -0.243 0.65 0.35 0.92 0.08 
ENSMUSG00000035395 Pet2 -0.243 0.54 0.46 0.91 0.09 
ENSMUSG00000025082 Vwa2 -0.242 0.60 0.40 0.92 0.08 
ENSMUSG00000028691 Prdx1 -0.242 0.42 0.58 0.64 0.36 
ENSMUSG00000002871 Tpra1 -0.241 0.60 0.40 0.83 0.17 
ENSMUSG00000059851 Suv420h2 -0.239 0.72 0.28 1.00 0.00 
ENSMUSG00000038115 Ano2 -0.238 0.68 0.32 0.96 0.04 
ENSMUSG00000090216 Gm16549 -0.238 0.73 0.27 1.00 0.00 
ENSMUSG00000041617 Ccdc74a -0.237 0.36 0.64 0.56 0.44 
ENSMUSG00000026072 Il1r1 -0.235 0.70 0.30 0.98 0.02 
ENSMUSG00000030897 Cnga4 -0.234 0.57 0.43 0.83 0.17 
ENSMUSG00000002897 Il17ra -0.233 0.61 0.39 0.89 0.11 
ENSMUSG00000074934 Grem1 -0.233 0.68 0.32 0.96 0.04 
ENSMUSG00000016179 Camk1g -0.233 0.62 0.38 0.87 0.13 
ENSMUSG00000031604 Msmo1 -0.233 0.58 0.42 0.86 0.14 
ENSMUSG00000029632 Ndufa4 -0.232 0.62 0.38 0.87 0.13 
ENSMUSG00000024940 Ltbp3 -0.231 0.63 0.37 0.86 0.14 
ENSMUSG00000062908 Acadm -0.231 0.71 0.29 0.96 0.04 
ENSMUSG00000004207 Psap -0.231 0.55 0.45 0.79 0.21 
ENSMUSG00000020205 Phlda1 -0.230 0.47 0.53 0.84 0.16 
ENSMUSG00000027570 Col9a3 -0.230 0.66 0.34 0.93 0.07 
ENSMUSG00000097113 Gm19705 -0.230 0.62 0.38 1.00 0.00 
ENSMUSG00000026112 Coa5 -0.230 0.55 0.45 0.79 0.21 
ENSMUSG00000032572 Col6a4 -0.226 0.61 0.39 0.93 0.07 
ENSMUSG00000036840 Siah1a -0.226 0.69 0.31 0.94 0.06 
ENSMUSG00000031834 Pik3r2 -0.226 0.61 0.39 0.89 0.11 
ENSMUSG00000032577 Mapkapk3 -0.226 0.76 0.24 0.99 0.01 
ENSMUSG00000060147 Serpinb6a -0.226 0.71 0.29 0.96 0.04 
ENSMUSG00000026121 Sema4c -0.226 0.57 0.43 0.85 0.15 
ENSMUSG00000060487 Samd5 -0.226 0.66 0.34 0.95 0.05 
ENSMUSG00000073700 Klhl21 -0.225 0.62 0.38 0.89 0.11 
ENSMUSG00000070056 Mfhas1 -0.225 0.64 0.36 0.97 0.03 
ENSMUSG00000031016 Wee1 -0.223 0.69 0.31 1.00 0.00 
ENSMUSG00000020605 Hs1bp3 -0.223 0.69 0.31 1.00 0.00 
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Ensembl Name Gene Name Delta value 
Control 
-Poly(A) 
Control 
+Poly(A) 
PostOA 
-Poly(A) 
PostOA 
+Poly(A) 
ENSMUSG00000031823 Zdhhc7 -0.220 0.53 0.47 0.80 0.20 
ENSMUSG00000030610 Det1 -0.219 0.73 0.27 0.98 0.02 
ENSMUSG00000028453 Fancg -0.218 0.61 0.39 0.93 0.07 
ENSMUSG00000008855 Hdac5 -0.218 0.70 0.30 1.00 0.00 
ENSMUSG00000008140 Emc10 -0.215 0.66 0.34 0.93 0.07 
ENSMUSG00000034121 Mks1 -0.214 0.68 0.32 0.99 0.01 
ENSMUSG00000031574 Star -0.214 0.70 0.30 0.94 0.06 
ENSMUSG00000040675 Mthfd1l -0.212 0.63 0.37 0.94 0.06 
ENSMUSG00000008730 Hipk1 -0.212 0.62 0.38 0.88 0.12 
ENSMUSG00000029622 Arpc1b -0.212 0.24 0.76 0.65 0.35 
ENSMUSG00000022722 Arl6 -0.211 0.46 0.54 0.71 0.29 
ENSMUSG00000003166 Dgcr2 -0.211 0.66 0.34 0.93 0.07 
ENSMUSG00000032128 Robo3 -0.211 0.67 0.33 0.95 0.05 
ENSMUSG00000063145 Bbs5 -0.211 0.59 0.41 0.77 0.23 
ENSMUSG00000022964 Tmem50b -0.209 0.67 0.33 0.95 0.05 
ENSMUSG00000037656 Slc20a2 -0.209 0.68 0.32 0.99 0.01 
ENSMUSG00000045639 Zfp629 -0.208 0.72 0.28 1.00 0.00 
ENSMUSG00000037373 Ctbp1 -0.208 0.52 0.48 0.68 0.32 
ENSMUSG00000030554 Synm -0.207 0.63 0.37 0.88 0.12 
ENSMUSG00000040860 Crocc -0.207 0.56 0.44 0.84 0.16 
ENSMUSG00000062270 Morf4l1 -0.207 0.55 0.45 0.75 0.25 
ENSMUSG00000075254 Heg1 -0.207 0.68 0.32 0.91 0.09 
ENSMUSG00000029108 Pcdh7 -0.207 0.75 0.25 1.00 0.00 
ENSMUSG00000027748 Trpc4 -0.206 0.70 0.30 0.96 0.04 
ENSMUSG00000029561 Oasl2 -0.206 0.75 0.25 0.96 0.04 
ENSMUSG00000013846 St3gal1 -0.206 0.73 0.27 0.98 0.02 
ENSMUSG00000051390 Zbtb22 -0.206 0.58 0.42 0.89 0.11 
ENSMUSG00000048486 Fitm2 -0.205 0.65 0.35 0.88 0.12 
ENSMUSG00000068099 1500009C09Rik -0.205 0.67 0.33 0.90 0.10 
ENSMUSG00000046722 Cdc42se1 -0.205 0.59 0.41 0.84 0.16 
ENSMUSG00000078350 Smim1 -0.205 0.72 0.28 1.00 0.00 
ENSMUSG00000021953 Tdh -0.204 0.62 0.38 1.00 0.00 
ENSMUSG00000021959 Lats2 -0.204 0.67 0.33 0.87 0.13 
ENSMUSG00000038074 Fkbp14 -0.204 0.72 0.28 0.94 0.06 
ENSMUSG00000004846 Plod3 -0.203 0.77 0.23 1.00 0.00 
ENSMUSG00000031714 Gab1 -0.202 0.63 0.37 0.90 0.10 
ENSMUSG00000041815 Poldip3 -0.202 0.68 0.32 0.93 0.07 
ENSMUSG00000048706 Lurap1l -0.201 0.64 0.36 0.86 0.14 
ENSMUSG00000063524 Eno1 -0.201 0.61 0.39 0.87 0.13 
ENSMUSG00000022636 Alcam -0.201 0.72 0.28 0.96 0.04 
ENSMUSG00000060601 Nr1h2 -0.201 0.58 0.42 0.76 0.24 
ENSMUSG00000020413 Hus1 -0.201 0.70 0.30 0.92 0.08 
ENSMUSG00000033396 Spg11 -0.201 0.68 0.32 0.95 0.05 
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Ensembl Name Gene Name Delta value 
Control 
-Poly(A) 
Control 
+Poly(A) 
PostOA 
-Poly(A) 
PostOA 
+Poly(A) 
ENSMUSG00000078970 Wdr92 -0.200 0.73 0.27 0.96 0.04 
ENSMUSG00000031654 Cbln1 -0.200 0.39 0.61 0.62 0.38 
ENSMUSG00000030035 Wbp1 -0.200 0.68 0.32 0.99 0.01 
ENSMUSG00000074129 Rpl13a 0.201 0.80 0.20 0.61 0.39 
ENSMUSG00000061360 Phf5a 0.202 0.70 0.30 0.51 0.49 
ENSMUSG00000021916 Glt8d1 0.204 0.75 0.25 0.58 0.42 
ENSMUSG00000059060 Rad51b 0.206 0.98 0.02 0.71 0.29 
ENSMUSG00000034278 Dnajc17 0.208 0.76 0.24 0.55 0.45 
ENSMUSG00000025147 Mob2 0.208 0.82 0.18 0.59 0.41 
ENSMUSG00000020440 Arf5 0.211 0.56 0.44 0.38 0.62 
ENSMUSG00000098090 2700099C18Rik 0.212 0.85 0.15 0.61 0.39 
ENSMUSG00000071662 Polr2g 0.213 0.73 0.27 0.57 0.43 
ENSMUSG00000076615 Ighg3 0.214 0.85 0.15 0.62 0.38 
ENSMUSG00000062275 Fbxw24 0.214 0.87 0.13 0.62 0.38 
ENSMUSG00000024772 Ehd1 0.216 0.90 0.10 0.69 0.31 
ENSMUSG00000033981 Gria2 0.216 0.89 0.11 0.67 0.33 
ENSMUSG00000024601 Isoc1 0.218 0.81 0.19 0.60 0.40 
ENSMUSG00000095595 Fam177a 0.219 0.68 0.32 0.46 0.54 
ENSMUSG00000030534 Vps33b 0.221 0.79 0.21 0.55 0.45 
ENSMUSG00000030316 Tamm41 0.223 0.90 0.10 0.66 0.34 
ENSMUSG00000030877 4933427G17Rik 0.224 0.75 0.25 0.54 0.46 
ENSMUSG00000076613 Ighg2b 0.225 0.80 0.20 0.55 0.45 
ENSMUSG00000032288 Imp3 0.228 0.77 0.23 0.56 0.44 
ENSMUSG00000053565 Eif3k 0.233 0.86 0.14 0.65 0.35 
ENSMUSG00000020018 Snrpf 0.235 0.47 0.53 0.27 0.73 
ENSMUSG00000023048 Prr13 0.235 0.88 0.12 0.58 0.42 
ENSMUSG00000025580 Eif4a3 0.235 0.82 0.18 0.57 0.43 
ENSMUSG00000066551 Hmgb1 0.237 0.80 0.20 0.56 0.44 
ENSMUSG00000022476 Polr3h 0.238 0.87 0.13 0.57 0.43 
ENSMUSG00000032839 Trpc1 0.238 0.85 0.15 0.56 0.44 
ENSMUSG00000001018 Snapin 0.240 0.86 0.14 0.61 0.39 
ENSMUSG00000031840 Rab3a 0.244 0.93 0.07 0.65 0.35 
ENSMUSG00000005161 Prdx2 0.244 0.77 0.23 0.54 0.46 
ENSMUSG00000029524 Sirt4 0.261 0.76 0.24 0.41 0.59 
ENSMUSG00000003824 Syce2 0.264 0.83 0.17 0.56 0.44 
ENSMUSG00000024863 Mbl2 0.268 0.87 0.13 0.58 0.42 
ENSMUSG00000029465 Arpc3 0.268 0.80 0.20 0.48 0.52 
ENSMUSG00000045690 Wdr89 0.269 0.81 0.19 0.60 0.40 
ENSMUSG00000029649 Pomp 0.269 0.88 0.12 0.64 0.36 
ENSMUSG00000085427 6430710C18Rik 0.274 0.82 0.18 0.57 0.43 
ENSMUSG00000041571 Sepw1 0.282 0.91 0.09 0.57 0.43 
ENSMUSG00000096262  0.289 0.74 0.26 0.48 0.52 
ENSMUSG00000037966 Ninj1 0.295 0.64 0.36 0.37 0.63 
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Ensembl Name Gene Name Delta value 
Control 
-Poly(A) 
Control 
+Poly(A) 
PostOA 
-Poly(A) 
PostOA 
+Poly(A) 
ENSMUSG00000036845 Lin37 0.296 0.81 0.19 0.51 0.49 
ENSMUSG00000067702 Tuba3a 0.299 0.68 0.32 0.46 0.54 
ENSMUSG00000076937 Iglc2 0.300 0.55 0.45 0.29 0.71 
ENSMUSG00000024406 Pou5f1 0.303 0.62 0.38 0.34 0.66 
ENSMUSG00000035112 Wnk4 0.304 0.85 0.15 0.52 0.48 
ENSMUSG00000045435 Tmem60 0.315 0.93 0.07 0.58 0.42 
ENSMUSG00000073016 Uprt 0.323 0.95 0.05 0.64 0.36 
ENSMUSG00000043923 Ccdc84 0.327 0.74 0.26 0.47 0.53 
ENSMUSG00000000088 Cox5a 0.327 0.86 0.14 0.52 0.48 
ENSMUSG00000021807 2700060E02Rik 0.338 0.75 0.25 0.41 0.59 
ENSMUSG00000010057 Nprl2 0.356 0.90 0.10 0.52 0.48 
ENSMUSG00000021660 Btf3 0.421 0.77 0.23 0.32 0.68 
ENSMUSG00000049214 Skint7 0.749 0.89 0.11 0.15 0.85 
 
 
 
Table S6: Poly(A) tail ePAT analysis of single genes from control and postovulatory-aged oocytes on an 
Agilent DNA chip.Indicated is the gene symbol, the region of interest used for the assessment, the treatment of 
the oocytes, the average fragment size and the DNA concentration within the region. 
Gene 
Region (bp) 
Oocytes Average  fragment size (bp) 
Concentration 
(ng/µl) from to 
Btf3 130 500 
Control 218 8.85 
PostOA 228 6.88 
Prdx2 360 700 
Control 429 1.08 
PostOA 471 1.01 
Ddx3x 500 1000 
Control 617 2.55 
PostOA 612 2.40 
Nupr1 220 400 
Control 270 3.28 
PostOA - - 
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Table S7: DNA methylation levels of Pou5f1 of control and 3 days preovulatory-aged embryos. Indicated is 
the MID of each embryo used for the deep bisulfite-sequencing and the methylation levels [%] of the maternal 
and paternal allel, as well as the mean methylation level over both alleles. Aberrant DNA methylation is 
indicated in red. 
Control embryos Preovulatory-aged embryos 
MID Maternal Paternal Mean MID Maternal Paternal Mean 
1 50 21 25.0 6    
2  5  7 0 0 0.0 
3 0 0 0.0 8 0 0 0.0 
4 1 5 3.0 9 0 0 0.0 
5 0 0 0.0 10 0 0 0.0 
11 8 8 8.0 16 0 0 0.0 
12 0 0 0.0 17    
13 0 0 0.0 18 5   
14 3 22 12.5 19 0 0 0.0 
15 0 0 0.0 20 0 0 0.0 
21 8 10 9.0 26 0 0 0.0 
22 0 0 0.0 27 9 21 15.0 
23  0  28 0 0 0.0 
24 0 0 0.0 29 0 0 0.0 
25 17 5 11.0     
Mean 6.7 5.1 6.1 Mean 1.2 1.9 1.4 
 
 
 
Table S8: DNA methylation levels of H19 of control and 3 days preovulatory-aged embryos. Indicated is 
the MID of each embryo used for the deep bisulfite-sequencing and the methylation levels [%] of the maternal 
and paternal allel, as well as the mean methylation level over both alleles. Aberrant DNA methylation is 
indicated in red. 
Control embryos Preovulatory-aged embryos 
MID Maternal Paternal Mean MID Maternal Paternal Mean 
1 52 77 64.5 6 23 92 57.5 
2 15 89 52.0 7 16 87 51.5 
3 13 85 49.0 8 10 85 47.5 
4  100  9 28 90 59.0 
5 20 91 55.5 10 7 77 42.0 
11 7 77 42.0 16 10 83 46.5 
12 11 74 42.5 17 13 89 51.0 
13 10 64 37.0 18 14 91 52.5 
14 4 80 42.0 19 11 88 49.5 
15 19 91 55.0 20 4 56 30.0 
21 22 84 53.0 26 0   
22 9 89 49.0 27 4 72 38.0 
23    28 0   
24 22 86 54.0 29 4 54 29.0 
25        
Mean 17.0 83.6 49.6 Mean 10.3 80.3 46.2 
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Table S9: DNA methylation levels of Snrpn of control and 3 days preovulatory-aged embryos. Indicated is 
the MID of each embryo used for the deep bisulfite-sequencing and the methylation levels [%] of the maternal 
and paternal allel, as well as the mean methylation level over both alleles. Aberrant DNA methylation is 
indicated in red. 
Control embryos Preovulatory-aged embryos 
MID Maternal Paternal Mean MID Maternal Paternal Mean 
1 48 23 35.5 6  7  
2 93   7  0  
3 93   8 76 21 48.5 
4 41 15 28.0 9 70 14 42.0 
5  0  10 75 23 49.0 
11 79 23 51.0 16 83 28 55.5 
12 62 16 39.0 17 84 15 49.0 
13 70 19 44.5 18 75 25 50.0 
14 85 28 56.5 19 86 35 60.5 
15 80 27 53.5 20 78 34 56.0 
21 41 15 28.0 26 55 8 31.5 
22 51 33 42.0 27 85 25 55.0 
23 81 26 53.5 28    
24 58 16 37.0 29  0  
25 73 19 46.0     
Mean 68.2 20.0 42.9 Mean 76.7 17.2 49.8 
 
 
 
Table S10: DNA methylation levels of Igf2r of control and 3 days preovulatory-aged embryos. Indicated is 
the MID of each embryo used for the deep bisulfite-sequencing and the methylation levels [%] of the maternal 
and paternal allel, as well as the mean methylation level over both alleles. Aberrant DNA methylation is 
indicated in red. 
Control embryos Preovulatory-aged embryos 
MID Maternal Paternal Mean MID Maternal Paternal Mean 
1 48 7 27.5 6 85 7 46.0 
2 99   7 90 8 49.0 
3 95 8 51.5 8 91 6 48.5 
4  0  9 92   
5 88 7 47.5 10 99   
11 92 8 50.0 16  0  
12 92 7 49.5 17  3  
13 85 10 47.5 18    
14  0  19 81 5 43.0 
15 87 8 47.5 20 93 9 51.0 
21 94 12 53.0 26  0  
22 90 9 49.5 27  5  
23 79   28    
24 91 14 52.5 29 89   
25 93       
Mean 87.2 7.5 47.6 Mean 90.0 4.8 47.5 
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